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Abstract 
Preventing nosocomial skin injury in vulnerable acute care patients presents 
an ongoing challenge for clinicians. Threats to skin integrity in the acute hospital 
patient are complex, multidimensional, and inter-related, with a range of potential 
skin injuries the result. Incontinence-associated dermatitis (IAD) is one such skin 
injury, caused by chronic skin exposure to urine and/or faeces as a result of 
incontinence. This complex and painful condition presents with erythema, with or 
without blisters, erosion, or serous exudate. IAD can predispose to superficial 
pressure injury and/or Candida infection. It is a painful, debilitating condition, that 
can affect patient wellbeing, impact on the complexity and cost of care, increase the 
length of hospital stay, and expose patients to the risk of serious complications. 
These complications include susceptibility to developing a perineal infection 
(commonly with Candida albicans) or a pressure injury (PI).   
However, despite the risks and challenges associated with IAD, there is a gap 
in understanding the extent of the risk and burden of IAD, in the general acute care 
setting, with no prevalence data available in Australia, and limited prevalence data 
available internationally. Furthermore, the natural history of the condition is not well 
understood, with a gap evident in the understanding of the epidemiology of Candida 
colonisation associated with IAD and incontinence, or the role of colonisation in the 
pathogenesis of IAD. 
The literature review revealed that there was no comprehensive, conceptual 
skin injury framework available to guide this research. A multitude of skin injury-
specific conceptual frameworks and consensus documents that address a range of 
nosocomial skin injuries, including IAD exist. However, a framework underpinned 
by the overarching concept of keeping skin safe from nosocomial injury in 
vulnerable, older hospital patients was lacking.  
The broad aim of this thesis was to explore the phenomenon of incontinence-
associated dermatitis (IAD) in the acute care setting. This involved an investigation 
of the prevalence of IAD in an Australian hospital, and also an examination of the 
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epidemiology of Candida colonisation and infection associated with continence 
status and IAD in acute care patients. Furthermore, this research aimed to present a 
new conceptual model in which to reconceptualise the phenomenon of IAD within 
the broader domain of maintaining skin integrity in this setting. An additional aim of 
the research was to test key constructs (selected based on gaps in the research) of the 
proposed model  
The Skin Safety Model (SSM) was developed in response to the lack of a 
unified skin integrity framework. This unique model reconceptualises skin integrity 
into a single framework. The model encompasses the multidimensional and inter-
related antecedents of injury, and positions the patient experience of a skin injury as 
the primary outcome. The SSM shows great promise in providing a new 
comprehensive theory with which to address the challenges of maintaining skin 
integrity for older adults in contemporary hospitals. The model is based on empirical 
research and expert consensus, so the constructs included in the model are valid and 
well-supported by evidence. The SSM is presented in Publication 1 of this thesis. 
The specific aims of two studies utilising a quantitative methodology were to: 
i) determine the prevalence of incontinence and IAD in the acute care setting; ii) 
describe the products worn to manage incontinence, and the products provided at the 
bedside for perineal skin care; iii) determine estimates of Candida colonisation in 
continent compared to incontinent patients, as well as those with IAD; iv) investigate 
the association between Candida colonisation and clinical presentation of IAD at 
hospital admission; and v) investigate risk factors associated with Candida 
colonisation. A further aim of this thesis was to test a number of the constructs and 
associations in the new conceptual model with the specific research questions of the 
two studies.  
To address the gap in understanding of the prevalence of IAD in the 
Australian acute care setting, Study 1 investigated the prevalence of IAD and 
incontinence in a major tertiary hospital in Australia. This study utilised a cross-
sectional observational design and found that the prevalence of incontinence was 
24%, with IAD present in 42% of those who were incontinent. Furthermore, Study 1 
found that the prevalence of Candida infection in those with IAD was 32%. These 
results provide convincing evidence that incontinence and IAD constitute a 
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substantial threat to skin integrity in the acute care setting. Study 1 gave rise to 
Publications 2 and 3. 
The combined IAD and annual PI survey protocol provided a unique 
opportunity to collect previously unrecorded, and, therefore, unrecognised 
incontinence and IAD data. Publication 3 presents the PI and IAD prevalence results 
from surveys before and after the introduction of the combined survey protocol. The 
surveys were conducted between 2009 and 2013, with the combined PI and IAD 
surveys undertaken from 2011-2013. PI prevalence in 2009 was 13% and decreased 
to 6% in 2013. IAD prevalence (calculated for the entire sample) was 10% in 2011, 
3.6% in 2012 and 2.7% in 2013. The practicable and effective combined survey 
procedure was subsequently adopted by the facility as a standard protocol. 
Publication 3 presents the protocol, the PI and IAD prevalence rates before and after 
the introduction of the combined survey protocol, and highlights the sustained 
decrease in IAD and PI prevalence over time. In addition, Publication 3 presents a 
range of important issues that have clinical and practical implications for the conduct 
of future IAD prevalence surveys.  
To address the gap in the understanding of the epidemiology of Candida 
colonisation associated with incontinence and IAD, Study 2 of this research program 
compared Candida colonisation rates between continent and incontinent patients and 
those with IAD. It recruited a purposive sample in three groups: continent; 
incontinent of urine; and incontinent of urine and faeces. The study, a pilot cross-
sectional, observational design was conducted in the medical wards of a major 
tertiary hospital. This study found that on admission there was a non-significant trend 
towards greater Candida colonisation at the perianal site in incontinent patients 
(43%) than in continent patients (28%), with a similar non-significant trend found at 
the inguinal site for incontinent patients (24%), compared to continent patients 
(14%). No significant association was found between Candida colonisation and the 
clinical presentation of incontinence-associated dermatitis at hospital admission. The 
results of Study 2 are presented in Publication 4. This unique study is the first to 
provide data to fill the gap in the understanding of the epidemiology of Candida 
colonisation in these patients.  
While the risk factors for Candida infection have been explored in a variety 
of patient groups, there is limited understanding of the risk factors for Candida 
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colonisation. It is known that colonisation is a prerequisite for infection; therefore, 
understanding the risks for colonisation may help to identify patients at risk of 
subsequent Candida infection. In response to the gap in the understanding of risk 
factors for Candida colonisation factors, Publication 5 reports on the analyses 
undertaken to investigate associations between Candida colonisation, and age, 
gender, administration of antibiotics, diabetes, body mass index (BMI), faecal quality 
and frequency, nutritional, or mobility status. No significant association between 
colonisation and gender, mobility, nutritional status, faecal frequency and quality, 
treatment with antibiotics, diabetes (Type 1 or 2), age, or BMI was demonstrated. 
However, there was a non-significant trend towards the association between 
colonisation and greater antibiotic use, poorer nutritional status, and greater mobility 
limitation in the colonised group. 
Maintaining skin integrity in the acute care setting, while a patient safety 
imperative, is complex, costly and challenging. The SSM provides a unique, 
integrated framework to guide skin integrity care in a holistic, comprehensive way. 
Furthermore, the research in this thesis tested a number of constructs in the SSM, 
with Study 1 and 2 finding significant results that supported the inclusion of several 
constructs in the model and confirming its validity. As a result of the exploration of 
one specific skin injury, IAD, in the present studies testing of all the constructs of the 
model was outside the scope of the research program.  
This thesis makes several important contributions to the understanding of the 
phenomenon of IAD in the acute care setting. The findings of Study 1 provide 
compelling and previously unrecognised evidence that incontinence and IAD pose a 
considerable threat to skin integrity in acute care patients. Study 2 has contributed 
important and also previously unrecognised evidence regarding patterns of Candida 
colonisation according to continence and IAD status in acute care medical patients. 
Furthermore, the SSM reconceptualises the maintenance of skin integrity in acute 
care into a comprehensive and unified framework. By improving the understanding 
of IAD, and presenting a new skin integrity framework, this research contributes to 
the overall goal of maintaining skin integrity in the acute care setting. In addition, the 
research program enabled several recommendations to be made in regard to the need 
to adopt the constructs of the SSM in order to provide more comprehensive and 
holistic skin integrity care, the imperative to collect IAD and incontinence data to 
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improve understanding of the scope of these threats, and to align national skin 
integrity policy with the comprehensive framework proposed in this research. 
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A Note Regarding Format  
This dissertation is a thesis by publication. It contains five publications that 
have been published or are under blind-peer review by refereed journals; therefore, 
the wording in the journal publications are as published. The logical flow of the 
thesis is maintained by introducing these articles where they fit most appropriately 
into the thesis structure. All articles have been reformatted using APA referencing 
style and reconfigured to Word to provide consistent formatting throughout the 
thesis. Moreover, a continuous numbering system was applied to the tables and 
figures for consistency. 
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1 
Chapter 1:  INTRODUCTION 
1.1 BACKGROUND 
Threats to skin integrity in the acute hospital patient are complex, 
multidimensional, and inter-related, with a range of potential skin injuries the result. 
Incontinence-associated dermatitis (IAD) is one such skin injury, caused by chronic 
skin exposure to urine and/or faeces as a result of incontinence (Beeckman et al., 
2015; Doughty et al., 2012; Gray et al., 2007). This complex and painful condition 
presents with erythema, with or without blisters, erosion, or serous exudate. IAD can 
predispose to superficial pressure injury and/or Candida infection. It is a painful, 
debilitating condition, that can affect patient wellbeing, impact on the complexity 
and cost of care, increase the length of hospital stay, and expose patients to the risk 
of serious complications. These complications include susceptibility to developing a 
perineal infection (commonly with Candida albicans) or a pressure injury (PI) 
(Beeckman, Van Lancker, Van Hecke, & Verhaeghe, 2014; Black et al., 2011; 
Gefen, 2014; Gray et al., 2007).  
IAD and its complications pose a significant risk to the skin integrity and 
quality of life of acute care patients, as well as posing a considerable challenge for 
healthcare providers by way of prevention and management. However, despite the 
risks and challenges associated with IAD, there remains a gap in the understanding 
of the burden of IAD in the acute care setting, with no prevalence data available for 
the Australian setting. Internationally, the prevalence of IAD is reported to range 
from 20% to 50%; however, much of this data is drawn from the long-term and 
critical care settings (Arnold-Long, Reed, Dunning, & Ying, 2009; Bliss & Powers, 
2011; Driver, 2007; Junkin & Selekof, 2007). The primary risk factor for developing 
IAD is incontinence (Beeckman et al., 2015), a condition common in older adults 
(Australian Institute of Health and Welfare, 2014; Lakhan et al., 2011). Incontinence 
is defined as the accidental or involuntary loss of urine from the bladder and/or 
faeces from the bowel (Abrams et al., 2010; Ahmed & Pearce, 2010; Homma, 2008; 
Inouye et al., 2007; Junkin & Selekof, 2007). 
The prevalence of incontinence in the acute care setting is reported to range 
from 10%-43% for urinary incontinence, and 7%-33% for faecal incontinence 
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(Australian Institute of Health and Welfare, 2014; Ostaszkiewicz, et al., 2008). As a 
consequence of the high prevalence of incontinence, a high proportion of acute care 
patients are exposed to skin contact with urine and faeces, and are subsequently at 
risk of IAD and its complications (Ersser, Getliffe, D.Voegeli, & Regan, 2005).  
Compelling arguments exist for improving the understanding of the 
prevalence of skin injuries in the acute care setting. Similar to the limited 
understanding of the prevalence of IAD in the acute care setting, there is little 
understanding of the epidemiology of Candida colonisation or infection in relation to 
continence status and IAD in the acute care setting. Infection with Candida is 
accepted as a common complication of IAD (Black et al., 2011; Doughty et al., 2012; 
Gray et al., 2007). Candida species (spp.) are common human fungal commensal 
organisms, which, in certain situations, can transform from harmless commensal to 
pathogen, resulting in serious invasive infections, or more commonly, superficial 
mucocutaneous infection (Charles et al., 2005; Clancy & Nguyen, 2012; Fidel, 1999; 
Odds, 1988). Reported predisposing factors for Candida spp. infections in the 
gastrointestinal or genitourinary tract include mucosal barrier impairment, extremes 
of age, female gender, administration of antimicrobial agents, diabetes, and the 
presence of increased bowel movements (Dorko, Virágová, & Pilipčinec, 2003; 
Fidel, 1999; Moran, Coleman, & Sullivan, 2012; Raz-Pasteur, Ullmann, & 
Berdicevsky, 2011). Despite the general acceptance of Candida infections as a 
complication of IAD (Black et al., 2011; Doughty et al., 2012; Gray et al., 2007), 
there remains a paucity of data explaining the prevalence of Candida colonisation in 
these patients, as well as empirical evidence to quantify the prevalence of Candida 
infection associated with IAD and incontinence.  
One of the reasons for the lack of microbiological data reporting on the 
epidemiology of incontinence and IAD-associated Candida infections may be due in 
part to the common clinical practice of presumptive diagnosis based on skin 
assessment, followed by empirical treatment, without microbiological confirmation 
of the pathogen. Consequently, a significant gap exists in the understanding of the 
epidemiology of these incontinence and IAD-associated Candida infections 
(Foureur, Vanzo, Meaume, & Senet, 2006). It is understood that skin colonisation 
with Candida is a necessary precedent to mucosal infection (Moran et al., 2012); 
therefore, a prerequisite for understanding the epidemiology of Candida infections 
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associated with incontinence and IAD is an understanding of Candida colonisation in 
both continent and incontinent adults, and those with IAD. Further, the aetiological 
role of Candida in IAD has had limited empirical consideration in the adult 
population (Foureur et al., 2006). 
In contrast to adult IAD, Candida albicans has been reported to have an 
aetiological role in paediatric diaper dermatitis. One paediatric study reported that 
Candida colonisation was significantly more common in the perianal skin, inguinal 
folds, and mouths of infants with diaper dermatitis, compared to infants without 
diaper dermatitis (Ferrazzini et al., 2003). Moreover, this study revealed that in 
infants with diaper dermatitis, higher levels of Candida colonisation correlated with 
diaper dermatitis severity (Ferrazzini et al., 2003). While paediatric data should not 
be extrapolated to adults due to differences in skin physiology, health status, and 
medications, the paediatric data does point to a potential role of Candida colonisation 
in the pathogenesis of IAD. Overall, understanding patterns of Candida colonisation 
and infection in these patients will contribute to the goal of maintaining skin integrity 
in the hospital setting. 
Skin integrity breaches have the potential to cause significant morbidity and 
mortality. The ability of skin to perform its multiple, complex, and life-sustaining 
functions depends on the maintenance of its integrity (Di Meglio, Perera, & Nestle, 
2011; Farage, Miller, Elsner, & Maibach, 2008). Threats to skin integrity are diverse, 
with intrinsic threats (particularly prevalent in individuals aged 65 years and older) 
arising from changes associated with ageing, mobility, continence, nutrition, and 
cognition, as well as the presence of multiple co-morbidities and polypharmacy 
(Inouye et al., 2007; Lakhan et al., 2011). Extrinsic threats to skin integrity arise 
from excess pressure, shear, friction and exposure to skin irritants, such as urine, 
faeces, and excess moisture. In addition, interaction with the healthcare environment, 
particularly acute care, can present multi-dimensional and complex difficulties (such 
as access to adequate nutrition, mobility limitations, alterations in continence status 
and unfamiliar environments)  in maintaining skin integrity for the older patient,  and 
for those managing their healthcare (Agarwal et al., 2012; Carville, 2012; Gray et al., 
2012; Inouye et al., 2007; LeBlanc & Baranoski, 2011). When these multiple 
intrinsic and extrinsic threats interact, older acute care patients can become 
vulnerable to a range of nosocomial skin injuries (Australian Wound Management 
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Association, 2012; Black et al., 2011; Carville, 2012; Coleman et al., 2013; Gray, 
2007; Inouye et al., 2007; Lakhan et al., 2011; LeBlanc & Baranoski, 2011; 
McNichol, Lund, Rosen, & Gray, 2013; National Pressure Ulcer Advisory, European 
Pressure Ulcer Advisory, & Pan Pacific Pressure Injury, 2014).  
The term ‘nosocomial’ is defined as a disease or condition originating in a 
hospital (Martin, 2015); a nosocomial skin injury is, therefore, a skin injury acquired 
during an episode of hospital care. Maintaining skin integrity and preventing 
nosocomial skin injuries forms an integral component of safe and high quality 
healthcare, and is a priority in the patient safety mandate (Bry, Buescher, & Sandrik, 
2012). The genesis of innovative solutions for maintaining skin integrity may be 
found in the development of new theories that integrate contemporary evidence into 
broad, overarching health service frameworks. These comprehensive frameworks 
will be more representative of the complexities and needs of the 21st century patient 
(Shortell &Singer, 2008). Currently, a plethora of skin-injury specific models that 
address IAD, skin tears, medical adhesive-related skin injury, peri-stomal or peri-
wound moisture-associated skin damage, and intertriginous dermatitis guide skin 
integrity care in the acute care setting (Beeckman et al., 2015; Black et al., 2011; 
Carville et al., 2007; Doughty et al., 2012; Gray et al., 2007; Gray et al., 2011; 
LeBlanc & Baranoski, 2014; McNichol et al., 2013) (Beeckman et al., 2015; Black et 
al., 2011; LeBlanc & Baranoski, 2011; McNichol et al., 2013). These skin injuries 
cannot be neatly separated into distinct prevention and management silos. The 
complex, multidimensional and overlapping predisposing factors for skin injury 
mean that it is timely to reconconceptualise IAD, PIs, skin tears, and other 
nosocomial skin injuries into a unified, comprehensive skin integrity framework. 
Such a framework may have important benefits for patients and healthcare providers 
alike, possibly identifying previously unrecognised connections, relationships, and 
innovative solutions to skin integrity challenges.  
This thesis proposes a new skin safety conceptual framework that 
encompasses multiple factors: the healthcare system, the patient, and situational 
stressors, as well as a multitude of skin injuries that may subsequently result. 
Adopting an overarching skin safety concept (rather than the concept of separate 
unrelated injuries) is timely given the challenges faced by healthcare providers in 
relation to the rapidly ageing population. The proposed framework, acknowledges 
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specific skin injuries, and reconceptualises these injuries within the broader 
framework of maintaining skin integrity, while situating the patient experience of a 
skin injury as the central outcome. This comprehensive approach to skin integrity 
may have the potential to improve patient outcomes, as well as improve healthcare 
effectiveness and efficiency in relation to delivering safe skin care to vulnerable 
patients. 
Globally, populations are ageing (United Nations, 2011; World Health 
Organisation, 2011). Ageing is accompanied by an increase in chronic disease, 
disability and the development of geriatric syndromes, for example, incontinence, PI, 
cognitive impairment or falls (Ezeh, Bongaarts, & Mberu, 2012; Inouye, Studenski, 
Tinetti, & Kuchel, 2007; Lakhan et al., 2011; Levant, Chari & DeFrancis, 2015; 
Scommegna, 2012; Sourdet et al., 2015; World Health Organisation, 2011; Zisberg, 
Shadmi, Gur‐Yaish, Tonkikh, & Sinoff, 2015). A significant consequence of the 
increase in complex and chronic health conditions associated with ageing is 
increased healthcare and hospital utilisation by older adults (United Nations, 2011; 
World Health Organisation, 2011). In Australia, between 2013-2014, 40% of 
hospitalisations were for people 60 years and older, yet this group accounted for only 
13% of Australia’s population (Australian Government, 2016). The increasing 
hospital utilisation by older adults means that consequently, the prevalence of 
patients with associated geriatric syndromes such as incontinence is likely to 
increase. This means that in the future, as a result of the increased prevalence of 
incontinence, the prevalence of IAD will also be likely to increase. Therefore, an 
urgent imperative exists to improve understanding of the prevalence of IAD, its 
pathogenesis, and the natural history of Candida colonisation and infections. This 
improved understanding of these dimensions of IAD will inform the development of 
innovative and effective IAD prevention and management strategies, and more 
broadly, inform the goal of maintaining skin integrity in acute care patients.  
Internationally, the most widely recognised nosocomial skin injury is a PI, 
with hospital acquired prevalence ranging from 6.4%-5% between 2006 to 2009 
respectively in the United States (Goldberg, 2012), 7%-9% between 2007-2011 
respectively in Australia (Mulligan, Prentice & Scott, 2011), and an overall 
prevalence of 18% in Europe and the United Kingdom in 2007 (Vanderwee, Clark, 
Dealey, Gunningberg & Defloor, 2007). Considered to be largely preventable, PIs 
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impact on morbidity, mortality, and service delivery in the acute care setting 
(National Pressure Ulcer Advisory, European Pressure Ulcer Advisory, & Pan 
Pacific Pressure Injury, 2014). While pressure injuries are regarded as nosocomial 
injuries, and subsequently reported as adverse events, other nosocomial skin injuries 
such as IAD or skin tears are rarely reported as adverse events, and in some 
situations are even considered to be an inevitable consequence of ageing (Carville, 
Leslie, Osseiran-Moisson, Newall, & Lewin, 2014; White, 2001). Categorising these 
skin injuries as inevitable can mean that they may ultimately be under-recognised 
under-treated and result in adverse outcomes for patients and healthcare providers.  
Categorising these skin injuries as inevitable may partly explain the limited 
prevalence data available to inform an understanding of the burden of these injuries 
in the acute care setting. By comparison, there is a wealth of PI prevalence data 
available nationally and internationally (Mulligan, Prentice, & Scott, 2011; Pieper & 
National Pressure Ulcer Advisory, 2012). In Western Australia, innovative, state-
wide wound prevalence surveys were undertaken between 2007 and 2011 by 
WoundsWest, to determine the prevalence of wounds (including hospital acquired, 
surgical and chronic wounds) in public hospitals (Mulligan et al., 2011). These 
surveys reported that the prevalence of hospital-acquired PIs in Western Australia 
ranged from 9% in 2008 to 6% in 2009 and 7% in 2011. 
PI prevalence data forms an essential component of the quality and safety 
mandate (Baharestani et al., 2010; Pieper & National Pressure Ulcer Advisory, 
2012); therefore, comparison of PI prevalence is common, within facilities over time, 
and benchmarking with other facilities nationally and internationally. However, 
benchmarking other nosocomial skin injuries such as IAD or skin tears, either within 
injury categories, or to understand the prevalence of these injuries comparative to 
each other is not common practice. However, the WoundsWest surveys provide one 
of the few data sets that allow for comparison of the prevalence of PI and skin tears 
(Mulligan et al., 2011). In the same surveys, during the same period, the prevalence 
of hospital-acquired skin tears ranged between 6% and 7%. (Mulligan et al., 2011), 
revealing strikingly similar prevalence rates to PIs (6% - 9%) in those surveys. The 
WoundsWest surveys did not collect prevalence data for IAD (J. Prentice, personal 
communication, November 19, 2015), meaning that comparison of IAD, PI, and skin 
tear prevalence rates was not possible. One of the few acute care studies that allows 
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for comparison of IAD and PI prevalence rates revealed almost identical prevalence 
rates for PI (21.7% in incontinent patients) and IAD (20% in the same incontinent 
cohort) (Junkin & Selekof, 2007). The limited prevalence data available for these 
skin injuries may reflect their status as a lesser patient safety priority than PIs. 
However, the acute care prevalence data for these injuries (albeit limited) highlight 
that the burden of these other nosocomial skin injuries parallels the prevalence of PI, 
and constitute a serious threat to skin integrity in the acute care setting.  
IAD is a common, complex, and painful condition that results from 
incontinence, and can expose patients to serious complications, such as infection or 
PI. Substantial gaps in the understanding of the prevalence of IAD, incontinence, the 
epidemiology of Candida colonisation and infection highlight the urgent need to 
improve the empirical evidence related to these aspects of IAD and associated 
infection in order to advance the broader imperative of maintaining skin integrity in 
the acute care patient.  
1.2 SIGNIFICANCE AND SCOPE 
This research is significant in that it has provided the first empirical evidence 
of the prevalence of IAD in the Australian acute care setting. Until this study the 
prevalence of IAD in this setting was unknown, meaning that consequently this skin 
injury was under-reported and poorly understood, with health care providers unaware 
of the considerable threat to skin integrity that IAD poses for these patients. 
Prevalence data is essential to inform the delivery of quality healthcare, guide 
decision-making in relation to resource allocation, patient safety initiatives, clinical 
governance, and for tracking quality initiatives (Pieper, with the National Pressure 
Ulcer Advisory, 2012). Prior to this study, IAD was not a priority for patient safety 
in Australia. However, as a result of the research, IAD prevalence is now measured 
annually in the research facility, with the adoption of the protocol employed in the 
study. The research facility has also changed the terms of reference of its PI 
Prevention Committee to include all iatrogenic skin injuries, and has also renamed 
the committee, The Skin Safety Committee (personal communication, K. 
McDonough, 9 November, 2012). This means that IAD prevention and management 
have become a priority in maintaining skin integrity in this facility. Furthermore, the 
state-wide annual PI prevalence audit conducted by the Patient Safety and Quality 
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Improvement Service Clinical Excellence Division, as a result of the research, has 
added a category to its data collection instrument to identify the presence of IAD. 
In addition to understanding the prevalence of IAD, the research investigated 
a key aspect of one of the complications of IAD, namely infection. Candida albicans 
is the most common aetiological organism for IAD and incontinence-associated 
perineal infection, yet there is limited understanding of the epidemiology of Candida 
colonisation or infection in relation to continence status or IAD. This study has 
provided the first empirical research informing Candida colonisation patterns, 
association between Candida colonisation and clinical presentation of IAD, and risk 
factors for colonisation in these patients. This research identifies an important, 
potentially pathogenic Candida reservoir in these patients, advances the 
understanding of the epidemiology of Candida colonisation in patients with IAD, 
provides evidence regarding risk factors for colonisation, and provides a unique 
frame of reference for investigating the association between Candida and IAD. This 
data may in turn lead to improved understanding of the pathogenesis of Candida 
infection and IAD in incontinent patients. 
 Preventing nosocomial injury is an integral component of providing safe and 
high quality healthcare. In addition to the patient safety and quality healthcare 
mandate, the increasing cost and complexity of healthcare and the rapidly ageing 
population mean that there are multiple challenges, ultimately resulting in healthcare 
systems that are under considerable strain. Therefore, innovative solutions are 
required to meet these challenges to (The Health Roundtable, 2012). A new 
conceptual model is proposed, the Skin Safety Model (SSM), that encompasses 
multiple factors: the healthcare system, the patient, and situational stressors, skin 
injuries that may subsequently result and positions the patient experience of a skin 
injury as the primary outcome. Adopting a comprehensive and unified skin safety 
model is timely given the challenges faced by contemporary healthcare providers. 
This model may reduce duplication, omission or fragmentation of skin integrity care, 
guide healthcare providers in developing improved holistic models of skin integrity 
care, improve efficiencies and effectiveness, and ultimately assist in the 
improvement of patient outcomes.  
Key constructs of this model were empirically tested according to the gaps 
identified in the literature. It was outside the scope of this thesis to empirically test 
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all of the constructs of the model. However, several of the constructs of the model 
that were tested were found to be significant, providing empirical support for their 
inclusion.  
This research is significant in that it has contributed to the understanding of 
several aspects of the phenomenon of IAD in the acute care setting. As a result of the 
research, anecdotal evidence suggests that awareness of IAD as an important skin 
injury has increased in the research facility, and has been recognised as an important 
skin injury in the statewide PI prevalence audit. Improved understanding of the 
extent of IAD as well as patterns of Candida colonisation can, in turn, inform the 
development of appropriate and holistic prevention and management plans. The SSM 
proposed in this research provides a unique and comprehensive framework to guide 
skin integrity care, including the prevention and management of the phenomenon of 
IAD.  
1.3 AIMS AND RESEARCH QUESTIONS 
The broad aims of this thesis by publication were to explore the phenomenon of 
incontinence-associated dermatitis (IAD) in the acute care setting by investigating 
the prevalence of IAD in an Australian hospital, to gain an understanding of the 
products used for perineal skin care and incontinence containment, factors which 
may influence the development of IAD, and also to investigate the epidemiology of 
Candida colonisation and infection associated with continence status and IAD in 
acute care patients. Furthermore, this research aimed to present a new conceptual 
model in which to reconceptualise the phenomenon of IAD within the broader 
domain of maintaining skin integrity in this setting. An additional aim of the research 
was to test key constructs (selected based on gaps in the research) of the proposed 
model.  
Research Questions 
The research program was guided by the following questions:  
1. What is the prevalence of incontinence (urine and faecal) in the acute care 
setting? 
2. What is the prevalence of IAD in the acute care setting?  
 10                                                                                                                                                                                                 Chapter 1: Introduction
     
3. What are the products worn to manage incontinence, and the products 
provided at the bedside for perineal skin care?  
4. Is colonisation with Candida albicans more common at hospital admission in 
incontinent patients compared with continent patients? 
5. In incontinent patients (urinary and faecal), is there an association between 
Candida albicans colonisation and clinical presentation of IAD?  
6. In acute care medical patients, are gender, mobility, nutritional status, faecal 
frequency and quality, treatment with antibiotics, diabetes (Type 1 or 2), age, 
or body mass index (BMI) risk factors for Candida colonisation?  
1.4 OPERATIONAL DEFINITIONS 
There are several key terms that require explanation or definition at the outset 
of this research program, as follows: 
Candida albicans is the most common human fungal coloniser (Jarvis, 1996). 
Candida albicans can reside as an asymptomatic commensal organism in the rectum, 
vagina, and oral cavity. There are certain conditions in both host and pathogen under 
which Candida albicans can convert from harmless commensal to serious pathogen 
(Anaissie, Pfaller, & McGinnis, 2003; Fidel, 1999; Jarvis, 1996; Moran et al., 2012). 
Colonisation is defined as the presence, growth, and multiplication of a 
microorganism in or on a host, with no obvious clinical signs, symptoms, or immune 
response seen in the host at the time the microorganism is isolated. In many 
situations, colonisation is a necessary precursor to infection. (Fidel, 1999; Jarvis, 
1996) 
Commensal is defined as an association between two organisms whereby the 
commensal derives benefit from the association, but the host derives neither benefit 
nor harm (Singleton & Sainsbury, 2012). 
Faecal incontinence is defined as an involuntary loss of liquid or faeces 
ranging from minor faecal soiling, to urge incontinence, or passive faecal 
incontinence (Ahmed & Pearce, 2010)  
Incontinence is defined as the inability to control the flow of urine and/or 
stool any time in the preceding 24 hours (Junkin & Selekof, 2007).  
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        Incontinence-associated Candida infection 
The term incontinence-associated Candida infection is proposed and used 
throughout this thesis to ensure clarity with reference to incontinence, IAD, and 
Candida infections. Terms commonly used in the literature, such as secondary 
Candida infection or superimposed Candida infection imply a possible causal 
relationship between IAD and Candida infection; however, this relationship is 
uncertain.  
Urinary incontinence is defined as any involuntary loss of urine (Abrams et 
al., 2010). Urinary incontinence has multiple sub-categories, including stress, urge or 
mixed urinary incontinence, enuresis, nocturnal enuresis, continuous urinary 
incontinence, or disturbance in bladder sensation (Abrams et al., 2010; Homma, 
2008; Inouye et al., 2007). 
Incontinence-associated dermatitis (IAD) is defined as erythema and oedema 
on the surface of the skin, sometimes accompanied by bullae with serous exudate, 
erosion, or infection in response to chronic skin exposure to urine and or faeces 
(Doughty et al., 2012; Gray et al., 2007; Gray et al., 2012). 
1.5 THESIS OUTLINE 
This thesis is a body of original work presented in five publications. Each 
publication informs subsequent research, as well as being a unique contribution to 
knowledge in the field. The thesis is presented in 10 chapters (see Figure 1.1).  
Chapter 1, the introductory chapter, provides the background and significance 
of the research program. It details the research questions for the study phases and 
provides an overview of the research methods. 
Chapter 2 presents an examination of the literature related to the overarching 
concept of maintaining skin integrity (including the phenomenon of IAD) for older 
adults within the context of the challenges faced by providers of 21
st
 century 
healthcare. A narrative synthesis of the literature informed the development of a 
conceptual framework that underpins this thesis, and is presented in Publication 1:  
Campbell J., Coyer F., & Osborne S. (2016). The Skin Safety Model: 
Reconceptualising skin vulnerability in older patients. Journal of Nursing 
Scholarship, 48(1), 14-22. 
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Chapter 3 presents a review of the literature pertaining to IAD, a historical 
perspective, risk factors, physiology of skin injury related to skin exposure to urine 
and faeces, clinical presentation of IAD, and subsequent complications. Chapter 3 
also presents a review of Candida albicans. 
Chapter 4 presents the results of a study investigating the magnitude of IAD 
in an Australian acute care facility. This chapter constitutes Publication 2 of this 
research program. The results of this study identified that the prevalence of IAD and 
Candida infection in patients with IAD was a significant problem in the acute care 
setting. This study also tests several constructs of the Skin Safety Model. The results 
of this study contribute unique and previously unknown IAD prevalence data, and 
informed the research questions and methodology for study two of this research 
program. Chapter 4 includes Publication 2:  
Campbell J. L., Coyer F. M., & Osborne S. R. (2014). Incontinence-
associated dermatitis: A cross-sectional prevalence study in the Australian acute care 
hospital setting, International Wound Journal, doi:10.1111/iwj.12322.  
Chapter 5 presents a review of pressure injury prevalence before (2009-2010) 
and after (2011-2013) the commencement of a protocol that combined pressure 
injury and IAD prevalence surveys, as well as a review of the IAD prevalence 
following the commencement of the combined audit protocol.  
Chapter 5 includes Publication 3:  
Campbell, J., Gosley, S., Coleman, K., & Coyer, F. (2016).Combining 
pressure injury and incontinence-associated dermatitis prevalence surveys; An 
effective protocol? Wound Practice and Research, 24(3). 170-177. 
Chapter 6 details the research methods, research questions, research design, 
and justification, sampling strategies, instrument development, recruitment 
processes, data collection, data analysis plan, and overview of the pertinent ethical 
consideration for Study 2. 
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 14                                                                                                                                                                               Chapter 1: Introduction                                          
Chapter 7 presents the results of Study 2 that compared the Candida albicans 
colonisation levels in continent and incontinent patients, as well as those with IAD. 
In addition, this study tests several constructs of the Skin Safety Model.  
Chapter 7 includes Publication 4: 
Campbell J., Coyer, F., Mudge A., Robertson I., & Osborne S. (2016). 
Candida albicans colonisation, incontinence-associated dermatitis and continence 
status in the acute care setting: A pilot study. International Wound Journal, doi: 
10.1111/iwj.12630 
Chapter 8 presents an investigation of risk factors associated with Candida 
albicans colonisation at the perianal and inguinal region of both continent and 
incontinent patients. It includes Publication 5:  
Campbell J., Coyer, F., Mudge A., & Osborne S. Risk factors for Candida 
colonisation at the perianal and inguinal sites in individuals admitted to acute 
medical wards. (This manuscript is to be submitted to the Journal of Hospital 
Infection).  
Chapter 9 presents a discussion of the Skin Safety Model, and a discussion of 
the testing of the model, using the study variables. Furthermore, the major findings, 
implications and limitations of the research are discussed, as well as an examination 
of the overall implications of this body of research that presents theoretical and 
empirical evidence that contributes to the understanding of the phenomenon of IAD 
in the acute care setting. 
Chapter 10 concludes this thesis by presenting a summary of the research, 
and proposing eight recommendations in the domains of the implications for 
practice, education, policy, and future research. 
  
1.6  SUMMARY 
This chapter has provided the framework for this thesis presented by 
publication. It introduced the research problem, presented its background 
significance and scope, and the research questions for each study were specified. The 
next chapter presents a detailed literature review that informs the development of the 
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Skin Safety Model, which was the conceptual framework developed to underpin this 
thesis. 
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Chapter 2: LITERATURE REVIEW, PART A - THE 
SKIN SAFETY MODEL: RE-
CONCEPTUALISING SKIN 
VULNERABILITY IN OLDER PATIENTS 
2.1 INTRODUCTION 
This chapter presents the literature review, Part A, and introduces the 
conceptual framework that underpins this research program. The conceptual 
framework presented represents the first publication of this thesis. The aim of this 
chapter is to provide the contextual background and rationale for the development of 
the skin safety conceptual framework for older acute care patients. While the 
research program investigated the phenomenon of IAD in the acute care setting, it is 
critical to explore IAD within the broader context of skin injury vulnerabilities, the 
changing health and care needs of contemporary patients, as well as the challenges 
faced by modern healthcare providers. 
2.1.1 Chapter overview 
This chapter highlights the unprecedented challenges faced by contemporary 
healthcare providers. Rapidly changing causes of illness, disability and death, ageing 
populations, increasing demands on hospital services, and the expectation that 
healthcare will be safe and of high quality, are issues that are exacerbated by fiscal 
constraints, and result in healthcare providers facing a period of enormous change. 
Ageing of the global population has resulted in increased utilisation of hospital 
resources in the 65 years and older age group. The increase in chronic disease, 
geriatric syndromes, and frailty that affect older adults results in complex healthcare 
needs for this group. (Ezeh, Bongaarts, & Mberu, 2012; Inouye et al., 2007; Lakhan 
et al., 2011; Levant, Chari & DeFrancis, 2015; Scommegna, 2012; Sourdet et al., 
2015; World Health Organisation, 2011; Zisberg, Shadmi, Gur‐Yaish, Tonkikh, & 
Sinoff, 2015). Therefore, new and innovative paradigms are urgently required to 
meet the needs of these complex and vulnerable patients. The conceptual framework 
presented in this chapter is a unique paradigm that was developed against the 
background of the complexities of contemporary healthcare delivery. 
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2.2 LITERATURE REVIEW AND CONCEPTUAL FRAMEWORK 
2.2.1 Contemporary healthcare challenges 
The convergence of multiple challenges, including rapidly ageing 
populations, financial constraints, and increasing complexity of patient illness, 
subsequent increase in healthcare utilisation, and the requirement to provide safe, 
quality healthcare, has resulted in healthcare systems that are under extreme strain 
(Roundtable, 2012). The significant increase in average life expectancy that occurred 
during the 20
th
 century reflects a great human achievement. However, the rapidity 
with which these demographic changes have taken place has left most healthcare 
providers struggling to cope (Kowdley & Ashbaker, 2011; World Health 
Organisation, 2011). Compounding the challenges of the ageing population is the 
rapidly escalating cost of healthcare provision, with healthcare expenditure 
outstripping growth in gross domestic product in countries across the globe 
(Kowdley & Ashbaker, 2011; Stabile et al., 2013). Management of the burgeoning 
prevalence of chronic, non-communicable diseases consumes a major share of 
healthcare resources. In the United States, 70% of the annual 2.2 trillion dollar health 
expenditure is spent on the treatment of chronic disease (Kowdley & Ashbaker, 
2011). In the early part of the 21
st
 century, healthcare providers face challenges that 
are unparalleled. Thus, urgent and unparalleled solutions are required to meet the 
rapidly changing needs and expectations of the contemporary healthcare consumer.   
Ageing populations 
Global population ageing has resulted from declining fertility rates and 
increasing life expectancy (United Nations, 2011; World Health Organisation, 2011). 
The average life expectancy of a child born in 1900 was 50 years; however, today the 
average life expectancy is 81 years, with the excetion of Africa, where the average 
life expectancy is 51 years as a result of the acquired immune deficiency syndrome 
pandemic (World Health Organisation, 2011). The most rapid life expectancy gains 
have been seen in East Asia, where it has increased from 45 years in 1950, to 74 
years in 2011 (World Health Organisation, 2011). The number of people aged over 
60 years is projected to increase from nearly 800 million in 2011, to two billion in 
2050, with the number of individuals aged over 80 years projected to increase almost 
eight-fold, reaching 400 million in 2050 (United Nations, 2011). The proportion of 
people over 65 is predicted to rise during the period from 2010 to 2050 from 16% to 
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27% in Europe, from 13% to 22% in the United States, and from 23% to 38% in 
Japan, while China will experience a staggering increase from 8% to 23%, 
representing a threefold rise in the over 60s age group (Ezeh et al., 2012; Hou & Li, 
2011). India will experience an increase in the ages 60 and older from 8% in 2010 to 
19% in 2050, with India’s overall population (currently 1.2 billion) expected to 
overtake China as the world’s most populous country by 2020 (Scommegna, 2012).  
Ageing and healthcare utilisation 
The ageing demographic has resulted in increased utilisation of healthcare 
services and hospital bed days by older age groups internationally (Schofield & 
Earnest, 2006; Scommegna, 2012). In the United States in 2010, adults aged 85 and 
over accounted for 9% of hospital discharges, yet constituted only 2% of the 
population, with the rate of hospitalisation five times higher for the 85 and over age 
group compared to those under 65 years (Levant, 2015).  Statistical modelling by 
Schofield and Earnest (2006) predicted that the proportion of bed days utilised by the 
65 and older age group will increase from 47% in 2005 to 67% in 2050. Australian 
trends in increasing health service utilisation by older adults are consistent with other 
countries. In Australia, between 2011 and 2012, around 20% of people aged 65 or 
older had been admitted to hospital, compared to 11% of younger people in the same 
time period (Australian Institute of Health and Welfare, 2014). Furthermore, while 
the 60 years and older age group only accounted for 13% of Australia’s population 
between 2013-2014, this age group accounted for 40% of hospitalisations (Australian 
Government, 2016). In Australia, between 2007-2008, across 23 major diagnostic 
categories average length of stay for patients 75 years or older was higher than 
patients aged 65-74 years, with the exception of the category diseases of the eye 
which was the same for both age groups (Brown, Abello & Thurecht, 2011). A study 
of presentations to Australian public hospital emergency departments, between 1999 
and 2009 found that the highest per capita increase was among the 85 year and older 
age group. In this group, 61% of emergency department presentations resulted in 
admission, compared to 21% in patients aged 20-59 years (Lowthian et al., 2012). 
 In 2014-2015, there were three million more hospital admissions than 
between 2004-2005 (Duckett, 2016). One author claims that just over one fith of the 
increase in hospital admissions was attributable to the increase in the number of 
people aged 70 years and over, making this a relatively small contributer to the 
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growth in hospital admssions (Duckett, 2016). Pressures on demand for hospital 
services due to due to the ageing population have been offset by policies such as 
changing patterns of care, early discharge and same day treatments, but maximum 
efficiency gains have been obtained (Duckett, 2016; Schofield & Earnest, 2006). 
However, hospital admission raates preseent just one facet of  the healthcare 
utilisation picture. It remains that the length of stay for older patients is longer than 
younger patients, 47% of hospital beds in Australia are occupied by older patients, 
and the trend towards population ageing will see about three-quarters of bed days 
required by older patients by 2050 (Brown, Abello & Thurecht, 2011; Schofield & 
Earnest, 2006). 
Chronic disease 
The trend towards ageing has been accompanied globally by a shift in the 
leading causes of disease from infectious and parasitic diseases (the major threats at 
the beginning of the 20
th
 century) to the current burgeoning prevalence of chronic, 
non-communicable diseases. These chronic diseases most commonly affect older 
people, and include heart disease, diabetes, cancer, and mental health conditions, 
such as Alzheimer’s disease and depression (Scommegna, 2012; World Health 
Organisation, 2011). The trend towards increasing chronic disease is having a 
significant global impact, affecting people in all countries. By 2030, more than 87% 
of the disease burden in those aged 60 years and older in all countries will be 
attributed to chronic non-communicable conditions (Scommegna, 2012; World 
Health Organisation, 2011). 
Moreover, ageing individuals can suffer from more than one chronic, 
comorbid condition, with Australian data showing that 31% of people aged over 65 
have one chronic condition, 25% have two chronic conditions, 13% have three 
chronic conditions, and 8% have four or more (Australian Institute of Health and 
Welfare, 2012). Ageing is accompanied not only by an increase in the number of 
chronic conditions, but also by the so-called geriatric syndromes, multifactorial 
health conditions that result from accumulated effects in multiple systems. These 
syndromes include incontinence, falls, pressure injury, delirium, and functional 
decline (Inouye et al., 2007). The prevalence of geriatric syndromes in the acute care 
setting is extremely high, with 95% of patients over 70 years having at least one 
geriatric syndrome prior to admission, with two thirds experiencing between one and 
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three syndromes (Lakhan et al., 2011). When pre-existing geriatric syndromes and 
chronic illness are superimposed by an acute illness and subsequent need for hospital 
admission, the complexity of the care needs of that individual increase substantially.  
Healthcare reform 
In response to the aforementioned challenges, healthcare reform is taking 
place in many countries. There is a pressing need for transition to care that is more 
responsive to the complex needs of contemporary patients. According to the 
American Nurses Association, bold initiatives are required to shape fundamental 
reforms (American Nurses Association, 2008). The key issues for global health 
reform have been identified as equitable access, quality and safety, cost, and 
workforce considerations (Anderson, 2010; American Nurses Association, 2008; 
Australian Government, 2014; Porter, 2010; Shortell & Singer, 2008). 
In addition to the drivers of healthcare reform, there is growing recognition 
that non-biomedical factors in health, such as inadequate hospital environments for 
the elderly, inappropriate healthcare management strategies, and poor adaptation of 
the healthcare system to the needs of the frail elderly result in a condition known as 
hospital-associated disability. This disability occurs whereby older patients admitted 
to hospital can experience preventable functional decline as a result of admission 
(Sourdet et al., 2015). It can be argued that the emergence of this phenomenon is the 
result of a combination of contemporary healthcare challenges, and provides further 
rationale for healthcare reform. 
Safety and quality  
Keeping patients safe from harm is legitimate expectation of health care 
consumers and a universal concern of health care providers. Patient safety has come 
to be synonymous with quality healthcare, with the Institute of Medicine in the 
United States considering patient safety indistinguishable from quality care (Kohn, 
2000). Patient safety is defined by the WHO (n.d., para 1) as the ‘prevention of errors 
and adverse effects to patients associated with healthcare’. The Agency for 
Healthcare, Research and Quality, Patient Safety Network (AHRQ PS Net, n.d., para 
1), defines patient safety as ‘freedom from accidental or preventable injuries 
produced by medical care’. Thus, practices or interventions that improve patient 
safety are those that reduce the occurrence of avoidable adverse events. Other 
definitions of patient safety highlight that the prevention of harm is dependent on a 
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system that prevents errors and learns from them, and is built on a culture of safety 
that involves healthcare professionals, organisations and patients (Kohn, 2000; 
Youngberg, 2013). 
Operationalising patient safety and quality within an organisation requires a 
system of clinical governance. This is defined as a systematic and integrated 
structure that ensures health systems, clinicians and staff work towards and are held 
accountable for delivering safe and quality health care, while continually improving 
the quality of their services (Australian Commission on Safety and Quality in 
Healthcare, 2012; Travaglia, Spigelman & Braithwaite, 2011). Sound clinical 
governance requires effective planning and leadership, appropriate resource 
allocation, reliable systems for ensuring the quality of clinical care, effective use of 
data and information to monitor and report on performance and well-designed 
systems for identifying and managing risk (Australian Commission on Safety and 
Quality in Healthcare, 2012). 
Powerful illustrations of the relationships between clinical governance, 
patient safety and quality can be found in the report of the enquiry into the Mid 
Staffordshire NHS Foundation (Francis, 2010). This enquiry found that hundreds of 
patients died between 2005 and 2009 in the Mid Staffordshire Trust as a result of the 
failure of the healthcare leadership, clinical governance and organisational culture of 
ignoring patient needs in favour of meeting the system needs. The effects of these 
failures manifested in multiple ways; however, in regard to skin integrity there were 
reports of patients developing serious PIs that remained untreated, patients not being 
fed or provided fluid, and patients left in beds contaminated with their own urine and 
faeces, all of which were due to poor staff morale and safety culture, staff shortages 
and lack of basic resources such as clean linen. The tragedies that occurred at the 
Mid Staffordshire Trust provide compelling evidence that clinical governance, 
patient safety and skin safety are inextricably linked, and that failures at the 
governance level are almost certainly likely to result in patient injury.  
Patient safety programs require valid, reliable and meaningful data, with 
common metrics including measures that seek to identify, measure and eliminate 
error as well as injuries (Scanlon, Karsh & Saran, 2008; Youngberg, 2013). A 
common example of the use of these metrics is the use of PI prevalence surveys to 
examine factors that contribute to PIs, assess the efficacy of prevention protocols, 
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assess quality of care and guide resource allocation decisions (Baharestani, 2009). A 
further metric is the use of the risk-based patient safety measurement, or hazard 
identification, which focuses on identifying risks in the system that may ultimately 
lead to injury (Scanlon et. al., 2008). Organisations are responsible for identifying 
and responding to error and injury, and also for assessing and responding to potential 
risks (Scanlon et. al., 2008; Youngberg, 2013). 
Rising cost of healthcare 
Universally, healthcare spending is increasing, with data from the 
Organisation for Economic Cooperation and Development (OECD), revealing an 
average per capita increase of more than 70% between 2000 and 2010 (Organisation 
for Economic Cooperation and Development, 2015; Stabile et. al., 2013), with the 
rate of per capita spending for healthcare provision for older people accelerating 
more rapidly than any other group (Organisation for Economic Cooperation and 
Development, 2015; Stabile et al., 2013). In Australia, health expenditure between 
2008-2009 for people aged 85 and older was almost 20 times higher per person 
compared to expenditure on children aged between five and 14 years (Australian 
Institute of Health and Welfare, 2016). 
Increases in healthcare expenditure can be attributed to the rapidly rising 
costs of hospital services, the development of new medical technologies in the form 
of new drugs, devices, or services, as well as the costs associated with addressing the 
upsurge in chronic disease and increased hospital utilisation by the ageing population 
(Kowdley & Ashbaker, 2011; Organisation for Economic Cooperation and 
Development, 2015; Stabile et al., 2013; Wallner & Konski, 2008). Hospital care is 
the single largest health expenditure, amounting to nearly one third of total spending 
in OECD countries. Efforts are being made to contain the cost burden, with the most 
frequent strategies to curb spending in hospitals in these countries reported as 
postponing staff replacement and delaying investment in infrastructure (Organisation 
for Economic Cooperation and Development, 2015). Populous countries such as 
China and India face the same challenges as other countries in the provision of health 
and hospital services, but with the additional pressure of the sheer number of ageing 
people threatening to overwhelm the health infrastructure (Fang et al., 2015; 
Scommegna, 2012; World Health Organisation, 2011). 
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As has been highlighted in the previous sections, contemporary healthcare 
providers are under enormous strain as a result of population ageing, the increase in 
chronic disease and the rapidly rising cost of healthcare. While dealing with these 
challenges, healthcare providers are required to provide safe and quality care, within 
an effective clinical governance framework, while constantly demonstrating quality 
improvement. The systems required to deliver safety and quality create a further 
level of complexity for healthcare providers to navigate. While the requirement for 
the provision of safe and quality healthcare is not questioned, safety and quality must 
be delivered in the challenging environment of shrinking resources and rapidly 
increasing demand.  
2.2.2 IAD nomenclature 
Despite growing understanding of IAD, and the impacts it has on patients and 
healthcare systems, the nomenclature of the condition remains imprecise. Gray and 
colleagues (2007) first proposed the term IAD in 2007. Prior to this definition, IAD 
was known by a range of different terms, such as perineal dermatitis, moisture 
dermatitis, intertrigo, heat rash, or even pressure injury. However, the term IAD is 
not recognised by NANDA International, Inc. (Herdman, 2012), nor does IAD have 
a specific code in the International Statistical Classification of Diseases and Related 
Health Problems (ICD-10, 2016; World Health Organisation, 2004).  
2.2.3 Specific IAD conceptual frameworks 
Despite the fact that skin injury from incontinence in adults is not a new 
phenomenon, IAD research has only appeared in the nursing literature in the last two 
decades. While a number of IAD frameworks have been advanced, none integrate 
IAD into the broader, comprehensive and holistic construct of maintaining skin 
integrity. In 1993, Brown and Sears (1993) proposed a perineal dermatitis conceptual 
framework that recognised that diaper dermatitis or perineal dermatitis affected all 
age groups, races, and genders in any healthcare setting. They recognised that not all 
individuals who have incontinence develop perineal dermatitis; therefore, the 
condition should be preventable with the implementation of nursing care 
interventions. Brown and Sears (1993) identified that there were similarities between 
risk factors for pressure injury and perineal dermatitis. The conceptual framework 
they proposed grouped risk factors for perineal dermatitis into three constructs, 
namely: 1) tissue tolerance, including subcategories of age, health status, nutrition, 
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oxygenation, perfusion, temperature; 2) perineal environment with subcategories of 
character and type of incontinence, mechanical chaffing, inducing agents, and 
increased skin permeability; and 3) toileting ability, with mobility, sensory 
perception, and cognitive awareness constituting the subcategories. They identified 
that the manifestation of perineal dermatitis consisted of objective signs, including 
erythema, swelling, vesiculation, oozing, crusting, and scaling, while subjective 
symptoms included tingling, itching, burning, and pain. This framework identified 
that perineal dermatitis (IAD) and PI share some common risk factors, that is tissue 
tolerance, mobility and cognition impairment. This framework, focused on perineal 
dermatitis while briefly acknowledging common risk factors for IAD and PI but did 
not constitute a comprehensive skin integrity model.  
In 1996, Jetter and Lutz proposed a conceptual framework describing the 
aetiology of IAD in adults, not as a single event, but as a cascade of interacting 
events that weaken the skin and create vulnerability to damage. This framework 
identified that risk factors for weakened skin are found in excess moisture which 
leads to increased friction, shear, skin permeability and microbial load while skin 
exposure to faeces results in damage from enzyme attack, altered pH, and increased 
skin permeability. Subsequent frequent washing, leads to further skin irritation, They 
proposed that weakened skin is vulnerable to incontinence dermatitis.  
In 2007, Farage, Miller, Berardesca, and Maibach presented a comprehensive 
conceptual framework that highlighted multiple factors that contribute to the 
morbidity associated with incontinence dermatitis in older people. This model 
identified that compromised aged skin results from skin contact with the irritants 
urine and faeces, and that skin damage is exacerbated by factors such as decreased 
mobility, impaired cognition, inadequate care and attention, diminished tissue 
regeneration capacity, compromised physical health, and lower immune function. 
In 2009, Beeckman, Schoonhoven, Verhaeghe, Heyneman and Defloor 
presented a further conceptual framework detailing the aetiology of IAD. This 
conceptual framework was based on the work of Jetter and Lutz (1996) and also 
Newman, Wallace, D. and Wallace J. (2001), and identified urine, faeces, double 
incontinence, and frequent cleansing as factors that eventually, via a series of 
interactions, create weakened skin and IAD. The IAD conceptual model presented by 
Langemo, Hanson, Hunter, Thompson, and Oh (2011) was a departure from the 
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conceptual models proposed up to this point in time. Other models included extrinsic 
patient factors and even care processes, for example, frequent skin cleansing, as 
having aetiological roles in the development of IAD. However, Langemo et al.’s 
(2011) model focused only on the effects of the urine, faeces, and bacterial 
overgrowth leading to weakened skin, and subsequently resulting in IAD.  
 The conceptual frameworks that have been discussed deal primarily with the 
aetiology of IAD. Brown and Sears (1993) identified factors such as patient factors 
in the construct of tissue tolerance and mobility, and sensory and cognitive 
awareness in the construct of toileting ability, while Jetter and Lutz (1996) 
mentioned pressure, poor nutrition and disease as contributing factors for skin 
breakdown in their framework. Several models also proposed that inappropriate 
incontinence care processes may constitute IAD risk factors (Beeckman et al., 2009, 
Brown & Sears, 1993; & Farage et al., 2007). The framework proposed by Farage et 
al. (2007) is a comprehensive model that encompasses multiple factors and, in 
addition, addresses skin vulnerability to injury experienced by older adults when 
exposed to urine and faeces. Risk factors for IAD identified in these conceptual 
frameworks are also identified in a range of conceptual frameworks as being key risk 
factors for other skin injuries, such as PI, skin tears and medical adhesive-related 
skin injury (Campbell, 2009; García-Fernández, Agreda, Verdú, and Pancorbo-
Hidalgo, 2014; LeBlanc & Baranoski, 2014; McNicol, Lund, Rosen & Grey, 2013). 
These models address a specific skin injury, perhaps reflecting the specialty focus of 
broader contemporary healthcare delivery. The exception is the model presented by 
Garcia- Fernández et al., 2014, who proposed a theory for the development of 
dependence related skin lesions that were considered as PIs. These injuries include 
moisture, friction, combined pressure-moisture or combined pressure-friction lesions 
that a range of skin injuries. While these frameworks identify the complexity of the 
antecedents for IAD, including patient and care factors, and Garcia- Fernández et al. 
(2014) include several injuries into a single model, no overarching framework was 
available that united these skin integrity risk factors into a single comprehensive 
model.  
2.3 LITERATURE GAP 
The literature search for this thesis identified the lack of a conceptual 
framework in which to contextualise IAD as a component of a comprehensive, 
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overarching framework that is concerned with the wider imperative of maintaining 
skin integrity in the acute care setting. Existing IAD guidelines and frameworks, 
while presenting and distilling the most contemporary evidence into important 
documents (Beeckman et al., 2015; Doughty et al., 2012; Gray et al., 2007), continue 
to address IAD as a discrete skin injury, distinct and unrelated to other skin injuries 
and separated from the wider overarching imperative of maintaining skin integrity.  
Consistent with the frameworks that address IAD, there are multiple skin injury-
specific frameworks that deal with a range of other nosocomial skin injuries 
including, skin tears, intertriginous dermatitis, peristomal or periwound moisture-
associated skin damage or medical adhesive-related skin injury (Black et al., 2011; 
LeBlanc & Baranoski, 2011; McNichol et al., 2013). A conceptual framework that 
provides a link unifying the array of these individual skin integrity models into a 
congruent, overarching theory is lacking. Approaches to maintaining skin integrity in 
the acute care setting that are guided by a series of individual concepts and 
frameworks, which may ultimately result in fragmented, duplicated, or even missed 
care, and furthermore, may foster siloed care (Blackman et al., 2014; Shortell & 
Singer, 2008). 
2.4 SKIN SAFETY MODEL 
It is against this background of the complex needs of the ageing population, 
and the challenges faced by modern healthcare providers, including the imperative to 
provide safe quality care and the need for a comprehensive, overarching theory that 
the Skin Safety Model (SSM) is proposed. Older hospital patients are vulnerable to 
multiple skin injuries as a result of complex, chronic and inter-related health 
conditions, geriatric syndromes and disability, as well as interactions with the 
healthcare system. The aim of the SSM is to provide a unique and overarching theory 
that addresses the holistic skin integrity vulnerabilities in older acute care patients. 
The SSM moves away from addressing single skin injuries and towards an inclusive, 
holistic model for skin safety. This transition from a single injury approach to an 
overarching, integrated skin integrity approach aligns with the broader healthcare 
reform agenda, that is, reform that is focused on consumer-driven, patient-centred, 
holistic models of care. (American Nurses Association, 2008). 
According to Fawcett and DeSanto-Madeya (2013), a conceptual framework 
provides a frame of reference, and functions to ‘organise and visualise abstract and 
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general phenomena and relations between various phenomena encompassed by the 
model’ (p. 13). The SSM presented in this chapter provides a new frame of reference 
for maintaining skin integrity into a single model, and represents a unique and 
comprehensive approach to maintaining skin integrity in the acute care setting. It 
highlights the interplay of and relationship between multiple elements, including 
abstract and general phenomena such as patient factors, care delivery systems, and 
acute situational stressors (for example, an acute illness or trauma that requires 
hospital admission) that may combine or even interact synergistically to result in a 
skin injury. The specific phenomenon of IAD is situated within the broader 
framework. The premise of the SSM is based on the understanding that skin is a 
complex organ, impacted on by a vast array of factors, extending beyond individual 
patient factors to include systems and situational stressors. Maintaining skin safety, 
particularly in the older acute care patient is complex and challenging. The SSM can 
guide clinicians in consideration and recognition of a broad range of factors that 
influence skin integrity in the older acute care patient.   
The following manuscript represents Publication 1 of this thesis and presents 
the SSM, which underpins the program of research. 
Campbell J. L., Coyer F. M., & Osborne S. R. (2016). The Skin Safety 
Model: Reconceptualising skin vulnerability in older patients. Journal of Nursing 
Scholarship, 48(1), 14-22. 
This manuscript was published in the Journal of Nursing Scholarship, which 
has a wide international readership, and an impact factor of 1.6. The article was 
selected as Journal of Nursing Scholarship Editor’s choice for January 2016. The 
article has cited in the Journal of Nursing Studies, which has an impact factor of 2.9 
Furthermore, this publication was featured in the April/May 2016 edition of Nursing 
Review, with a Podcast recorded with the first author. The podcast features on the 
Nursing Review website, http://www.nursingreview.com.au/2016/04/guide-maps-
out-complexities-of-maintaining-skin-integrity/ 
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2.5 PUBLICATION 1 
The Skin Safety Model: Re-conceptualising Skin Vulnerability in Older 
Patients. 
Abstract 
Purpose: To develop a unique Skin Safety Model (SSM) that offers a new 
and unified perspective on the diverse yet interconnected antecedents that contribute 
to a spectrum of potential iatrogenic skin injuries in older hospitalised adults. 
Organising construct: Discussion paper 
Methods: A literature search of electronic databases was conducted for 
published articles written in English addressing skin integrity and iatrogenic skin 
injury in elderly hospital patients between 1960 and 2014.   
Findings: There is a multiplicity of literature outlining the aetiology, 
prevention, and management of specific iatrogenic skin injuries. Complex and inter-
related factors contribute to iatrogenic skin injury in the older adult, including 
multiple co-morbidities, factors influencing healthcare delivery, and acute situational 
stressors. A range of injuries can result when these factors are complicated by skin 
irritants, pressure, shear, or friction; however, despite skin injuries sharing multiple 
antecedents, no unified, over-arching skin safety conceptual model has been 
published. 
Conclusions: The Skin Safety Model (SSM) presented in this paper offers a 
new, unified framework that encompasses the spectrum of antecedents to skin 
vulnerability, as well as the spectrum of iatrogenic skin injuries that may be 
sustained by older acute care patients. Current skin integrity frameworks address 
prevention and management of specific skin injuries. In contrast, the SSM recognises 
the complex interplay of patient and system factors that may result in a range of 
iatrogenic skin injuries. Skin safety is reconceptualised into a single model that has 
the potential for application at the individual patient level, as well as healthcare 
systems and governance levels. 
Clinical relevance: Skin safety is concerned with keeping skin safe from any 
iatrogenic skin injury, and remains an ongoing challenge for healthcare providers. A 
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conceptual framework that encompasses all of the factors that may contribute to a 
range of iatrogenic skin injuries is essential, and guides the clinician in maintaining 
skin integrity in the vulnerable older patient. 
Key words: Older adult, acute care, skin safety, incontinence-associated dermatitis, 
pressure ulcer.  
Introduction 
Skin is the largest organ in the human body and is vulnerable to a multitude 
of threats. Vulnerability to skin integrity threats is particularly marked in older 
individuals (Carville, 2012). While the impact of pressure ulcers (PUs) in the acute 
setting is well understood, there are a range of potential iatrogenic skin injuries that 
are often regarded as an inevitable part of ageing, yet remain under-appreciated, 
under-reported, and somewhat invisible within this setting. Beyond PUs, other 
iatrogenic skin injuries include skin tears, medical adhesive-related skin injury 
(MARSI), incontinence-associated dermatitis (IAD), peri-stomal or peri-wound 
moisture-associated skin damage (MASD), and intertriginous dermatitis (ITD) (see 
Table 2.1). Skin integrity threats in older individuals arise from interactions between 
skin changes associated with ageing, presence of multiple co-morbidities, 
polypharmacy, changes in mobility, continence, and cognition; as well as the risks of 
acute illness and subsequent hospitalisation. Maintaining skin integrity in the older 
acute care patient is an ever-present challenge for healthcare providers. These 
challenges are compounded by shrinking financial and clinical resources, a rapidly 
ageing population, and the expectation that patients remain safe from harm.  
For several decades, pressure ulcer (PU) prevention has been the primary 
focus of maintaining skin integrity. Moreover, the terms ‘pressure ulcer prevention’ 
and ‘maintaining skin integrity’ have, to some extent, become interchangeable. 
However, like pressure ulcers, the prevalence of these other skin injuries is 
significant (see Table 2.1), yet unlike PUs, their impact in the acute care setting is 
under-appreciated. These iatrogenic skin injuries have the potential to impact on 
morbidity, mortality, cost, and burden of care, in addition to causing pain, 
disfigurement, or disability. Importantly, any skin injury sustained in the delivery of 
healthcare should be classified as an adverse event. Further, research is emerging that 
strategies to prevent one iatrogenic skin injury can have positive effects on 
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preventing other skin injuries, thus highlighting the inter-connection between 
seemingly distinct skin injuries (Coyer et al., 2015).  
Historically, despite shared risk factors, skin injury prevention and 
management programs address a single skin injury (for example PU). For 
individuals, under-appreciation of the complexity and scope of skin integrity risks 
can result in adverse skin integrity outcomes. For healthcare providers, this singular 
approach to skin injury prevention and management can result in fragmented, 
duplicated, inconsistent care that often takes place in silos. In response to the range 
of potential iatrogenic skin injuries, a multitude of injury-specific conceptual 
frameworks have been published (Beeckman et al., 2015; Black et al., 2011; LeBlanc 
& Baranoski, 2011; McNichol et al., 2013). However, to our knowledge, there is no 
framework that represents a unified, holistic paradigm for maintaining skin integrity. 
This gap represents an opportunity for an innovative paradigm shift. This paper 
presents a framework that views skin as a complex organ, vulnerable to a multitude 
of threats and injuries. These diverse yet inter-related injuries can result from 
complex interactions between patient and systems factors, as well as acute situational 
stressors. The framework draws together important concepts into a single unified 
paradigm, highlighting the inter-connection of the spectrum of skin frailty 
antecedents and resultant skin injuries. This paper argues that the imperative to 
prevent the diverse range of iatrogenic skin injuries in older hospitalised patients 
warrants a new skin safety conceptual framework.  
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Table 2.1  
Skin Injuries - Definitions and Significance of the Problem 
     Term Definition Significance of the problem 
Pressure ulcer A localised injury to the skin and/or underlying tissue, usually over a 
bony prominence, resulting from sustained pressure (including 
pressure associated with shear), (National Pressure Ulcer Advisory 
et al., 2014). 
6.3-16.6% in acute care, with stage 1and 2 PUs making up the 
majority of lesions (50% -55%) (National Pressure Ulcer Advisory et 
al., 2014). 
Incontinence-
associated  
dermatitis (IAD) 
Skin damage associated with exposure to urine or stool. It is a type 
of irritant dermatitis found in patients with urinary/and or faecal 
incontinence (Beeckman et al., 2015). 
Prevalence data for general acute care is limited.  Two studies in 
acute care range from 3.9-10% of overall samples, and 20-42% of 
incontinent patients in the samples (Campbell, Coyer, & Osborne, 
2014; Junkin & Selekof, 2007). 
Intertriginous 
dermatitis (ITD) 
ITD is an inflammatory dermatitis of opposing skin surfaces caused 
by moisture, commonly found in the inframammary, axillary and 
inguinal skin folds (Black et al., 2011). 
One hospital study of 1162 female patients reported 11.2% had ITD 
beneath the breasts (McMahon, 1991). A survey of 100 obese 
individuals found 63% had more than one skin problem (Brown, 
Wimpenny, & Maughan, 2004).  
Peri-wound 
dermatitis 
Maceration of periwound skin caused by excess wound exudate. In 
some cases, it may extend beyond 4cm from the wound edge 
(Colwell et al., 2011). 
No prevalence data for this condition has been published. 
Peri-stomal 
dermatitis 
Inflammation and erosion of the skin related to moisture that begins 
at the stoma/skin junction and can extend outward in a radius 
(Colwell et al., 2011). 
There is a wide range reported (10-70%) due to variable definitions 
and assessment of peristomal skin conditions (Colwell et al., 2011). 
Skin tear A wound caused by shear, friction, and/or blunt force, resulting in 
separation of skin layers. A skin tear can be partial-thickness 
(separation of the epidermis from the dermis) or full thickness 
(separation of both epidermis and dermis from underlying structures) 
(LeBlanc & Baranoski,2011). 
 Studies conducted in Western Australian hospitals between 2007-
2011 found skin tear prevalence to range from 8-10%, with the 
majority of skin tears being hospital acquired (Carville et al., 2014). 
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     Term Definition Significance of the problem 
Medical adhesive 
related skin injury 
Erythema and/or other manifestation of cutaneous abnormality 
(including, but not limited to, vesicle, bulla, erosion or tear) persists 
30 minutes or more after removal of the adhesive (McGahan, 
Kucharski, & Coyer, 2012). 
Prevalence data is scarce. Skin stripping in the paediatric setting 
ranges from 8-17%, with prevalence of tension blisters ranging from 
6-41% in an adult orthopaedic setting (McNichol, Lund Rosen & 
Gray, 2013). 
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Aim 
The aim of this paper is to develop a unique Skin Safety Model (SSM) that 
offers a new and unified perspective on the diverse, yet interconnected antecedents 
that contribute to a spectrum of potential iatrogenic skin injuries in older hospitalised 
adults.  
Methods 
A review of the literature was conducted to identify current frameworks, 
consensus documents, guidelines, or position statements in the area of maintaining 
skin integrity. Electronic databases including PubMed/Medline, Cumulative Index to 
Nursing and Allied Health Literature (CINAHL), PsycINFO, Web of Science, and 
Cochrane Library were searched for literature published between 1960 and 
December 2014. The year 1960 was chosen to capture seminal papers addressing PU 
aetiology published in that decade. The search strategy was limited to human 
subjects and those published in English speaking countries. The search was 
conducted using the key words: skin integrity, skin injury, skin safety, iatrogenic skin 
injury, pressure sore, pressure ulcer, pressure injury, bedsore, decubitus ulcer, 
moisture lesion, perineal dermatitis, IAD, moisture-associated skin damage, ITD, 
skin tear, peri-stomal skin injury, peri-wound skin injury, MARSI, patient safety, 
quality improvement, and combined with additional key words including conceptual, 
framework, model, theoretical, guideline, and consensus statement. Meta-analyses 
and systematic reviews (Level I), randomised controlled trials (Level II), pseudo-
randomised controlled trials (Level III-1), and comparative studies with or without 
concurrent controls (Levels III-2 and III-3) exploring risk factors, aetiology, 
prevention, treatment or management of skin injury of any type regardless of 
outcomes were included using the National Health and Medical Research Council 
(NHMRC) hierarchy of evidence (National Health Medical Research Council, 2000). 
The search also included searches of websites of relevant national and international 
organisations, government websites, and conference proceedings. A hand search of 
reference lists of relevant articles was undertaken.  
Results 
The search results yielded 2,980 records, and after excluding duplicates, 
2,851 titles were screened. Two independent reviewers evaluated 179 potentially 
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relevant abstracts with, 21 papers meeting the criteria for inclusion in this review. 
Papers included presented a conceptual framework, theory, model, consensus, 
guideline, or position statement related to skin integrity, iatrogenic skin injury, 
pressure sore, pressure ulcer, pressure injury, bedsore, decubitus ulcer, moisture 
lesion, perineal dermatitis, IAD, moisture-associated skin damage, ITD, skin tear, 
peri-stomal skin injury, peri-wound skin injury, or MARSI. Papers were excluded if 
they tested effectiveness of a single intervention. A narrative synthesis was 
undertaken. 
Narrative Synthesis of the Literature 
Skin integrity risk is defined by the international nursing diagnosis group, 
NANDA International, Inc. (Herdman, 2012) as a ‘patient being at risk for alteration 
in epidermis and/or dermis’ (p. 437), and classifies skin integrity risk in the domain 
of safety/protection. Despite this broad definition, maintaining skin integrity has 
become a surrogate term in the literature for pressure ulcer (PU) prevention. 
However, beyond PUs, older patients can be at risk for a range of iatrogenic skin 
injuries. Prevention of hospital acquired PUs has shaped policy, funding, and 
research agendas internationally, and has been the primary activity in maintaining 
skin integrity in the acute care setting. Multiple conceptual frameworks (Braden & 
Bergstrom, 1987; Coleman et al., 2014; DeFloor, 1999; National Pressure Ulcer 
Advisory, European Pressure Ulcer Advisory, & Pan Pacific Pressure Injury, 2014) 
have been published that address pressure ulcer risk factors and aetiology. However, 
publication of a range of consensus documents has resulted in increased appreciation 
of other iatrogenic skin injuries (Beeckman et al., 2015; Black et al., 2011; LeBlanc 
& Baranoski, 2011; McNichol et al., 2013). These injuries include incontinence-
associated dermatitis (IAD) (Beeckman et al., 2015), intertriginous dermatitis, 
peristomal or periwound moisture-associated skin damage (MASD) (Black et al., 
2011), skin tears (LeBlanc & Baranoski, 2011) or medical adhesive-related skin 
injury (MARSI) (McNichol et al., 2013) (see Table 2.1).  
A compelling argument in support of an integrated skin safety paradigm is an 
appreciation of the multiple contributing factors that many iatrogenic skin injuries 
share. A recent narrative synthesis of 54 published studies, with more than 34,000 
participants was conducted by Coleman and colleagues (2013), to identify pressure 
ulcer risk factors. The most common PU risk factors identified were in the domains 
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of mobility/activity, perfusion, PU status, skin moisture, age, haematological 
measures, and general health status. They concluded that a complex interplay of 
factors, rather than a single risk factor increased the probability of PU development. 
It is noteworthy that these PU risk factors are also cited as risk factors for other 
iatrogenic skin injuries, such as skin tears or IAD (Beeckman et al., 2015; LeBlanc & 
Baranoski, 2014). However, apart from the work of García-Fernández, Agreda, 
Verdú, and Pancorbo-Hidalgo (2014) proposing the mechanism for dependence-
related lesions, and the work of Campbell (2009), recognising the association 
between PU and frailty, there is a general paucity of research exploring shared and 
synergistic factors contributing to iatrogenic skin injury in older adults. 
While iatrogenic skin injuries share multiple contributing factors, prevention 
and management of these skin injuries is commonly undertaken in silos. This siloed 
approach can result in fragmented, duplicated, or inconsistent care, as well as a 
multitude of conceptual frameworks and consensus documents addressing individual 
skin integrity outcomes (Brown & Sears, 1993; Coleman et al., 2014; Doughty et al., 
2012; LeBlanc & Baranoski, 2011). To our knowledge, there is no over-arching skin 
integrity framework recognising shared risk factors and acknowledging a variety of 
potential outcomes.  
In the last three decades, several conceptual frameworks have been published 
that deal specifically with pressure ulcer aetiology. A seminal paper by Braden and 
Bergstrom (1987) identified tissue tolerance and pressure as critical determinants of 
pressure ulcer development. Subsequently, the term tissue tolerance has been used 
throughout PU literature to denote the ability of the skin and supporting structures to 
endure the effects of pressure without adverse sequale (Benoit & Mion, 2012; 
Coleman et al., 2014; DeFloor, 1999; National Pressure Ulcer Advisory et al., 2014). 
Further, a central concept in these frameworks is the recognition that risk of PU 
development results from an interplay between multiple factors, including individual 
tissue tolerance, and the influence of the type, intensity, and duration of an external 
force acting on the body. In addition to recognising the influence of tissue tolerance 
and external forces acting on the body, Defloor’s model (1999) includes nursing and 
medical interventions as determinants of both pressure and shear, and ultimately PU 
development. The recent conceptual model proposed by Garcia-Fernandez et al. 
(2014) moves beyond considering only PU aetiology, to identify shared risk factors 
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common to pressure ulcers and other dependence lesions, suggesting a growing 
appreciation of shared antecedents of iatrogenic skin injury. 
Consensus documents dealing with skin injuries other than PUs reveal several 
common themes regarding skin injury contributing factors and aetiology (Brown & 
Sears, 1993; Coleman et al., 2014; Doughty, 2012; LeBlanc & Baranoski, 2011). 
Firstly, the response to potentially harmful forces acting on skin is highly influenced 
by tissue tolerance and is unique to each individual. Secondly, that impaired tissue 
tolerance is a key aetiological factor for any iatrogenic skin injury, not just pressure 
ulcers. Tissue tolerance is a construct that varies slightly between authors, but is 
consistently linked with an individual’s advancing age, pre-existing health status, and 
comorbidities, nutrition, medications, perfusion, oxygenation, mobility, and sensory 
perception. Finally, elements that threaten skin integrity in vulnerable individuals are 
pressure, shear, friction, moisture, and trauma.  
Pressure ulcer prevention strategies are well documented in the literature, and 
include nursing and medical interventions (such as skin assessment, repositioning, 
and appropriate equipment selection) (National Pressure Ulcer Advisory et al., 2014). 
The impact of healthcare interventions on skin integrity outcomes is largely under-
appreciated in PU or other skin integrity conceptual frameworks. Defloor’s (1999) 
insightful inclusion of the influence of healthcare systems factors (such as medical 
and nursing interventions) as PU risk factors demonstrates a comprehensive 
framework that moves beyond physiological and biomechanical causes of PU and 
recognises broader threats to skin integrity. 
Recognition of healthcare systems and processes as a potential component of 
a risk profile is echoed in the quality health outcomes model proposed by Mitchell, 
Ferketich and Jennings (1998). This model proposed the existence of dynamic 
feedback between patients, healthcare interventions, and the system in which care 
was provided. Further, they asserted that patient characteristics directly affected the 
intervention outcome. Their model highlights the need for consideration of the 
influence of organisational or system factors on outcomes, and that interventions 
should be evaluated within the context of interactions and feedback between the 
patient and the system (Mitchell et al., 1998). While not specifically dealing with PU 
or skin integrity, Mitchell and colleagues’ model (1998) supports Defloor’s (1999) 
contention that systems and process elements (i.e., nursing and medical 
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interventions) should be considered in care delivery and subsequent patient 
outcomes.  
Overall, there is agreement in the literature that iatrogenic skin injuries result 
from complex, multifactorial, and interconnected threats. It is clear from the 
literature review that the phenomenon of skin safety, or iatrogenic skin injury, as a 
holistic concept is not represented. The term skin safety used in this paper denotes 
the protection from possible alteration or injury to the epidermis and/or dermis in the 
older patient resulting from the interplay between multiple and complex threats to 
skin integrity. While there is a significant body of literature regarding PU aetiology, 
prevention and management, and similarly, a growing body of research addressing 
other discrete iatrogenic skin injuries, a gap remains in the conceptualisation of skin 
vulnerability to injury as an over-arching phenomenon.  
A Model for Skin Safety 
In a single model, the SSM (see Figure 2.1) guides clinicians in the 
recognition and consideration of diverse yet inter-related contributing factors in the 
aetiology of a range of iatrogenic skin injuries and subsequent outcomes. The model 
consists of four domains or constructs: (a) potential contributing factors to skin 
injury, (b) exacerbating elements, (c) potential skin injury, and (d) potential 
outcomes of skin injury. Within each domain is a subset of determinants, which can 
be considered as dynamic, or on a continuum. There are a myriad of combinations of 
these determinants, with varying severity, relevance, or impact for each individual. 
The determinants have the potential to change according to a specific situation, 
interaction with other domains, or the passage of time. The relationship between the 
potential contributing factors and exacerbating elements domains is represented by a 
plus symbol to indicate the cumulative or magnifying effect of the first domain on 
the second. The relationship between the exacerbating elements and potential skin 
injuries domains is represented by an arrow, indicating the potential range of 
consequences (that is skin injuries) that flow from interactions between the previous 
two domains. An arrow represents the direct relationship between the potential skin 
injury and the final domain, the range of potential outcomes as experienced by an 
individual. 
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Figure 2.1 Skin Safety Model. 
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Patient Factors 
Patient factors in the SSM are determinants situated within the domain of 
potential contributing factors to skin injury. The determinants constituting patient 
factors are advanced age, multiple co-morbidities, mobility limitations, poor 
nutrition, incontinence, factors affecting perfusion and oxygenation, polypharmacy, 
alterations in sensation, and cognition. Ageing is associated with the presence of 
accumulating chronic illnesses, multi-morbidity, and geriatric syndromes (Dagmar 
2013, Inouye et al., 2007; Lakhan et al., 2011). The term geriatric syndrome/s refers 
to multifactorial health conditions that result from accumulated effects in multiple 
systems, and describes conditions in older people that are not categorised as discrete 
diseases, including incontinence, falls, PUs, delirium, and functional decline (Inouye 
et al., 2007). Multiple co-morbidities add cost and complexity to healthcare due to 
disease interactions and the resultant complexity of the required care (Greene, Dasso, 
Ho, & Genaidy, 2014). It is clear that the presence of multiple disease states and 
geriatric syndromes influence all body systems, including skin.  
System Factors 
Systems factors are determinants also situated within the domain of potential 
contributing factors to skin injury. A system is defined as a set of things working 
together as parts of a mechanism or an interconnecting network, to form a complex 
whole (Fowler H. W., Fowler F. G., & Crystal, 2011). The system represented in the 
SSM denotes the organised agency where care of the patient happens, specifically the 
hospital (McClellan et al., 2014; Mitchell et al., 1998). The domain of the system of 
care is conceptualised in the SSM as comprising both structural and process elements 
(Mitchell et al., 1998). Structural elements of the system can include clinical 
governance, safety culture, funding models, leadership, staffing, and skill–mix 
(Mitchell et al., 1998; Youngberg, 2013). A process is defined as a series of actions 
or steps taken in order to achieve a particular end (Fowler H. W. et al., 2011). 
Process elements represented in the SSM refer to direct and indirect interventions 
and activities by which care is delivered (Mitchell et al., 1998; Youngberg, 2013). 
The process elements in the SSM refer to interventions and activities that influence 
skin integrity outcomes, for example: skin assessment, documentation, bed rest, 
mobilisation, fasting, medication administration, use of mechanical barriers (such as 
restraints or bed rails), or tethers (such as catheters, drains or intravenous lines) (Bry 
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et al., 2012; Montalvo, 2007; Youngberg, 2013). Ultimately, structural and process 
elements of the system interact to affect patient outcomes (Mitchell et al., 1998), in 
this case, skin integrity outcomes.  
The means by which a hospital receives its funding is integral to the system 
of care and has a profound influence on its structures and processes. Traditionally, 
many healthcare systems have been provider or supply driven, whereby separate 
elements of care are remunerated (McClellan et al., 2014). The goal of provider or 
supply driven funding models is to improve patient access to service and outcomes 
(Solomon, 2014). An example of the use of funding systems being used as leverage 
to influence skin integrity outcomes is seen in the reduction of reimbursement for 
treatment of hospital acquired pressure ulcers (HAPUs), or the introduction of 
financial incentives for HAPU prevention. It can be argued that funding disincentives 
for specific aspects of skin safety (i.e., PU prevention) may foster a narrow focus on 
a specific activity (to avoid financial penalty), while opportunities to provide broader 
overarching skin safety programs are potentially overlooked (McClellan et al., 2014).  
The structure and process by which nursing care is delivered within the 
hospital system can influence skin integrity outcomes. Missed nursing care is seen as 
a systems error of omission (Kalisch, Landstrom, & Hinshaw, 2009), and may 
include missing scheduled repositioning, not undertaking a skin inspection, 
inappropriate management of incontinence, or missed feeding. These aspects of care 
all have a direct role in maintaining skin integrity, therefore, if any or all of these 
aspects of care are delayed, incomplete, or even omitted, skin injury may result 
(Kalisch et al., 2009). Predictors of missed care in a recent study (Blackman et al., 
2014) included nursing resource allocation, workload intensity, and workload 
predictability. It can be seen that the structure and process by which nurses are able 
to provide care has a direct impact on PU risk and subsequent outcomes, and 
warrants consideration in the broader skin safety paradigm. 
Situational Stressors 
A situational stressor is a further determinant in the domain of potential 
contributing factors to skin injury. A situational stressor is conceptualised in the SSM 
as an acute event, illness, or trauma requiring a hospital admission for an older 
individual. A situational stressor may be a fall resulting in trauma, an acute infection, 
or an exacerbation of a pre-existing condition. Increases in an individual’s 
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vulnerability to stressors such as infection, injury, surgery, or hospitalisation can 
result in significant and sometimes fatal declines in health (Fried et al., 2001). The 
combination of multiple patient factors interacting with the complex hospital system, 
compounded by an individual’s lack of capacity to respond to these stressors, can 
potentially lead to a multiplicity of adverse events, including iatrogenic skin injury.  
Exacerbating Elements 
The next domain in the SSM is exacerbating elements, conceptualised by the 
determinants pressure, shear, friction, or the presence of irritants on the skin. 
Exposure to one or a combination of these determinants can result in skin injury. 
These skin integrity threats have been well defined and conceptualised in the 
literature (Beeckman et al., 2015; Gefen, 2014; Gray, 2007; National Pressure Ulcer 
Advisory et al., 2014; Oomens, Bader, Loerakker, & Baaijens, 2015; Shaked & 
Gefen, 2013).  
Potential Skin Injuries 
The fourth domain in the SSM is potential iatrogenic skin injuries, with the 
determinants being PU, skin tears, IAD, intertriginous dermatitis, and MARSI. These 
injuries are the result of the interactions and convergence of the domains of potential 
contributing factors and exacerbating elements. For instance, an older person who is 
able to mobilise at home, but falls frequently, may be vulnerable to skin tears as a 
result. However, if a situational stressor is experienced (for example, acute diarrhoea 
requiring hospital admission), the same individual is likely to be at increased risk of 
PU and IAD, as well as concomitant skin tear risk. Due to the multiple shared 
contributing factors, older patients can be simultaneously at risk of a range of 
different skin injuries. 
Potential Outcomes of a Skin Injury 
The potential outcome of a skin injury constitutes the final domain of the 
SSM. Regardless of aetiology, disruption to skin integrity can impact on wellbeing 
and predispose an individual to infection, pain, increased morbidity, and mortality 
with the attendant increase in the demand on healthcare services (Carville, 2012). 
The experience of a skin injury is highly individual, can change over time, and can 
impinge on all domains of wellbeing (physical, mental, social, and spiritual/cultural) 
(Augustin et al., 2012). The inclusion of potential outcomes of skin injury in the 
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SSM is unique. Rather than limiting the framework to identifying the skin injury, 
recognition of the patient’s experience of iatrogenic skin injury is fundamental for 
delivery of holistic person-centred care. 
Shifting the Paradigm From Prevention to Skin Safety 
The SSM proposes a paradigm shift away from specific skin injury 
prevention towards a holistic patient-centred goal of maintaining skin integrity. 
Patient individuality in the context of multiple and shared risk factors is a central 
premise of the SSM, allowing numerous skin integrity outcomes to be 
accommodated in a single integrated framework. The SSM recognises that dynamic 
and individual interactions between skin injury antecedents may result in different 
outcomes for each individual. Managing multiple individual risks separately may 
result in competing risk assessments, care pathways, systems demands, and 
priorities; ultimately resulting in fragmented or duplicated care. The SSM provides a 
single integrated framework to facilitate skin integrity management at the individual 
patient level. 
Contemporary patient care is compounded by traditional biomedical models 
of disease that have a linear focus on aetiology, pathological processes and ultimately 
specific clinical outcomes (Chiarelli, Bower, Wilson, Attia, & Sibbritt, 2005). This 
specialised care delivery can result in the perception of the hospital being a series of 
departments or silos (with each concerned with their own budgets and performance 
indicators) delivering fragmented care, rather than being a fully integrated process or 
continuum of care (Shortell & Singer, 2008). The impact of the multifactorial 
complexity and individuality of the patient can be easily lost in the specialty silo 
(Denham, 2009; Inouye et al., 2007). Multiple narrow condition focused care 
paradigms, with attendant narrow solutions, and the potential for duplication and 
inconsistency, is neither sustainable, nor desirable in the modern healthcare 
environment. Improving care delivery and systems requires initiatives that address 
multiple problems across a continuum of care.  
Vulnerability to iatrogenic skin injury in the older acute care patient results 
from the convergence of multiple complex factors. An appreciation of the 
complexity and diversity of all of these factors can create the circumstances whereby 
genuine holistic care can be planned and delivered, with the overall goal of care 
being skin safety/the prevention of iatrogenic skin injury. The SSM encompasses this 
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complexity and offers a theoretical foundation for innovative skin injury prevention 
in the acute care environment. 
Conclusion 
Maintaining skin integrity in the older hospitalised adult is a priority for 
healthcare providers. Diverse antecedents interact synergistically to cause a range of 
possible iatrogenic skin injuries. These injuries have implications for patients and the 
healthcare system alike, including pain and suffering, as well as increased cost and 
length of hospital stay. This paper has presented a model formulated from a review 
of the literature for conceptualising skin safety in a unified way. The SSM moves 
beyond physiology and biomechanics to encompass and reconceptualise varied and 
complex factors that can converge, interact, and ultimately lead to skin injury in 
older patients. However, the SSM is not a risk assessment tool; rather, it is a 
framework to guide clinicians and healthcare providers in the recognition and 
consideration of the complexity of skin injury aetiology. Further testing and 
validation of the SSM is required. Opportunities for further research include the 
development and validation of an integrated skin safety risk assessment tool. 
Research and quality activities, such as PU prevalence and incidence studies in the 
acute care setting could be expanded to encompass data collection on any concurrent 
iatrogenic skin injury, rather than simply determining PU status. Reframing quality 
indicators to include an organisation’s response to skin risk rather than PU 
management and prevention may result in improved overall patient outcomes, as 
well as improved system efficiencies. The paradigm shift from focus on specific skin 
injury prevention to an appreciation of over-arching skin integrity vulnerability in the 
older adult patient is timely in light of the challenges healthcare systems are facing. 
A comprehensive and innovative approach to skin safety is essential to deal with 
increasing patient age, acuity, and complexity, increasing fiscal challenges, and the 
fundamental expectation that healthcare is safe. 
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2.5.1 Research published following Publication 1 
Research published after Publication 1 of this thesis identified that there are a 
range of factors that occur during a hospital admission that can lead to functional 
decline in elderly patients. These factors include poor mobilisation, inappropriate use 
of incontinence aids, indwelling urinary catheters, poor continence management, 
under-nutrition, and hospital environments that are noisy, disorienting, and socially 
isolating (Admi, Shadmi, Baruch, & Zisberg, 2015; Sourdet et al., 2015; Zisberg et 
al., 2015). This research demonstrates a growing appreciation of the challenges of the 
hospital environment for older patients, and healthcare systems that may not be 
equipped to deal with their complex needs, and as such, pose a threat to this group. 
While these findings cite functional decline rather than skin injuries as primary 
outcomes, analogies can be drawn regarding the premise of the SSM (Campbell, 
Coyer, & Osborne, 2015), in that interactions between complex and multifactorial 
antecedents have the potential to result in a wide range of adverse outcomes. 
2.6 CHAPTER SUMMARY  
The literature review revealed that contemporary healthcare faces multiple 
challenges from unsustainable increases in healthcare expenditure, rapidly ageing 
populations, and changing patterns of disease and disability. Globally, these rapid 
changes have become the drivers for 21st century healthcare reform. Contemporary 
healthcare continues to be delivered in specialty silos, yet this system of care is at 
odds with the complex care needs of contemporary patients, and even creates 
situations in which care is fragmented, duplicated or missed. Parallels between 
contemporary healthcare delivery and contemporary skin integrity practices can be 
observed. Like contemporary healthcare, skin integrity care is frequently delivered in 
silos, as is evidenced by the multiple, individual skin injury frameworks, as well as 
being influenced by the traditional biomedical model of disease, which focuses on 
aetiology, pathological processes and ultimately specific clinical outcomes (Chiarelli, 
Bower, Wilson, Attia, & Sibbritt, 2005). In addition, maintaing skin integrity in the 
modern healthcare environment is also affected by increasing patient complexity 
resulting from chronic, comorbid diseases, geriatric syndromes and frailty. At the 
same time, skin integrity care grapples with similar challenges faced by other 
healthcare providers; that is, providing cost-effective, efficient care, and offering 
innovative solutions to contemporary challenges. 
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Until now, a unifying skin safety framework has been lacking. The literature 
review culminated in the development of the SSM, an overarching evidence-based 
framework that guides skin integrity decision-making while appreciating the 
complexity of the contemporary acute care patient. The SSM addresses the 
conceptual and clinical need for a comprehensive framework that guides skin care in 
the older acute care patient, and constitutes the conceptual framework that underpins 
this research.  
The following chapter presents a review of the literature pertaining to skin 
structure and function, skin changes associated with ageing, a historical overview of 
IAD research, as well as IAD pathophysiology, risks, clinical presentation, and 
complications.  
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Chapter 3: LITERATURE REVIEW, PART B - 
INCONTINENCE-ASSOCIATED 
DERMATITIS AND INCONTINENCE-
ASSOCIATED CANDIDA INFECTION 
3.1 INTRODUCTION 
This chapter presents a review of the literature on IAD, including its 
aetiology, risk factors, and prevalence in the acute care setting. Understanding the 
structure and function of skin, its critical barrier function, and the unique skin 
changes experienced by older adults forms the foundation for understanding the 
pathophysiology of IAD. Furthermore, an overview of the effects of moisture, urine, 
and faeces on skin barrier function as a result of incontinence, the effects of 
occlusion (as a result of wearing an incontinence aid) on skin, and the clinical 
presentation of IAD are presented in this chapter. The complications of IAD, 
including Candida albicans infection, are also discussed.   
3.1.1 Literature search strategy 
The search strategy for this chapter is per the search strategy detailed in 
Chapter 2, with the addition of the search terms, incontinence-associated dermatitis, 
perineal dermatitis, diaper dermatitis, moisture-associated skin damage, combined 
with additional key words including aetiology, prevention, management, risk 
factor/s, risk assessment, complication/s, superimposed, secondary, fungal, Candida, 
albicans, and colonisation. The literature for this chapter was searched between 1985 
and December 2014. The year 1985 was chosen to capture seminal papers addressing 
IAD in the early 1990s.  
3.1.2 Incontinence 
IAD is a condition resulting from chronic skin exposure to urine and faeces 
due to incontinence. In order for an individual to develop IAD, they must be 
incontinent (Gray et al., 2007), therefore, an appreciation of incontinence is essential 
in order to understand IAD. Incontinence is defined as the unwanted and involuntary 
leakage of urine and/or faeces (Abrams et al., 2010; Ahmed & Pearce, 2010; 
Homma, 2008; Inouye et al., 2007; Junkin & Selekof, 2007). It can affect any age 
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group, but is more common in older adults, with more than half of incontinent 
individuals aged over 50 years, and those aged over 65 years are 12 times more 
likely to experience severe incontinence (Australian Institute of Health and Welfare, 
2014). The prevalence of incontinence in the acute care setting is poorly understood 
(Ostaszkiewicz et al., 2008). One study conducted in this setting in the United States 
found the prevalence of incontinence to be 19.7% (Junkin & Selekof, 2007). Another 
study reported the prevalence of incontinence to range from 10%-43% for urinary 
incontinence and 7%-33% for faecal incontinence (Ostaszkiewicz et al., 2008). In 
Australia, a study investigating the prevalence of geriatric syndromes in the acute 
care setting, found that the prevalence of bladder incontinence in a cohort of 570 
medical patients aged over 70 years was 44% (Lakhan et al., 2011). The prevalence 
of incontinence is an indicator of the magnitude of risk of IAD in a given group of 
patients (Ersser et al., 2005). However, while it is clear the prevalence of 
incontinence is significant, and set to rise and, like the prevalence of IAD, it remains 
poorly understood in the hospital setting.  
3.1.3 Skin structure and function 
Skin is the largest and most visible organ in the body. It is divided into three 
distinct layers: firstly, the epidermis or outer layer; secondly, the dermis, known as 
the factory of the skin; and finally, the hypodermis, which is the supporting layer of 
the skin (Carville, 2012). The epidermis, the outermost skin layer, varies in thickness 
according to location, and is comprised of stratified squamous epithelial cells or 
keratinocytes (Rolstad, Ermer-Seltun, & Bryant, 2011). The epidermis itself consists 
of a further five layers; from the very outer layer, the stratum corneum, followed by 
the stratum lucidum, the stratum granulosum, the stratum spinosum, and finally the 
stratum germinativum or basale (2015; Carville, 2012; Wysocki, 2007). Stem cells in 
the basal layer of the epidermis divide and form differentiated keratinocytes that 
mature and travel upwards to the stratum corneum. As these keratinocytes travel 
through the epidermal layers, they become flat, densely packed and anucleate, 
eventually forming the stratum corneum (Rolstad et al., 2011). The process of 
epidermal turnover takes approximately 28 days, but can be accelerated in some skin 
diseases and be significantly slower in older age, sometimes up to 42 days (Fore, 
2006; Rolstad et al., 2011). An intact epidermis is responsible for the important 
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barrier function of the skin (Carville, 2012; Ersser et al., 2005; Wysocki, 2007 ) (see 
Section 3.1.4).  
The basement membrane zone (BMZ), or dermal-epidermal junction, anchors 
the epidermis to the dermis (Wysocki, 2007). The BMZ is divided into two zones—
the lamina lucida and lamina densa. The proteins present at the BMZ, such as 
fibronectin, laminin, type IV collagen, and heparin sulphate, all play a role in cellular 
adhesion or anchoring the epidermis to the dermis (Wysocki, 2007). Flattening of the 
dermo-epidermal junction as a result of loss of dermal papillae and reduced 
interdigitation between layers results in less resistance to shearing forces and an 
increased vulnerability to skin injury (Farage, Miller, Elsner & Maibach, 2013). 
Skin is the interface between the internal and external environment and is 
required to perform multiple functions in order to maintain homeostasis (Carville, 
2012; Ersser et al., 2005; Fore, 2006). These functions include protection against a 
multitude of external agents, including chemical, thermal, and mechanical insults, 
moisture, microorganisms, electromagnetic radiation; and protection against 
dehydration (Carville, 2012; Fore, 2006). The essential protective sensory function of 
skin is facilitated by receptors that respond to pain, heat, cold, touch pressure, and 
vibration. Thermoregulation is another vital function and occurs by a variety of 
mechanisms, for example, radiation of heat from blood vessels and excretion and 
evaporation of sweat (Carville, 2012; Wysocki, 2007). Skin also facilitates the 
synthesis of vitamins and hormones, as well as playing a role in immunity (Baroni et 
al., 2012; Carville, 2012; Di Meglio, Perera, & Nestle, 2011b). Finally, the cosmetic 
function of skin (cosmesis) is a key function of psychosocial health (Carville, 2012). 
3.1.4 Skin barrier function 
As discussed in the previous section, a vital function of the skin is to provide 
an effective barrier between the internal and external environment (Gray, 2004; 
Menon & Kligman, 2009; D.Voegeli, 2012). Understanding the skin’s barrier 
function is of particular importance in understanding, preventing, and managing 
IAD. The ability of the skin to function effectively as a barrier depends on several 
factors, including the integrity of the skin and its structure, the presence of inter- and 
extra-cellular lipids, and the skin’s pH (Gray, 2004).  
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The skin’s barrier function is found in the stratum corneum and was 
demonstrated in 1953 by the seminal work of Blank (1953). An intact stratum 
corneum or outer skin layer is a vital component of the physical barrier (Menon & 
Kligman, 2009). The stratum corneum is organised into two compartments, 
comprising corneocytes, 18-20 layers thick enveloped in a lipid matrix. This 
structure has been described as resembling ‘bricks and mortar’ (Michaels, 
Chandrasekaran, & Shaw, 1975). The corneocytes are held together by 
corneodesosomes, which gradually degrade to allow for the desquamation of the 
outermost corneocytes (Menon, Cleary, & Lane, 2012). The lipids surrounding the 
corneocytes contain a range of ceramides, cholesterol, and free fatty acids that 
provide the permeability barrier. The stratum corneum also contains lipolytic and 
proteolytic enzymes that contribute to its biochemical activities (Menon et al., 2012; 
Menon & Kligman, 2009). While the extracellular space in the stratum corneum (the 
so-called mortar) is hydrophobic, the corneocytes themselves maintain their 
hydrophilic nature from keratins and natural moisturising factors found within the 
corneocytes (Menon et al., 2012; D.Voegeli, 2012). The role of the natural 
moisturising factor is to maintain skin hydration, plasticity, and allow the effective 
function of desquamation, ultimately supporting skin barrier function (Rawlings, 
Scott, Harding, & Bowser, 1994).   
 The pH of skin ranges from 4.2-5.6, with the slightly acidic pH commonly 
known as the acid-mantle (Carville, 2012;Wysoski, 2007). The acidic skin surface 
provides several important functions. Firstly, acidic pH provides a defence against 
invading organisms. Normal skin flora growth is optimal at acidic pH levels, whereas 
pathogenic bacteria and yeast such as Candida albicans flourish at neutral or raised 
pH levels (Ali & Yosipovitch, 2013; Baroni et al., 2012; Lambers, Piessens, Bloem, 
Pronk, & Finkel, 2006). Secondly, acidic skin pH plays a role in maintaining the skin 
barrier function. Lipid processing enzymes responsible for a competent skin barrier 
in the stratum corneum are dependent on an acidic pH (Ali & Yosipovitch, 2013; 
Baroni et al., 2012). Studies have shown that elevations of skin pH reduce the 
activity of ceramide-generating enzymes and increase the activity of serine proteases, 
resulting in a disturbed skin barrier (Ali & Yosipovitch, 2013). Furthermore, skin pH 
changes are involved in the pathogenesis of irritant contact dermatitis, atopic 
dermatitis, acne vulgaris, and Candida albicans infections (Baroni et al., 2012). 
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Overall, disruptions to the skin barrier function form the basis for IAD. There 
are multiple factors that cause disturbances to the skin barrier. These factors and their 
impact on the skin barrier function are discussed in the following sections. 
3.1.5 Effects of moisture, urine, and faeces on skin barrier function 
Moisture from urine, liquid faeces, and perspiration is responsible for a 
significant component of the skin damage seen in IAD. Urine is typically 95% water, 
with a variety of solutes present, including urea; however, the duration of moisture 
exposure is the most important skin irritation factor (Gray et al., 2011). A study 
conducted by Mayrovitz and Sims (2001) found that pads saturated with synthetic 
urine and applied to the forearms of healthy volunteers resulted in significant 
reductions in skin hardness, temperature, and blood flow during pressure load, 
leading the authors to conclude that skin wetness results in skin injury. Water also 
increases skin permeability, allowing for the passage of irritants that can create 
allergic or contact dermatitis (Tsai & Maibach, 1999; D.Voegeli, 2013). 
Furthermore, the presence of moisture, exacerbated by occlusion, removes the 
stratum corneum lipids and natural moisturising factors leading to dry and cracked 
skin (Tsai & Maibach, 1999). Excess moisture also disrupts the stratum corneum 
intercellular space and causes stratum corneum swelling (Tsai & Maibach, 1999; 
D.Voegeli, 2013). In addition to stratum corneum disruption, excess skin moisture 
creates injury by increasing the coefficient of friction (that is the measurement of the 
amount of friction existing between two surfaces) resulting in a chaffing injury as 
well as increased susceptibility to pressure injury (Gefen, 2014; Reger, 2010). 
Skin contact with bacteria in faeces also contributes to loss of skin barrier 
function. Bacteria in faeces cause skin damage by converting urea from urine to 
ammonia, which in turn raises the skin pH and reactivates the digestive enzymes 
lipase and protease that are present in faeces (Berg, Milligan, & Sarbaugh, 1994; 
Farage, Miller, Berardesca et al., 2007; Gray et al., 2007). Furthermore, liquid faeces 
are the highest in digestive enzymes, explaining in part why individuals who have 
liquid faecal incontinence suffer from greater skin irritation (Beeckman et al., 2015; 
Farage, Miller, Berardesca et al., 2007; Gray et al., 2007; Nix, 2002). It has been 
shown that patients with urinary and faecal incontinence and/or liquid faeces are 
more likely to develop IAD (Beeckman et al., 2015; Gray et al., 2007). 
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3.1.6 Occlusion 
Skin occlusion, resulting from the requirement to wear incontinent aids or 
pads can potentially cause several deleterious effects, including reduction in 
evaporative water loss, increases in skin pH, increases in local skin temperature, and 
microbial populations (Aly, Shirley, Cunico, & Maibach, 1978; Fidel, 1999; Honig, 
1983; Tsai & Maibach, 1999; Zhai & Maibach, 2002). Further, occlusion increases 
local skin pH, which has been demonstrated to be a risk factor for the development 
of Candida infections (Ali & Yosipovitch, 2013; Baroni et al., 2012). 
3.1.7 Effects of ageing on skin 
As an individual ages, a range of changes in skin structure and function 
become apparent that can lead to vulnerability to a range of injuries and diseases 
(Farage et al., 2008). Influenced by intrinsic and extrinsic factors, skin changes 
include biochemical alterations, reduction in neurosensory perception, and skin 
permeability, changes in response to injury and repair ability. (Farage et al., 2008; 
Lawton, 2007). Physiological skin changes result in the loss of dermal and 
subcutaneous tissue, with a loss of as much as 20% of dermal thickness (Farage et 
al., 2008; LeBlanc & Baranoski, 2011). Thinning and flattening of the dermal-
epidermal junction occurs, decreasing junctional strength (Farage, Miller, Elsner & 
Maibach, 2013). Decreased production and increased degradation of collagen, as 
well as a decline in elastin production and organisation results in thinning and 
atrophy of the dermis. This causes loss of tensile strength and skin elasticity 
(LeBlanc & Baranoski, 2011; Thomason & Hardman, 2009). This loss of elasticity 
results in skin becoming more vulnerable to injury from mechanical forces such as 
shearing and friction (Carville, 2012; LeBlanc & Baranoski, 2011). Further, thinning 
of the hypodermis combined with the aforementioned factors predisposes an 
individual to injury from excessive pressure (Wysocki, 2007). 
Skin circulation is diminished due to the decline and disorganisation of 
capillaries and small vessels, as well as reduced vessel density, with decreased 
vascularity and atrophy of the dermis and hypodermis (LeBlanc & Christensen, 
2011; Wysocki, 2007). The immune and inflammatory responses are impaired, with 
decreased numbers of Langerhans’ cells (antigen-presenting cells), as well as cells 
and melanocytes (cells responsible for pigmentation) (Carville, 2012; Farage et al., 
2008; LeBlanc & Baranoski, 2011; Wysocki, 2007). In addition, the loss of 
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superficial pain sensation, as well as a delay in pain perception, creates vulnerability 
to injury as the skin’s early warning signals, that is pain, erythema, and oedema do 
not appear as quickly in aged skin as in younger persons (Farage et al., 2008).  
The aged individual may have impaired wound healing as a result of reduced 
immune response, angioneogenesis, fibroblast function, and epidermal proliferative 
capacity (Thomason & Hardman, 2009; Wysocki, 2007). Skin deterioration and 
concomitant comorbidities predispose older individuals to a multitude of potential 
skin integrity threats. Understanding the unique vulnerability of aged skin is 
especially important for the clinician who provides healthcare for this population.  
3.1.8 Incontinence-associated dermatitis: A historical perspective 
 IAD affects all age groups, from infants to the elderly, all races and genders, 
and can be found in incontinent individuals in community, long term, and acute care 
settings (Brown & Sears, 1993). In infants, IAD is known as diaper dermatitis or 
napkin rash (Brookes, Hubbert, & Sarkany, 1971; Brown & Sears, 1993) and has 
been researched extensively for the last 50 years (Benson, Slobody, Lillick, Maffia, 
& Sullivan, 1947; Brookes et al., 1971; Ferrazzini et al., 2003; Gokalp, Aldirmaz, 
Oguz, Gultekin, & Bakici, 1990; Goldstein, 1949; Hayakawa & Matsunaga, 1987; 
Honig, 1983; Kayaoglu, Kivanc-Altunay, & Sarikaya, 2015; Keiter, 1970; 
Koblenzer, 1973; Leonard, 1967; Litchfield, 1959; Zimmerer, Lawson, & Calvert, 
1986). Research into adult IAD did not commence in earnest until the early 1990s. 
 During the last two decades, nurses have driven the IAD research 
agenda, with some of the earliest research conducted in 1991 by Lyder, Clemes-
Lowrance, Davis, Sullivan, and Zucker, (1992). This group investigated the efficacy 
of a structured skin care regimen to prevent perineal dermatitis in geriatric psychiatry 
inpatients. Lyder et al.’s (1992) research identified that the combination of skin 
exposure to both urine and faeces increases the incidence of perineal dermatitis and 
concluded that that the use of a structured skin care regimen is warranted for the 
prevention of the condition. 
In 1993, a conceptual framework addressing the predisposing factors for 
perineal dermatitis was proposed by Brown and Sears. Identified predisposing factors 
were categorised according to tissue tolerance (age, health status, nutrition, 
oxygenation, perfusion, and temperature), perineal environment (character and type 
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of incontinence, mechanical chafing, inducing agents, and increased skin 
permeability), and toileting ability (mobility, sensory perception, and cognitive 
awareness) (Brown & Sears, 1993). 
In 2007, the release of the seminal consensus document by Gray et al. 
proposed the term IAD. This term was chosen as it accurately reflected the response 
of the skin to exposure to urine and/or faeces, specifically identifying the source of 
the irritant and acknowledging that a larger area of skin than the perineum is 
affected. A definition of IAD was also proposed by Gray et al. (2007): ‘the response 
of the skin to chronic exposure to urine or faecal materials (inflammation and 
erythema with or without erosion or denudation)’ (p. 46). The consensus document 
(Gray et al., 2007) also acknowledged that IAD can affect an extensive area of skin, 
namely the perineal and perianal areas, labial folds, scrotum, groins, lower abdomen 
and upper inner thighs region of incontinent individuals. Gray and colleagues (2007) 
identified gaps in the understanding of IAD and outlined areas where further research 
was needed, including understanding of the prevalence of the condition, particularly 
in the acute care setting, and understanding of the epidemiology and pathophysiology 
of IAD. 
A further expert consensus conference was convened in 2010, with its 
outcome being the publication of consensus statements regarding the prevention and 
treatment of IAD, as well as the identification of unresolved issues including 
challenges with the differential assessment of IAD and pressure injuries, as well as 
the assessment, prevention, and management of IAD (Doughty et al., 2012). Overall, 
there was agreement that the key components of an effective program for IAD 
prevention included gentle cleansing with a no rinse pH neutral cleanser, application 
of a moisture barrier product, and the use of a moisturiser to maintain skin barrier 
function (Doughty et al., 2012). 
Issues surrounding the accurate classification of IAD and pressure injuries 
were recognised by Defloor, Schoonhoven, Vanderwee, Weststrate, and Myny, 
(2006), who found that IAD was frequently misclassified as a stage I or II pressure 
injury. Subsequently, in 2007, the National Pressure Ulcer Advisory Panel (Black et 
al., 2007) issued an update regarding the description of stage II pressure injuries 
stating that this category should not be used to describe ‘skin tears, tape burns, 
perineal dermatitis, maceration or excoriation’ (p. 40). In response to these 
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challenges, Beeckman, Schoonhoven, Boucque, Van Maele, and Defloor, (2008) 
developed an e-learning tool to assist clinicians to improve the accuracy of 
differentiating these lesions. 
3.1.9 IAD risk assessment and categorisation 
IAD, unlike PI, does not have accepted or standardised risk assessment tools, 
nor an agreed categorisation system. A range of categorisation tools have been 
proposed, including the IAD Assessment and Intervention Tool (IADIT), (Junkin & 
Selekof, 2008), the Incontinence-Associated Dermatitis and its Severity (IADS) 
Instrument (Borchert, Bliss, Savik, & Radosevich, 2010), and the Skin Assessment 
Tool (SAT) (Kennedy & Lutz, 1996), with the Perineal Assessment Tool (PAT) 
proposed by Nix in 2002. However, while some of these tools have been used for 
research, their use in clinical practice remains limited. This may be, in part, because 
of a lack of evidence regarding improvements to clinical decision-making and care 
with their use (Beeckman et al., 2015). 
3.1.10 IAD risk factors 
The primary risk factor for IAD is skin contact with urine and /or faeces. The 
type of incontinence influences the level of risk, with patients with faecal 
incontinence with liquid faeces combined with urinary incontinence having the 
highest risk. The risk is lower for those with formed faeces, followed by a lower risk 
for those with urinary incontinence only (Beeckman et al., 2015). The use of skin 
occluding incontinence pads are also constitutes an IAD risk factor. In addition, poor 
skin condition, impaired mobility, impaired cognitive awareness, inability to perform 
personal hygiene, pain, pyrexia, poor nutrition status, and critical illness are also 
recognised as contributing factors for IAD (Beeckman et al., 2015; Bliss, Savik, 
Harms, Fan, & Wyman, 2006; Brown & Sears, 1993; Gray et al., 2007; Junkin & 
Selekof, 2007; Kottner, Blume-Peytavi, Lohrmann, & Halfens, 2014; D. D.Voegeli, 
2013). Older age does not appear to be an independent risk factor for IAD 
development; however, older age is associated with a higher prevalence of IAD 
(Beeckman et al., 2015; Kottner et al., 2014). 
3.1.11 Clinical presentation of IAD  
IAD initially presents with mild erythema, ranging from pink to red in 
individuals with light skin, and may present in individuals with darker skin tones as 
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yellow, white, or even dark purple (Beeckman et al., 2015; Farage, Miller, 
Berardesca et al., 2007; Junkin & Selekof, 2008). Secondary to inflammation, 
erythematous areas may feel warm to the touch, and may be indurated (Beeckman et 
al., 2015). Erythema may be followed by skin erosion, with epidermal damage 
varying in depth. In some cases, the entire epidermis may be eroded, revealing a 
moist weeping dermis. Lesions, such as papules, pustules, bullae, or vesicles may 
also be present (Beeckman et al., 2015; Farage, Miller, Berardesca et al., 2007). 
Affected areas have poorly defined edges and present as patchy or continuous over 
large areas (Beeckman et al., 2015). If a patient is able to communicate, they may 
describe burning, pruritis, or tingling sensations (Gray et al., 2007), or pain, with the 
pain of IAD being likened to a burn (Junkin & Selekof, 2007). 
3.2 IAD COMPLICATIONS 
IAD can cause several complications, including the development of PI, 
infection (commonly with Candida albicans), pain and decreased quality of life.  
3.2.1 Pressure injury 
Incontinence and increased skin moisture have been widely accepted as risk 
factors for PI development (Baharestani et al., 2010; National Pressure Ulcer 
Advisory et al., 2014). One study demonstrated that patients who are incontinent and 
immobile have a 37.5% increased risk of developing a PI (Maklebust & Magnan, 
1994). More recently, there has been a new understanding of the role of IAD as a risk 
factor for PI development. Gefan (2014) identified that IAD decreases the tolerance 
of skin for superficial PI by several mechanisms. Firstly, inflammation associated 
with IAD increases the local skin temperature, secondly, the skin-clothing or skin-
support coefficient of friction is increased due to wetness, and finally, the moist 
environment causes vasoconstriction, which causes wrinkling of the skin. All of 
these effects ultimately result in increased shear loads on the skin. A systematic 
review and meta-analysis conducted by Beeckman and colleagues (2014) to identify 
the association between IAD and PIs found an association between IAD, 
incontinence, and moisture and PI development, although the authors advised that 
methodological issues in the included studies should be considered when interpreting 
the results of the review (Beeckman et al., 2014). 
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3.2.2 Candida infection 
Candida infection is reported as a frequent complication of IAD (Black et al., 
2011; Farage, Miller, Berardesca et al., 2007; Gray et al., 2007; D.Voegeli, 2013). 
Candida albicans is more than one of almost 200 species in the Candida genus, and 
by far the most common and important species for humans is Candida albicans 
(Fidel, 1999; Moran et al., 2012; Odds, 1988). Candida species are classified as 
yeasts, that is, having a primarily unicellular mode of development. Candida grows 
as an oval-shaped budding yeast (blastospore or blastoconidia), as pseudohyphae, or 
as true hyphae. The blastospore is present in the commensal state, while the hyphal 
form of Candida albicans is often observed in the infective state (Fidel, 1999; Odds, 
1988). This organism can exist as a harmless commensal or transform into a serious 
pathogen, capable of causing superficial or invasive disease. Candida albicans 
colonises the genitourinary and gastrointestinal tracts and can be recovered from 
intertriginous areas but is rarely recovered from glabrous skin (Black et al., 2011; 
Fidel, 1999; Moran et al., 2012; Odds, 1988; Tobin et al., 2013)   
Candida infection results from the overgrowth of an individual’s endogenous 
colonising Candida species (most commonly Candida albicans) (Beeckman et al., 
2015; Farage, Miller, Berardesca et al., 2007; Gray et al., 2007; D.Voegeli, 2013). 
The risk factors or triggers for the transformation of Candida from commensal to 
pathogen are unclear, but it is thought that local skin environments that result in 
increased temperature, moisture, and pH, such as that found in those wearing an 
incontinent pad favour Candida growth (Aly et al., 1978; Fidel, 1999; Honig, 1983; 
Tsai & Maibach, 1999; Zhai & Maibach, 2002). Candida infection associated with 
IAD can present as either a bright red maculopapular rash spreading from a central 
area, with satellite lesions (characteristic of Candida infection) at the edge of the rash 
extending into normal skin, or non-specific confluent papules, making clinical 
diagnosis difficult (Beeckman et al., 2015; Habif, 2015).  
The prevalence of Candida infection associated with incontinence and IAD in 
the acute care setting is poorly understood. There is also a gap in the availability of 
microbiological data that confirms the diagnosis of Candida infection associated 
with IAD. This gap may be due, in part, to current clinical practice. The mainstay of 
diagnosis of a suspected Candida infection associated with IAD is visual inspection, 
commonly followed by empirical treatment. However, visual assessment can be 
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inaccurate, as the presentation of a Candida infection can vary from a central 
maculopapular rash, with characteristic satellite lesions, to a non-specific confluent 
rash (Habif, 2015; J. Sobel, personal communication, April 3, 2014). Therefore, 
while these presentations may be characteristic of Candida infection, they are not 
unique to Candida infections and could be attributed to other causes (Odds, 1988). 
This can result in Candida infections being under or over-estimated in clinical 
practice (Odds, 1988). Moreover, the presence of Candida on a microbiological 
specimen in the absence of clinical signs or symptoms does not necessarily constitute 
a Candida infection, rather it may represent colonisation. A positive result on a 
microbiological specimen should be interpreted with caution and simultaneous 
consideration of the clinical picture, otherwise over-estimation of the Candida 
infection may result (Odds, 1988).  
3.3 CHAPTER SUMMARY 
After the initial literature review for this thesis, a further international IAD 
expert panel was convened in 2014 to review IAD knowledge deficits, and to 
advance best practice principals to address these gaps. The resultant publication is a 
detailed expert consensus document (Beeckman et al., 2015) that recommends that 
the term, IAD should be defined and included in the World Health Organisation’s 
ICD-10, which will subsequently result in consistent terminology for the condition. 
The expert panel also proposed a new IAD severity categorisation tool, involving a 
straightforward, three-category instrument that, while requiring validation, has the 
potential for acceptance and use in clinical practice. The panel also recommended a 
change to the IAD prevention protocol which involved replacing skin moisturisation 
as a standard component of the skin care regime with the step ‘restore’ (p. 15), 
whereby skin moisturiser is used only when necessary to restore or maintain the 
integrity of the skin’s barrier function (Beeckman et al., 2015). Furthermore, the 
panel identified areas for future research, including further IAD prevalence and 
incidence studies using standardised definitions and methodology, research into the 
natural history of IAD, including the aetiology, pathophysiology, and progression of 
the condition (Beeckman et al., 2015). 
Overall, the literature review revealed that IAD poses a significant skin 
integrity threat to acute care patients, is a painful condition, places patients at risk of 
infection and PI, is costly to treat, impacts negatively on quality of life, can result in 
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loss of independence, and increases the burden of care (Beeckman et al., 2015; 
Doughty et al., 2012). Understanding the magnitude and pathogenesis of IAD, 
including Candida colonisation and infection can inform the development of 
prevention and management strategies and importantly, contextualise IAD within the 
broader framework of maintaining skin integrity. An understanding of the prevalence 
of IAD is imperative to guide decision-making and care planning at the individual 
patient level and the wider healthcare level. Chapter 4 presents Publication 2 of this 
thesis: an investigation of the prevalence of incontinence and IAD in the Australian 
acute care setting.  
 64                       Chapter 3: Literature Review, Part B - Incontinence-Associated Dermatitis and Incontinence-Associated Candida Infection 
 
  
Chapter 4: Incontinence-Associated Dermatitis: A Cross-Sectional Prevalence Study in the Australian Acute Care Hospital Setting - Study 
1                       65   
 
Chapter 4: INCONTINENCE-ASSOCIATED 
DERMATITIS: A CROSS-SECTIONAL 
PREVALENCE STUDY IN THE 
AUSTRALIAN ACUTE CARE HOSPITAL 
SETTING - STUDY 1 
4.1 INTRODUCTION 
This chapter comprises Publication 2, which represents Study 1 of this thesis. 
Campbell J. L., Coyer F. M., & Osborne S. R. (2014). Incontinence-
associated dermatitis: A cross-sectional prevalence study in the Australian acute care 
hospital setting, International Wound Journal, doi:10.1111/iwj.12322 
 This publication was published in the International Wound Journal, which 
has an impact factor of 2.15. The publication has been cited five times, including a 
citation by Beeckman and colleagues (2015) in a seminal IAD global consensus 
document.  
The aim of this study was to determine the prevalence of incontinence and 
incontinence-associated dermatitis (IAD) in the Australian acute care setting.  
This study addressed the following research questions:  
1. What is the prevalence of incontinence (urine and faecal)? 
2. What is the prevalence of IAD?  
3. What are the products worn to manage incontinence, and the products 
provided at the bedside for perineal skin care?  
4.1.1 Prevalence studies 
Understanding the scope of a problem or condition is the critical first step in 
developing effective prevention and management strategies (Coggon, Barker, & 
Rose, 2003). A common method employed to understand the magnitude of 
conditions in healthcare facilities is to determine the prevalence of the condition. 
Prevalence is a measure of the proportion of a population that has a specific 
 66                       Chapter 4: Incontinence-Associated Dermatitis: A Cross-Sectional Prevalence Study in the Australian Acute Care Hospital 
Setting - Study 1 
occurrence at a specific time, and represents the disease burden of a population 
(Gordis, 2009; Oleckno, 2008). In addition to determining the burden or magnitude 
of a condition at a point in time, prevalence studies can also be used to assess quality 
of care and effectiveness of prevention protocols (Baharestani et al., 2009a; Pieper & 
National Pressure Ulcer Advisory, 2012). 
However, prevalence studies are difficult and costly to perform and require a 
significant number of adequately trained personnel (Ashmore, Ruthven, & 
Hazelwood, 2011; Prentice, Stacey, & Lewin, 2003). Many factors can influence the 
results of these studies, including the definitions of the epidemiological terms used 
(that is, prevalence or incidence), source of the data (for example, from direct skin 
inspection, data extraction from care records, or adverse event registers), the skill of 
assessors in identifying PI and differentiating between other lesions such as IAD, 
case mix, length of time over which data are collected and data reporting 
(Baharestani et al., 2009a; Defloor et al., 2005). Overall, prevalence surveys require 
extensive planning to ensure they are valid and reliable (Ashmore, et al., 2011; 
Prentice et al., 2003).  
Inter-rater reliability can be an important element of prevalence survey 
methodology. It is defined as agreement or consistency among raters, or the extent to 
which raters judge phenomena in the same way (Vogt, 2005). A seminal study by 
Prentice and colleagues (2003) proposed a detailed PI prevalence methodology. In 
particular, with reference to inter-rater reliability, the procedure included the 
requirement for an education program for surveyors that encompassed training on 
staging of PIs according to the NPUAP classification system (Bergstrom et al., 1992) 
followed by inter-rater reliability testing, using multiple choice questions and clinical 
photographs to identify PI stages. In 2005, the European Pressure Ulcer Advisory 
Panel (EPUAP) (Defloor et al., 2005) statement on prevalence and incidence 
monitoring of PI occurrence specifically stated that it is essential that surveyors be 
able to distinguish PIs from other lesions, such as incontinence damage. For more 
than a decade recommendations have been made to ensure surveyors have the 
knowledge and skill to classify PIs accurately, and to differentiate them from other 
lesions, commonly IAD. The procedures for PI prevalence surveys are relevant for 
IAD prevalence surveys and were adapted for use in Study 1. 
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4.1.2 Challenges in understanding incontinence-associated dermatitis 
prevalence in acute care 
There is limited empirical data available that sheds light on the prevalence of 
IAD in the general acute care setting. Prevalence ranges from 20% to 50%, but 
several of these studies reported IAD prevalence in critically ill patients (Bliss et al., 
2000; Driver, 2007), while the study by Arnold-Long et al. (2011) reported IAD 
prevalence in long term acute care. One of the few studies conducted in the general 
acute care setting reported IAD prevalence to be 20% in the incontinent patients in 
the sample (Junkin & Selekof, 2007). 
 The reasons for limited IAD prevalence data in the acute care setting may be 
multifactorial. Firstly, limited systematic evaluation for IAD takes place as part of 
the skin assessment, with generally scant systematic or organisational recognition of 
IAD as a nosocomial skin injury. This can result in at best, ad hoc IAD specific 
prevention procedures, policies, or IAD prevalence surveys (Beeckman, 2016; 
Beeckman et al., 2015). Secondly, there is a lack of standardisation of diagnostic 
criteria and established IAD categorisation instruments (see Section 3.1.7) (Borchert 
et al., 2010; Gray et al., 2012; Junkin & Selekof, 2008), as well as a lack of an agreed 
IAD prevalence survey methodology that may contribute to the prevalence being 
under-estimated or unrecognised at all. Finally, difficulties faced by clinicians when 
distinguishing between IAD and PIs, and the potential for IAD to be misclassified as 
a stage I or II PI can result in the prevalence of IAD being under-estimated 
(Beeckman et al., 2015; Defloor et al., 2006; Doughty, 2012; Mahoney, Rozenboom, 
Doughty, & Smith, 2011). 
4.1.3 Incontinence-associated dermatitis prevalence survey methodology 
In the absence of an agreed methodology for the IAD prevalence surveys, the 
best available evidence and recommendations for the conduct of PI prevalence 
surveys was reviewed and adapted for this study (Baharestani et al., 2009b; 
Beeckman, Defloor, Demarré, Van Hecke, & Vanderwee, 2010; Defloor et al., 2006; 
Junkin & Selekof, 2007; National Pressure Ulcer Advisory Panel and European 
Pressure Ulcer Advisory Panel, 2009; Prentice et al., 2003). The decision to adapt PI 
prevalence methodology for Study 1 was based on several factors, including the 
similarity between the shared risk factors for IAD and PI (Doughty, 2012), the 
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understanding that IAD and PI often co-exist and are co-located, and the imperative 
for accurate IAD and PI prevalence data (Defloor et al., 2006; Mahoney et al., 2011). 
Direct skin inspection is accepted as the gold standard methodology for PI 
prevalence studies, with the proviso that data collectors have adequate skill in 
classifying PIs and differentiating them from other lesions such as IAD (Baharestani, 
2009b; Defloor, 2005; Pieper & National Pressure Ulcer Advisory Panel, 2012). One 
of the primary reasons for the recommendation for direct skin inspection is the 
recognition that clinical documentation is often poor with respect to PIs (Baharestani 
et al., 2009b; Bethell, 2002; Defloor et al., 2005; Gunningberg, Donaldson, Aydin, & 
Idvall, 2012).  
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4.2 PUBLICATION 2 
Incontinence-Associated Dermatitis: A Cross-Sectional Prevalence Study in the 
Australian Acute Care Hospital Setting 
Abstract 
The purpose of this cross sectional study was to identify the prevalence of 
incontinence and incontinence-associated dermatitis in Australian acute care patients, 
describe the products worn to manage incontinence, and products at the bedside to 
provide perineal skin care. Data were collected over two days at a major Australian 
teaching hospital on 376 inpatients. The mean age of the sample was 62 years and 
52% were male. The prevalence rate of incontinence was 24% (n = 91). Urinary 
incontinence was significantly more prevalent in females (10%) than males (6%) 
χ2(1, N = 376) = 4.458, p = .035. Incontinence-associated dermatitis occurred in 10% 
(n = 38) of the sample, with 42% (n = 38) of incontinent patients having 
incontinence-associated dermatitis. Semi-formed and liquid stool were significantly 
associated with incontinence-associated dermatitis χ2(1, N = 376) = 5.520, p = .027. 
Clinical indication of fungal infection was present in 32% (n = 12) of patients with 
incontinence-associated dermatitis. Absorbent disposable briefs were the most 
common incontinence aids worn (80%, n = 70), with soap/water and disposable 
washcloths the most commonly available (60%, n = 55) clean–up products present at 
the bedside. Further data are needed to validate this high incontinence-associated 
dermatitis prevalence. Studies that address the prevention of incontinence-associated 
dermatitis and effectiveness of management strategies are also required.  
  
Key words: Acute care, cross-sectional study, incontinence-associated dermatitis, 
incontinence, prevalence. 
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Key Messages 
 Nearly one in four hospitalised adults experience incontinence, with more 
than 40% of those having incontinence-associated dermatitis (IAD). 
 Semi-formed and liquid stool are associated with IAD. 
 Older patients are significantly more likely to experience incontinence 
than younger patients.  
 More data are needed about IAD prevalence and management in the acute 
care setting in Australia.       
 This is the first Australian study to report both the prevalence of 
incontinence and IAD in the acute care setting, and to differentiate IAD 
from pressure injury and clinical indication of fungal infection.  
Introduction 
   Incontinence-associated dermatitis (IAD) is a complex, painful condition 
that is expensive and hard to treat (Doughty et al., 2012; Gray et al., 2007). It occurs 
in the perineum, labial folds, groin, upper thighs, buttocks, rectal area, and gluteal 
cleft, as well as areas where increased friction occurs between skin and clothing, or 
skin and absorptive devices (Black et al., 2011; Gray, 2011). IAD is characterised by 
inflammation and erythema, and may have blisters, erosion, denudation, or serous 
exudate (Gray et al., 2007; Junkin & Selekof, 2008). This results in high cost to the 
individual in pain and suffering, increased morbidity, and increased length and cost 
of the hospital stay (Junkin & Selekof, 2008).  
 Until recently, there was no international agreement on the name of the 
condition, its definition, or its implications for clinical practice. However, in 2007 a 
seminal consensus document by Gray et al. (2007) defined IAD as the response of 
the skin to chronic exposure to urine and faecal materials (inflammation and 
erythema with or without erosion or denudation). This definition acknowledges the 
source of the irritant, the response of the skin to that irritant, and that an area beyond 
the perineum is commonly affected. The standardised definition will allow 
researchers and clinicians to generate and compare data using a uniform 
conceptualisation of the condition.  
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Excess moisture on the skin acts as an irritant and contributes to skin 
breakdown and increased susceptibility to pressure injury from friction and shear 
(Black et al., 2011; Doughty et al., 2012; Gray, 2007; Gray et al., 2007; Gray et al., 
2011). Moisture damaged skin can be vulnerable to infection with Candida albicans 
or coliform bacteria (Black et al., 2011). Wearing an absorptive containment product 
(pad) causes occlusion, resulting in increased (more alkaline) baseline skin pH, 
increased moisture from perspiration, and compromised skin barrier function (Gray 
et al., 2007; Gray et al., 2012b). The alkaline pH of urine promotes activity of the 
digestive enzymes lipases and proteinases in faeces, which in turn makes keratin in 
the stratum corneum vulnerable to breakdown (Black et al., 2011). Wet skin is less 
resistant to injury from friction, and is at increased risk of erosion from rubbing on 
bed linens or incontinence pads (Black et al., 2011; Gray et al., 2012b; Junkin & 
Selekof, 2007). Exposure to both faeces and urine is more damaging to skin than 
exposure to urine alone (Bliss, Savik, Harms, Fan, & Wyman, 2006).    
Identification of IAD depends on skin inspection and accurate differentiation 
between other skin lesions, particularly pressure injury. Studies indicate that the 
differential diagnosis between a pressure injury and IAD is difficult, with IAD 
frequently misclassified by nurses as a pressure injury (Beeckman et al., 2008; 
Doughty et al., 2012). In fact, the National Pressure Ulcer Advisory Panel (NPUAP) 
recommends that the stage II pressure injury category should not be used to describe 
skin tears, tape burns, perineal dermatitis, maceration, or excoriation (National 
Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel, 2009). 
IAD also needs to be differentiated from intertriginous dermatitis, a moisture 
associated skin injury resulting from trapped moisture and friction in skin folds. 
(Black et al., 2011; Bliss & Powers, 2011; Doughty et al., 2012; Gray, 2007). IAD 
has further been confused with fungal or bacterial infections, as well as other 
dermatological conditions (Farage, Miller, Elsner, & Maibach, 2007). 
Misclassification of these lesions can result in poor patient outcomes, as well as in 
the inappropriate and ineffective use of healthcare resources (Beeckman, 
Schoonhoven, Verhaeghe, Heyneman, & Defloor, 2009a). The primary goal of the 
prevention and treatment for IAD is to minimise skin exposure to irritants (Black et 
al., 2011).  
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Understanding IAD requires an appreciation of incontinence, a condition 
associated with significant morbidity, decreased quality of life, as well as being a 
burden for carers and the healthcare system. Urinary incontinence is an involuntary 
leakage of urine (Abrams, Blaivas, Stanton, & Andersen, 1988) and while no 
consensus definition exists for faecal incontinence, its generally accepted definition 
is involuntary loss of solid or liquid stool (Halland & Talley, 2012). Incontinence 
occurs more frequently in older adults, although it can affect any age group (Junkin 
& Selekof, 2007; Lakhan et al., 2011). Further, faecal incontinence is the second 
leading cause of admission to long-term care in the United States (Beitz, 2006).   
Prevalence of incontinence among patients in the acute care setting is 
estimated to range from 10% to 37% (Junkin & Selekof, 2007; Lakhan et al., 2011; 
Ostaszkiewicz et al., 2008). Incontinence in the critical care environment ranges 
from 12% to 30% (Bliss, Johnson, Savik, Clabots, & Gerding, 2000; Driver, 2007) 
and in long-term acute care settings is 22% for urinary incontinence and 57% for 
faecal incontinence (Arnold-Long, Reed, Dunning, & Ying, 2011). Limited data 
exists identifying the scope of incontinence or demographic variables associated with 
incontinence in the Australian acute care setting. 
IAD also presents challenges for the acute care setting where the prevalence 
ranges from 20% to 50% (Arnold-Long et al., 2011; Bliss et al., 2000; Driver, 2007; 
Gray et al., 2012b; Junkin & Selekof, 2007). The prevalence of IAD in adults in 
Australian acute care hospitals is not known. Prospective Australian data are needed 
to provide insights into the scope of both incontinence and IAD in the acute care 
setting to aid healthcare providers in the development of prevention and management 
strategies. 
Aims 
    The purpose of this study was to explore incontinence and IAD in the 
Australian acute care hospital setting. Specific research aims were to: 
 identify the prevalence of incontinence (urine and faecal), 
 identify the prevalence of IAD, and 
 describe the products worn to manage incontinence and products at the 
bedside to provide perineal skin care. 
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Methods 
Study design 
    A cross-sectional study design was used. 
Study setting and sample 
    This study was conducted at a 929-bed major acute care teaching hospital 
in southeast Queensland, Australia. The facility provides acute care over a 
comprehensive range of specialities including medicine, surgery, orthopaedics, 
oncology, obstetrics, gynaecology, intensive care, burns, and trauma. It is the largest 
tertiary referral hospital in Queensland, providing care in 2012 to almost 94,000 
inpatients (Royal Brisbane and Women's Hospital Marketing and Communications, 
2013). 
Hospitalised adults aged 18 years and older, admitted to the facility were 
eligible for inclusion. Patients were surveyed from Internal Medicine, Surgery, 
Critical Care (which includes a 36 bed intensive care unit and an 18 bed transit ward 
attached to the emergency department), Cancer Care, and Women’s and Newborns 
(only adults were surveyed from this service) admitting services. Patients from 
maternity and mental health services were excluded from the study.   
Operational definitions  
 Incontinence is the inability to control the flow of urine and/or stool any 
time in the preceding 24 hours (Junkin & Selekof, 2007). Patients with 
indwelling urinary catheters were deemed continent of urine for the 
analysis. The presence of a urinary catheter prevents urine from coming 
into contact with skin, and therefore removes the source of irritation 
(urine) necessary for the development of IAD. Patients with faecal 
containment devices were deemed incontinent of faeces due to the high 
likelihood of faecal leakage from the containment device resulting in 
faecal contact with skin. These categorisations are consistent with previous 
studies (Halfens et al., 2013; Junkin & Selekof, 2007).  
 IAD is the presence of any skin redness with or without erosion due to skin 
contact with urine and/or faeces (rather than other sources of moisture) on 
the buttocks, coccyx, rectal area, scrotum, labia, lower abdomen, upper 
thighs, gluteal cleft, or groins in an incontinent patient (Gray et al., 2007).  
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 Fungal infection is based on the clinical presentation of a central 
maculopapular rash with characteristic satellite lesions in patients with 
IAD (Black et al., 2011; Zulkowski, 2012). No microbiological testing was 
performed to confirm the presence of a fungal infection in this study. This 
is consistent with current clinical practice, as well as a previous IAD study 
(Junkin & Selekof, 2007). Diagnosis of superficial fungal infection relies 
more heavily on clinical findings and less on laboratory support (Maertens, 
2007; Richardson, 2012).  
 Pressure injuries are a localised injury to the skin and/or underlying tissue, 
usually over a bony prominence, as a result of pressure, or pressure in 
combination with shear (National Pressure Ulcer Advisory Panel and 
European Pressure Ulcer Advisory Panel, 2009). Pressure injuries were 
staged according to the Australian pressure injury staging guidelines at the 
time of data collection (Australian Wound Management Association, 
2001). 
Measures 
Continence Status and Products: Continence status, incontinence 
containment, clean-up and skin protection products, as well as demographic data 
were recorded on a data collection instrument that was designed by the Principal 
Investigator (JC), based on a literature review (see Appendix C). The instrument was 
pilot tested with 10 registered nurses at the research site and face validity established. 
Minor changes to the wording and layout of the continence section of the tool were 
made based on feedback from the pilot group. Demographic data collected were age, 
gender, and admitting service. 
Stool Quality Assessment: Stool quality was measured based on the Bristol 
Stool form scale (see Appendix D), but collapsed into dichotomous variables: 
formed, which equates to type 1- 4 on the Bristol Stool form scale; and semiformed-
liquid, equates to type 5-7 (Lewis & Heaton, 1997). 
IAD Severity: IAD severity was measured by clinicians with the Skin 
Assessment Tool (SAT) (Kennedy & Lutz, 1996) (see Appendix A). This tool does 
not require the patient to report symptoms (Gray, 2007; Junkin & Selekof, 2008), nor 
does it assess pain. The SAT was designed to derive a cumulative IAD severity score 
with a numerical score assigned according to severity within each of three categories: 
  
Chapter 4: Incontinence-Associated Dermatitis: A Cross-Sectional Prevalence Study in the Australian Acute Care Hospital Setting - Study 
1                       75   
skin redness, area of skin breakdown (cm²), and erosion. A cumulative severity score 
(maximum score = 10) is the sum of the scores for the three categories. It has good 
inter-rater reliability, κ =0.81 (95% CI, 0.69 - 0.87), for skin observation, 
(Beeckman, Verhaeghe, Defloor, Schoonhoven, & Vanderwee, 2011). Word 
descriptors were assigned to match numerical severity categories. Numerical cut-off 
points for each category were determined by consensus from a panel of experts 
comprising the authors and three wound care clinicians with 40 combined years of 
experience in the specialty. The cut points are 0 = no IAD; 1-3 = mild IAD; 4-6 = 
moderate IAD; 7-9 = severe IAD; 10 = extreme IAD.  
Procedures 
Prior to data collection, all research assistants (n =30; comprising registered 
nurses, an occupational therapist and a medical practitioner) were trained in the 
identification of IAD, pressure injury, and fungal infection. Inter-rater reliability was 
established at the conclusion of the education session by scores on a multiple-choice 
test of clinical photographs of a variety of IAD lesions, pressure injuries, and fungal 
infections. The test required participants to differentiate between IAD, pressure 
injury, and a fungal infection, as well as classify the IAD images according to the 
study instrument. A score of 80% was required for the research assistant to 
participate in the study. The use of photographs to test inter-rater reliability has 
previously been used (Beeckman et al., 2007; Beeckman et al., 2008; Defloor & 
Schoonhoven, 2004).  Research assistants also were trained in study procedures.  
This study was conducted over two consecutive days in November 2011 by 
the principal investigator (JC) and 30 research assistants. Skin inspections were 
conducted by the research assistants on all eligible, consenting patients. The 
incontinent management product the patient was wearing was recorded. Each 
patient’s buttocks, coccyx, rectal area, scrotum, labia, lower abdomen, upper thighs, 
gluteal cleft, and groins were inspected and loss of skin integrity classified as IAD, 
PI, or clinical indication of fungal infection. Continence data were collected, and for 
those who were incontinent, the type of incontinence was obtained from the patient, 
bedside nurse, and/or clinical records. Stool quality and frequency data for faecally 
incontinent patients were collected from the patient, bedside nurse, and/or clinical 
records. Data were also recorded on the type of incontinence clean up and skin 
protection products at the bedside. When patients were absent from the ward at the 
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time of data collection, the research assistants returned and included those present 
when possible. Demographic data were collected on all patients. To assure accuracy, 
the principal investigator (JC), who is a skin integrity expert, conducted an 
independent pelvic girdle inspection on all cases identified by the research assistants 
as having IAD and validated the SAT score.  
Ethical Considerations 
The study was approved by the Human Research Ethics Committees for both 
the research site and the university. Written information about the study was 
distributed to all eligible patients the day prior to data collection. Patients provided 
verbal consent as required by the Human Research Ethics Committees (see 
Appendices E & F). 
Statistical Methods 
Participants were assigned a study number and all data were de-identified. 
Data were entered into Statistical Packages for Social Sciences (SPSS) (Version 
20.0, Armonk, NY, USA). A random 10% of data entry was crosschecked for 
accuracy. Incomplete data were coded as missing data.  
Descriptive statistics were used to describe study variables (means and 
standard deviations for continuous variables; frequencies and percentages for 
categorical variables). Prevalence of incontinence was calculated by the total number 
of incontinent patients in the sample divided by the total number of study patients. 
Prevalence of IAD was calculated by the total number of IAD cases in the sample 
divided by the total number of study participants. Prevalence of IAD among 
incontinent patients was calculated by the total number of IAD cases divided by the 
total number of incontinent participants. Bivariate analysis using descriptive 
correlational statistics (Chi-square test for independence with Yates continuity 
correction and Fisher’s exact test, where expected cell counts were less than five) 
were used to explore characteristics of sample with incontinence and IAD. p values 
less than 0.05 were considered statistically significant. Direct logistic regression 
analysis was performed to predict whether independent variables gender, admitting 
service and age predict the outcome, incontinence. The variables entered into the 
model were based on what is known about incontinence; in particular, association 
with increasing age, association with being female, and the prevalence of geriatric 
syndromes, specifically incontinence in medical patients (Lakhan et al., 2011). In 
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addition, selection of these independent variables facilitates comparison of our 
results with other studies providing clinical applicability. The Hosmer-Lemeshow 
test was used to examine the goodness of fit of the logistic regression model. 
Results 
Of the 552 patients assessed for eligibility (see Table 4.1, and Figure 4.1), 
545 patients were eligible, 379 patients consented to take part and were surveyed. 
Data for 376 patients were included in the analysis. Three patients were excluded 
from analyses, as the screening tool was not completed. The mean age of the sample 
was 62 (SD = 19.3) years and 52% (n =194) of patients were male (see Table 4.2). 
The mean age of incontinent patients (n = 91) was 70 years (SD = 17.4), and the 
mean age of patients with IAD (n = 38) was 75 years (SD = 15.3) Patients were 
admitted most frequently to the internal medicine (44%, n = 167) and surgical 
services (39%, n = 146). The Hosmer-Lemeshow test was used to examine the 
goodness of fit of the logistic regression model. The result was non-significant, χ2 (8, 
N = 379) = 3.03, p = .932, indicating that the model fit was satisfactory.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Participant recruitment and flow diagram. 
Patients assessed for eligibility 
                 n = 552 
Data available for analysis 
n = 376 
Excluded 
    Ineligible, < 18 years old, n = 7 
    Refused to participate, n = 166 
Patients recruited 
n = 379 
Data set incomplete 
n = 3 
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Table 4.1  
Age and Gender of Patients Assessed for Eligibility (N = 552) 
Admitting service 
Assessed for 
eligibility 
Age 
M (SD) 
Male 
n (%) 
Female 
n (%) 
Internal Medicine       216 68.2 (17.2) 100 (46.3) 116   (53.7) 
Surgical        214 55.5 (19.4) 140 (65.4)   74   (34.6) 
Cancer Care         67 61.3 (17.8)   39 (68.2)   28   (41.8) 
Critical Care         40 48.8 (19.3)   19 (47.5)   21   (52.5) 
Women’s & Newbornsa          15 50.4 (18.4)     0   (0)   15 (100) 
Total       552 56.8 (22.7) 298 254 
   
a
Only adults were evaluated from this admitting service. 
 
Prevalence of Incontinence 
The prevalence of incontinence was 24% (n = 91). Double incontinence 
(urinary and faecal) was most common (12%, n = 45), followed by faecal 
incontinence (8%, n = 31), with the prevalence of urinary incontinence only 3.5% (n 
= 13). Urinary catheters were present in 13% (n = 49) of patients. Faecal 
incontinence was more prevalent in females (11%, n = 42) than males (9%, n = 35). 
Urinary incontinence was significantly more prevalent in females (10%, n = 38) than 
males (6%, n = 23), χ2(1, N = 376) = 4.458, p = .035; however, the reason for urinary 
catheter placement was not determined by this study, so the prevalence of urinary 
incontinence may be underestimated. Direct logistic regression was performed to 
assess the impact of a number of factors on incontinence. The model contained three 
independent variables (age, gender, and admitting service). The full model 
containing all predictors was statistically significant, χ2 (6, N = 376) = 31.48, p < 
0.001. Gender made no difference to the odds of having incontinence (OR = 0.85, p 
= .516) (see Table 4.3). Older patients had a greater likelihood of having 
incontinence compared to younger patients (OR = 1.03, p < .001). Patients in the 
surgical service were less likely to have incontinence, compared to patients in the 
internal medicine service (OR = 0.51, p = .029). Internal medicine and other 
admitting services showed no difference in the likelihood of patients having 
incontinence (p > .05) (see Table 4.3).  
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Table 4.2  
Sample (N = 376) Characteristics for Patients with Incontinence (n = 91) and IAD 
(n = 38) 
 
Sample 
n (%) 
Incontinent  
n (%) 
IAD 
n (%) 
Gender    
   Male       194 (51.6)         41 (45)         13 (34.2) 
   Female       182 (48.4)         50 (54.9)         25 (65.8) 
Indwelling urinary catheter          49 (13)         23 (25.3)           9 (23.7) 
Admitting service     
    Internal medicine       167 (44.4)         55 (60.4)         23 (60.5) 
    Surgical        146 (38.8)         21 (23.1)           8   (1.1) 
    Critical care          21   (7.7)           6   (6.6)           3   (7.9) 
    Cancer care         29   (7.7)           6   (6.6)           2   (5.3) 
    Women’s & newbornsa         13   (3.5)           3   (3.3)           2   (5.3) 
a
Only adults were evaluated from this admitting service. 
 
 
Table 4.3  
Predictors of Incontinence (N = 376) 
Characteristics & 
intercept  
β SE χ2 p OR 95% CI 
Intercept -2.750 .617 19.226 <.001   .067  
Gender 
  (Ref: Female) 
      
   Male -.168 .259     .421   .516 0.85 (0.51, 1.4) 
Age   .029 .008 13.610 <.001 1.03 (1.01, 1.05) 
Admitting service 
   (Ref: Internal   
   medicine) 
      
   Critical care   .272 .537   .257   .612 1.31  (0.46,  .76) 
   Surgery -.670 .308 4.745   .029 0.51  (0.28,  .94) 
   Cancer care  -.508 .496 1.048   .306 0.60  (0.23,  .59) 
   Women & newborns
a
 -.189 .712   .070   .791 0.83  (0.2,  3.34) 
Note. SE = standard error, OR= odds ratio, CI = confidence interval. 
a
Only adults were evaluated from this admitting service. 
 
 
 
 80                       Chapter 4: Incontinence-Associated Dermatitis: A Cross-Sectional Prevalence Study in the Australian Acute Care Hospital 
Setting - Study 1 
Prevalence of Incontinence-Associated Dermatitis 
IAD was present in 10% (n = 38) of the sample and the prevalence of IAD in 
those who were incontinent was 42% (n = 38) (see Table 4.2). Among incontinent 
patients, chi-square analysis showed that there was a significant association between 
type of incontinence (urinary verses faecal) and IAD, χ2(1, N = 91) = 7.237, p = .007. 
Among patients with IAD, chi-square analysis showed that patients with semi-
formed or liquid stool were more likely to have IAD than those patients with formed 
stool, χ2(1, N = 38) = 5.520, p = .027. Faecal frequency and IAD were not 
significantly associated, χ2(1, N = 38) = 3.536, p =.116 (see Table 4.4). Mild skin  
Table 4.4  
Clinical Characteristics of Patients with Incontinence (n = 91) and IAD (n = 38) 
 
 aPercentages may not add up to 100 due to rounding. 
 
redness was present in 84% (n = 32) of patients with IAD, a small area of skin 
breakdown occurred in 32% (n = 12), mild erosion was present in 32% (n = 12) of 
patients, while 50% (n = 19) of patients had no erosion. The most common 
anatomical locations for skin injury were buttocks (42%, n = 16), followed by the 
rectal area (34%, n = 13). The SAT severity score showed 82% (n = 31) were 
suffering from mild IAD, 13% (n = 5) were suffering from moderate IAD, 6% (n = 
2) were suffering from severe IAD, and no patients suffering from extreme IAD (see 
Table 4.5).  
Characteristic 
Incontinent  
n (%) 
IAD 
n (%)  
Urinary incontinence   
   Male          6   (6.6)        1  (2.6) 
   Female          7   (7.8)        0  (0) 
Faecal incontinence    
   Male         18 (19.8)        5 (13.1) 
   Female        14 (15.4)      10 (26.3) 
Double (urine and faecal) incontinence   
   Male       17 (18.7)        7 (18.4) 
   Female       29 (31.9)
a
      15 (39.5)
a
 
Faecal quality    
   Formed          5   (5.5)        0   (0) 
   Semi-formed or liquid        36 (39.6)      19 (50) 
   Missing       50 (54.9)      19 (50) 
Faecal frequency    
   < 3 day        13 (14.3)        5 (13.2) 
   3 or more per day        28 (30.8)      17 (44.7) 
   Missing       50 (54.9)      16 (42.1) 
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Table 4.5  
Characteristics, Location, and Severity of IAD (n = 38) 
  n   % 
Skin redness    
   Mild 32 84.2 
   Moderate   4 10.5 
   Severe   2   5.3 
Area of skin breakdown    
   None 19 50.0 
   Small  13 34.2 
   Moderate   2   5.3 
   Large   4 10.5 
Skin erosion    
   None 19 50.0 
   Mild 18 47.4 
   Moderate   1   2.6 
   Severe   0    0 
   Extreme   0   0 
Area affected
a
   
   Buttocks 16 42.1 
   Coccyx   5 13.2 
   Gluteal cleft   4 10.5 
   Groins   6 15.8 
   Lower abdomen   3   7.9 
   Rectal area 13 34.2 
   Scrotum/labia   7 18.4 
   Upper thighs   2   5.3 
IAD severity score   
   1-3 Mild IAD  31 81.6 
   4-6 Moderate IAD    5 13.1 
   7-9 Severe IAD    2   5.3 
   > 9 Extreme IAD    0   0 
Pressure injury   8 21.1 
Clinical indication of fungal 
infection  
12 31.6 
a
Total > 100% as patients may have more than one area affected. 
 
Clinical indication of fungal infection was present in 32% (n = 12) of patients 
with IAD. However, presence of fungal infection may have been over or 
underestimated, as no microbiological testing to confirm the diagnosis of fungal 
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infection was undertaken in this study. Pressure injuries were present in 6% (n = 22) 
patients, with 21% (n = 38) patients with IAD having a pressure injury (see Table 
4.5).  
Products worn to manage incontinence and products used to provide perineal skin 
care. 
Wrap-around incontinent briefs or pads (that is, those aids worn as an 
alternative to underwear) were worn by 77% (n = 70) of incontinent patients at the 
time of evaluation (see Table 4.6). Soap/water and disposable washcloths were the  
Table 4.6 
Products Worn to Manage Incontinence and Products Used to Provide Perineal Skin 
Care (n = 91) 
Variable n % 
Incontinence aid for urinary incontinence   
None   2   2.2 
Wrap around pad   4   4.4 
Pull up pad   5   5.5 
Insert pad   1   1.1 
Incontinence aid for faecal incontinence   
None 11 12.1 
Wrap around pad 10 11.0 
Pull up pad   8   8.8 
Insert pad   1   1.1 
Incontinence aid for double incontinence   
None   1   1.1 
Wrap around pad 21 23.1 
Pull up pad 22 24.2 
Insert pad   1   1.1 
Incontinent aid - missing    4   4.4
a
 
Incontinence clean-up    
Soap/water and disposable cloth  55 60.4 
Missing 36 39.6 
Moisturiser    
Yes 31 34.1 
No 22 24.2 
Missing 38 41.7 
Skin protection products    
Yes 52 57.1 
Missing 39 42.8
a
 
a
Percentages may not add up to 100 due to rounding. 
 
most common incontinence clean-up products at the bedside for incontinent 
patients (60%, n = 55). Moisturising agents were present at the bedside in 34% (n = 
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31) of incontinent patients. Skin protection products were present at the bedside in 
57% (n = 52) patients. Examples of these products are 3M™ Cavilon™ No Sting 
Barrier Film (3M, Saint Paul, MN) and Skin Basics™ Zinc and Castor Oil Cream 
(Biotech Pharmaceuticals, Victoria, Australia). 
Discussion 
Incontinence occurred in one in four patients hospitalised in a major acute 
care setting in Australia, indicating it is a frequent and serious problem. IAD 
occurred in 42% of those who were incontinent, demonstrating that IAD is a 
prevalent and under-appreciated skin injury in hospitalised patients. The most 
common incontinence aid worn was an incontinent brief (80%), with soap/water and 
disposable cloths the most common incontinence clean-up present at the bedside 
(60%). This is the first Australian study to report both the prevalence of incontinence 
and IAD in the acute care setting and to differentiate IAD from pressure injury and 
fungal infection.  
Incontinence-associated dermatitis 
Acute care patients are subjected to treatment regimes that may result in IAD, 
for example, antibiotics, changes in dietary intake and enteral feeds. Thus, acute care 
patients are a unique population that are at increased risk. IAD has been under-
appreciated, as is not the primary reason for admission. Anecdotal evidence suggests 
it is not only accepted, but actually expected that older patients will be incontinent. 
IAD prevalence data for the general acute care setting is limited. The majority 
of published data are drawn from specialised settings such as critical care or the aged 
care setting. A study in three urban hospital critical care units found an IAD 
prevalence of 36% (Bliss et al., 2011) and prevalence in a long-term acute care 
setting was 23%, (Arnold-Long et al., 2011). Prevalence of IAD ranges in aged care 
from 6%-22% (Beeckman et al., 2010; Bliss et al., 2006).  
An important finding to emerge from our study is that liquid and semi-formed 
stool was associated with IAD compared to formed stool. No other published studies 
examined the association between stool quality and IAD. Congruent with our 
finding, the extensive review by Gray and colleagues (2012) identified that stool is 
implicated as an aetiological factor in IAD; with clinical experience strongly 
suggesting that liquid stool is more irritating than solid or formed stool. Further 
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research is warranted to determine if stool quality, particularly semi-formed/liquid 
stool, promotes the development of IAD. 
Most (82%) IAD severity in our study was mild. Junkin and Selekof (2007) 
classified IAD as red and dry, red and weepy, or having blisters in the areas likely to 
be exposed to urine or faeces. Of the patients with IAD, 75% had red and dry skin, 
with 25% having red and weepy skin. Both of these categories could be interpreted 
as being at the less severe end of a severity continuum, which correlates with the 
severity of IAD in our study. The natural history of IAD is poorly understood (Gray 
et al., 2007), but progression from ‘mild’ through to ‘severe’ IAD is inevitable in the 
presence of persisting incontinence, inadequate management of incontinence and 
inadequate or inappropriate incontinence clean-up, skin protection, and treatment of 
any cutaneous infections. Early recognition and treatment thus is optimum. 
IAD needs to be differentiated from other skin lesions, especially in the 
pelvic girdle. Pressure injuries historically have been confused with IAD. The 
NPUAP and the European Pressure Ulcer Advisory Panel (EPUAP) have specifically 
stated that IAD is not a pressure injury (National Pressure Ulcer Advisory Panel and 
European Pressure Ulcer Advisory Panel, 2009). A strength of this study is that both 
IAD and pressure injury were identified, so accurate prevalence of each could be 
determined. Future pressure injury prevalence studies would benefit from also 
measuring incontinence and IAD. 
Presence of urine and faeces on denuded skin creates a favourable 
environment for development of fungal infection, with fungal infection frequently 
reported as a potential complication of IAD (Gray et al., 2007; Gray et al., 2011; 
Zulkowski, 2012). The presence of a fungal infection needs to be differentiated from 
IAD. Presence of fungal infection for our study was determined based on clinical 
presentation of a central maculopapular rash with characteristic satellite lesions 
(Black et al., 2011). No quantitative microbiological testing was undertaken. 
According to Professor Jack Sobel (J. Sobel, personal email, 3 April, 2014) the 
fungal rash may also present as non-specific, confluent and papular, creating some 
difficulty in clinical diagnosis. The presence of a fungal infection would require 
treatment, but it is desirable to obtain a microbiological culture prior to commencing 
anti-mycotic therapy (Maertens, 2007; Richardson, 2012; Vazquez & Sobel, 2002). 
Accordingly, the presence of a fungal infection may have been under or 
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overestimated in our study. Our data showed 32% of patients with IAD demonstrated 
clinical evidence of a fungal infection. This is higher than the United States data 
from Junkin and Selekof (2007) that showed 10% of incontinent patients had a 
fungal rash (based on clinical examination). The higher prevalence of suspected 
fungal infection in our study may be associated with the higher IAD prevalence rate. 
These infections are a serious threat to patient outcomes because of the possibility of 
under-diagnosis or missed diagnosis, and the potential for delay in treatment. It is not 
clear whether a fungal infection may have an aetiological role in IAD, rather than 
being a secondary infection. 
Pressure injuries were present in 6% of our entire sample, with 12% of 
incontinent patients having a pressure injury. This prevalence is lower than that 
reported by Junkin and Selekof (2007), where 22% of incontinent patients had a PI. 
In part, our lower PI rate may reflect the increased emphasis on PI prevention in 
recent years.  
One of the issues in the literature continues to be the lack of a universal 
definition for IAD prevalence. That is to say, should the denominator be the entire 
sample, or only those with incontinence? Since IAD cannot occur without 
incontinence (that is, skin exposure to urine and or faeces) (Gray et al., 2007), the 
number of incontinent patients logically would be the denominator. Most studies 
report IAD prevalence with the denominator being the number of incontinent patients 
(Beeckman, Verhaeghe, et al., 2011; Driver, 2007; Junkin & Selekof, 2007), but a 
consistent standard needs to be established. However, we recommend that until a 
standard definition is accepted, that researchers present the IAD rate for the entire 
sample and for those who are incontinent to ensure clarity and accuracy. We have 
used that approach in this paper.  
Incontinence  
The definition of incontinence for an IAD prevalence study needs further 
clarification, specifically, how to categorise patients who have a urinary catheter. 
The presence of a urinary catheter prevents skin exposure to urine – a known cause 
of IAD. Previous studies have categorised patients with urinary catheters as continent 
(Halfens et al., 2013; Junkin & Selekof, 2007). However, it should be acknowledged 
that categorising patients with a urinary catheter as continent can result in an 
underestimation of incontinence prevalence. In the acute care setting, patients can be 
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catheterised for a multitude of reasons, including incontinence. For example, in this 
study, 11 of 15 patients surveyed in ICU had a urinary catheter. The use of a urinary 
catheter in ICU is to monitor kidney function, fluid balance in the critically ill.  
Our data showed a significant association between increasing age and 
incontinence. Junkin and Selekof (2007) found the odds of older patients having 
incontinence were greater (OR = 4.979, 95% CI = 1.015-22.427). Incontinence is 
recognised as one of the geriatric syndromes (Inouye et al., 2007; Lakhan et al., 
2011), and has been associated with longer length of hospital stay and greater risk of 
being discharged to a residential care setting (Chiarelli et al., 2005; Fonda, Nickless, 
& Roth, 1988; Green, Smoker, Ho, & Moore, 2003). Ageing of the global population 
(Kinsella, 2009) coupled with the rising cost of healthcare (Australian Institute of 
Health and Welfare, 2012b; Kinsella, 2009; Rak & Coffin, 2013), means that 
managing incontinence in the acute care setting is an ever-increasing challenge. 
The limited prospective prevalence data for incontinence in the acute care 
setting in Australia is noteworthy, since incontinence is associated with significant 
morbidity and decreased quality of life for individuals (Inouye et al., 2007). 
Healthcare providers require an understanding of the magnitude of this condition to 
provide appropriate care. We are not certain why the probability of incontinence is 
lower in the Surgical admitting service than the Internal Medicine admitting service, 
although there is some evidence supporting increased prevalence of geriatric 
syndromes (including incontinence) in older medical patients in the acute care setting 
(Lakhan et al., 2011). Our study adds important results that assist in understanding 
the burden of incontinence in the Australian acute care setting. 
Products worn to manage incontinence and products used to provide perineal skin 
care 
Our study showed disposable incontinence briefs were the most common 
incontinence aids worn (77%), soap/water and disposable washcloths the most 
common clean-up products at the bedside (60%), and skin barrier protection 
available at the bedside of 57% of patients. A consistent, structured approach to 
prevention and treatment of IAD is required (Black et al., 2011; Gray et al., 2007). 
Having supplies at the bedside provides an efficient approach and ensures that a 
consistent strategy is used. Three steps are recommended: (i) gentle cleansing, using 
a soft disposable washcloth and cleansers without perfumes or irritants and close to 
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skin pH (a no rinse formulation is suggested); (ii) moisturisation to preserve the lipid 
barrier (Black et al., 2011), and (iii) application of a skin barrier product is required 
to protect the stratum corneum from moisture and irritants (Black et al., 2011; Gray, 
2007). Lack of bedside supplies suggests there is a gap between available 
products/recommendations and care. Further research is needed to identify how 
products are used, as well as their effectiveness in preventing and treating IAD.  
Limitations 
Several limitations need to be noted. This is a cross-sectional study and no 
cause and effect can be inferred. Every effort was made to recruit eligible 
participants; however, direct clinical examination of patients in this type of study can 
be intrusive and may have limited enrolment, (in our study, this was 69%). Data was 
not recorded as to why patients refused to participate. This study did not have ethical 
approval to collect data from those patients who did not consent. The IAD Severity 
Assessment tool was chosen in this study to classify severity of the condition. 
However, this scale does not include a measure of patient pain. IAD and faecal 
quality analysis was conducted at a bivariate level as the amount of missing data in 
these variables made adjusting for confounders and logistic regression analysis 
unfeasible. Clinical inspection was used to determine the presence of fungal infection 
in this study. The prevalence of fungal infection may have been over or 
underestimated as no quantitative laboratory measure was used to confirm the 
diagnosis. Future research needs to use appropriate quantitative measures to confirm 
the presence of fungal infection.  
Conclusion 
This is the first Australian study to report both the prevalence of incontinence 
and IAD in the acute care setting and to differentiate IAD from pressure injury and 
fungal infection. Almost one quarter of hospitalised adults were incontinent, and of 
the incontinent patients in the study, more than 40% developed IAD. Faecal 
incontinence occurred more frequently than urinary incontinence. Liquid and semi-
formed stool was significantly associated with IAD compared to formed stool. In 
addition, our data confirmed that the likelihood of incontinence increases with age, 
especially in those >80. Products for incontinence containment, clean up, and skin 
protection need to be available at the bedside to facilitate incontinence management. 
Further, prospective observational prevalence studies are essential to confirm these 
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data in hospitalised Australian adults. The availability of results informing the 
prevalence of both incontinence and IAD is essential to measure the scope of the 
problem. More research addressing the effectiveness of treatment of incontinence 
and IAD in the acute care setting is needed. Additional research examining the 
aetiology of IAD and the role of fungal infections is warranted. 
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4.3 CHAPTER SUMMARY 
Study 1 shed light on the prevalence of both incontinence and IAD in an 
Australian acute care setting. This study, the first of its kind in Australia, found a 
high prevalence of incontinence of nearly one quarter of participants (24%), with 
42% of these found to have IAD (Campbell et al., 2014). These findings highlight 
that incontinence and IAD pose a considerable threat to skin integrity in these 
patients. Consistent with other studies, Study 1 found an association with older age 
and incontinence (Furlanetto & Emond, 2014; Inouye et al., 2007; Lakhan et al., 
2011; Ostaszkiewicz et al., 2008).  
This study provides evidence to support the inclusion of several constructs in 
the Skin Safety Model (SSM). It provided data on the prevalence of incontinence 
(24%) and IAD (42%) in the acute care setting. In addition, the study reported that 
disposable incontinent briefs were the most common incontinence containment 
device used in the  hospital (77%), soap/water and disposable washcloths the most 
common incontinence clean-up products at the bedside (60%), and skin protection 
products present at the bedside in just over half of  patients (57%). As discussed in 
Chapter 2, (Section 2.2.1), effective clinical governance is a critical determinant of 
patient safety and quality outcomes. Underpinning effective clinical governance is 
the requirement for accurate and valid data, which informs decision-making, 
planning resource allocation and continuous quality improvement. In the domain of 
maintaining skin integrity, PI prevalence data is traditionally the most common 
metric informing clinical governance. Clinical governance is included as an element 
in the first construct of the SSM, because, without robust clinical governance 
regarding the maintenance of skin integrity, skin injury is likely to ensue. This study 
provides prevalence data that can guide skin safety protocols and procedures at the 
level of clinical governance. Given the responsibility that clinical governance has in 
responding to and managing prevalence data, the serious prevalence results revealed 
by Study 1 indirectly support the validity of including the construct of clinical 
governance in the SSM.  
Another systems factor proposed in the in the first construct of the SSM is 
skin assessment. While skin assessment was not a variable investigated in the study, 
accurate skin assessment was crucial for inter-rater reliability and data validity in 
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terms of accurately identifying and classifying injuries such as IAD, PI or fungal 
infection in this study. Further, to assure inter-rater reliability, skin injuries reported 
during the survey were reinspected on the same day by nurses with expertise in 
assessing skin integrity. This supports the validity of the inclusion of skin assessment 
as a systems factor in the first construct of the SSM. 
Study 1 demonstrated a significant association between the variables older 
age and incontinence (OR = 1.03, p < .001). These variables are identified in the first 
construct of the model as potential contributing factors. All participants in the study 
by virtue of their hospital admission were subject to an acute situational stressor, 
either acute illness, exacerbation of a chronic condition, surgery, trauma or 
psychosocial stressors, or a combination of these factors. The second model construct 
identifies a range of exacerbating elements that contribute to skin injury. Study 1 
investigated the exacerbating elements of skin irritants, in this case, urine and/or 
faeces as a result of incontinence. Of the incontinent patients in the sample, 42% 
suffered from IAD. This result provides evidence that there is an association between 
incontinence, resultant exposure to urine and faeces and the development of IAD as 
proposed in the SSM. In addition, the study found a significant association between 
IAD and semi-formed or liquid stool. The final construct of the model addresses 
potential outcomes of skin injury. The study found that 32% of patients with IAD 
presented with clinical evidence of a fungal infection. This adds empirical evidence 
to the scant data available demonstrating infection as a possible outcome of IAD.  
With the global trend towards population ageing, it is likely that the 
prevalence of incontinence and associated IAD will continue to increase, placing 
further burdens on already strained heath care systems and placing patients at risk of 
adverse outcomes. This data has made a significant contribution to the understanding 
of the prevalence of IAD in the Australian acute care setting.  
4.4 RATIONALE FOR STUDY 2  
The results of Study 1 highlighted the significant magnitude of incontinence 
and IAD within the research facility. The imperative to understand the prevalence of 
IAD and to prevent nosocomial skin injury has been presented in the previous 
chapters. In response to the significant implications of this data for skin integrity 
outcomes, the facility’s pressure injury prevention committee made the important 
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decision that the ongoing gathering of this data was warranted. Subsequently, the 
committee adopted (with some minor adaptations) the combined PI and IAD 
prevalence survey protocol for future facility-wide surveys. The unique, combined 
pressure injury and IAD prevalence survey protocol (used in Study 1) and pressure 
injury data are presented in Publication 3 outlined in Chapter 5. 
A key finding from Study 1 highlighted the presence of a fungal infection in 
32% of patients with IAD. However, this finding was based on clinical judgement, 
and not validated with microbiological testing. Further research was warranted into 
the association between Candida infection and IAD, as demonstrated by the 
significant prevalence of this condition found in Study1. The results of Study 1 
provide rationale for Sudy 2. 
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Chapter 5: COMBINING PRESSURE INJURY AND 
INCONTINENCE-ASSOCIATED 
DERMATITIS PREVALENCE SURVEYS  
5.1 INTRODUCTION 
This chapter presents Publication 3 of the thesis: 
Campbell, J., Gosley, S., Coleman, K., & Coyer, F. Combining pressure 
injury and incontinence-associated dermatitis prevalence surveys: An effective 
protocol? This manuscript has been accepted for publication with minor revisions by 
Wound Practice and Research.  
The objectives of the publication were to:  
1. Review the PI prevalence before and after the commencement of the 
protocol of combining the PI and IAD surveys  
2. Review the utility of combining the PI and IAD prevalence survey 
protocols in an Australian metropolitan hospital.  
The research facility has conducted annual pressure injury prevalence surveys 
for the last decade. However, the impetus to adopt the combined prevalence survey 
protocol was underpinned by several drivers. The key driver resulted from Study 1, 
with the revelation of the significant scope of the problem of IAD within the facility, 
a previously under-appreciated problem. In Queensland, a system of financial 
penalties for hospitals applies for stage III or IV for hospital-acquired PIs, with a 
stage III injury incurring a penalty of $30,000, and a stage IV incurring a penalty of 
$50,000 (Department of Health, 2013). Coupled with the understanding that IAD and 
pressure injuries are frequently misclassified (Beeckman et al., 2008; Doughty, 2012; 
D.Voegeli, 2011), which subsequently results in inappropriate prevention and 
management of both lesions, the combined survey protocol was adopted as a strategy 
to improve patient outcomes and data accuracy. 
The Skin Safety Model (SSM) (see Chapter 2, Publication 1), guided the 
understanding of the complex and inter-related antecedents of skin injury in 
vulnerable patients in the acute care setting. The conduct of the combined PI and 
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IAD prevalence surveys represented a pragmatic clinical application of the concepts 
set forth in the Skin Safety Model. Appreciation of the requirement to understand the 
prevalence of several inter-related skin injuries, as well as the extent of the patients at 
risk for these inter-related skin injuries reflected the move towards a holistic 
approach to managing skin integrity, and a move away from the delivery of siloed, 
narrow, injury-focused skin integrity care. 
The following publication is a collaboration between the researcher, the 
research facility's quality and safety unit, and the Nurse Practitioner Complex Wound 
Care, and was presented as an oral presentation at the Australian Wound 
Management Association’s 10th national conference in 2014.  
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5.2 PUBLICATION 3 
Combining Pressure Injury and Incontinence-Associated Dermatitis Prevalence 
Surveys: An Effective Protocol? 
 
Abstract 
Incontinence-associated dermatitis (IAD) is a largely preventable skin injury 
that can occur following chronic skin exposure to urine and faeces as a result of 
incontinence. Limited data is available regarding the prevalence of IAD in the 
Australian acute care setting. In 2011, the facility combined the annual pressure 
injury (PI) prevalence survey with a survey to determine the prevalence of IAD. This 
paper examines the PI and IAD prevalence results from surveys before and after the 
introduction of the combined survey protocol. The surveys were conducted in a 
major acute care Australian hospital between 2009 and 2013, with the combined PI 
and IAD surveys undertaken from 2011-2013. Overall, PI point prevalence decreased 
from 12.8% (n = 64) in 2009 to 6.3% (n = 28) in 2013. IAD prevalence was first 
reported in the 2011 survey. IAD prevalence decreased from 10% (n = 38) in 2011, 
to 2.7% (n = 12) in 2013. Combining the PI and IAD survey protocols provided 
valuable and previously unknown IAD data. In addition, combining the surveys was 
accomplished without increased financial or staff resources, nor increased survey 
participation burden for patients. Key aspects of the combined protocol have 
subsequently been adopted by the facility as standard procedures for ongoing PI 
prevalence surveys.  
Key words: Incontinence-associated dermatitis, incontinence, pressure injury, 
prevalence. 
 
Introduction 
Pressure injuries (PIs) are localised injuries to the skin and /or underlying 
tissue, usually over a bony prominence resulting from sustained pressure (including 
pressure with shear). Largely preventable, PIs, if sustained while in hospital care are 
considered to be nosocomial skin injuries (National Pressure Ulcer Advisory, 
European Pressure Ulcer Advisory, & Pan Pacific Pressure Injury, 2014). Prevalence 
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surveys are a common and well-established method for determining the number of 
existing PIs in the acute care setting (Baharestani et al., 2009a). Prevalence data 
provides a snapshot of the burden of a condition at the time of the survey, and can 
provide data to assist in evaluating clinical and preventative practices, benchmarking, 
and resource allocation (Amlung, Miller, & Bosley, 2001; Baharestani et al., 2009a; 
Baumgarten, 1998; Beeckman et al., 2007). Incontinence-associated dermatitis (IAD) 
is skin injury that can occur following chronic skin exposure to urine and faeces as a   
Therefore, the primary risk factor for IAD is incontinence (Beeckman et al., 2015). 
Moreover, IAD can predispose patients to serious complications, such as superficial 
PI and/or superimposed infections (Beeckman et al., 2015; Doughty et al., 2012; 
Furlanetto & Emond, 2014; Gefen, 2014; Gray et al., 2007; Junkin & Selekof, 2007). 
Like PIs, IAD is largely preventable. IAD and PIs commonly co-exist, are often co-
located, and are frequently misclassified by clinicians (Beeckman et al., 2015; 
Voegeli, 2011). If misclassification occurs within the context of a PI prevalence 
survey, it is possible that IAD may be classified as a stage I or II PI, thereby 
erroneously increasing PI prevalence (Baharestani et al., 2009a; Beeckman et al., 
2015). Patients at risk of skin injury due to pressure and shear are also likely to be 
vulnerable to injury from moisture, friction, and irritants found in urine and /or 
faeces (Doughty, 2012; Gefen, 2014; Voegeli, 2011). Unlike the extensive 
understanding of PI prevalence in the acute care setting, there is a gap in the 
understanding of IAD prevalence in this setting. Furthermore, established protocols 
or agreement on the ideal methods to conduct prevalence surveys are lacking 
(Beeckman et al., 2015). Given the potentially serious complications of IAD, 
understanding the scope of this condition in the acute care setting is imperative for 
maintaining skin integrity, and the broader mandate of patient safety (Campbell, 
Coyer & Osborne, 2015). 
In Australia, there is evidence that the prevalence of PIs in the acute care 
setting has been decreasing steadily over the last decade. For example, in Ballarat 
Victoria, PI prevalence decreased from 11% in 2009, to 2.5% in 2012 (Antonio & 
Conrad, 2013), at a large metropolitan hospital in Brisbane Queensland hospital-
acquired PI prevalence fell from 14% in 2002 to 4.0% 2012 (Miles, et al., 2013),  and 
statewide hospital PI prevalence audits conducted in Victoria found that PI 
prevalence decreased from 26.5% in 2003 to 17.6% in 2006 (Victorian Quality 
  
Chapter 5: Combining Pressure Injury and Incontinence-Associated Dermatitis Prevalence Surveys      101
       
 
Council, 2008). Internationally, PI prevalence has also declined over the last decade. 
Prevalence in the United States ranged from 13% in 2003 to 11% in 2009 (Vangilder, 
Amlung, Harrison, & Meyer, 2009). An appreciation of incontinence is required to 
understand IAD (Campbell, Coyer & Osborne, 2014), with the prevalence of 
incontinence providing a guide as to the proportion of patients at risk of IAD (Ersser, 
Getliffe, Voegeli, & Regan, 2005). The prevalence of IAD in the acute care setting is 
reported to range between 20-42% (Bliss et al., 2011; Campbell et al., 2014; Junkin 
& Selekof, 2007). A 2014 Australian study (Campbell et al., 2014), found the 
prevalence of incontinence to be 24%, with 42% of those incontinent patients having 
IAD, reflecting the significant extent of the condition in this setting.  
Awareness of the importance of IAD as a significant skin injury has been 
growing over the last decade (Beeckman, 2016; Voegeli, 2016). One of the 
challenges that persists in regard to IAD is the difficulty clinicians face in accurately 
differentiating between IAD and PI (Beeckman et al., 2007; Defloor, Schoonhoven, 
Vanderwee, Weststrate, & Myny, 2006; Mahoney, Rozenboom, Doughty, & Smith, 
2011; Voegeli, 2011). Several factors may contribute to this difficulty. Firstly, while 
there is an agreed categorisation system for PIs (National Pressure Ulcer Advisory et 
al., 2014), at the time of the study, there was no internationally agreed categorisation 
system for IAD. PIs are classified or staged according to a classification system that 
includes stage I-IV injuries, as well as unstageable and suspected deep tissue injury 
categories (National Pressure Ulcer Advisory et al., 2014). While several IAD 
severity categorisation systems have been proposed, (Beeckman et al., Borchert, 
Bliss, Savik, & Radosevich, 2010 2015; Junkin, 2008, Kennedy & Lutz, 1996), use 
of these categorisation systems in clinical practice is limited. This may in part, be 
due to the lack of evidence regarding improvements to clinical decision-making and 
care when these systems are used (Beeckman et al., 2015). Secondly, accurate 
classification is complicated by similarities in clinical presentation and location of 
PIs and IAD (see Table 5.1) with particular challenges found in differentiating IAD 
from Category/stage I and II PI (Beeckman et al., 2015) (see Appendix G).  
In 2011, as a result of a growing appreciation of the significance of IAD as 
nosocomial skin injury, the role of IAD and incontinence as risk factors for PI, and 
the imperative for accurate and reliable PI data, the facility conducted a combined PI 
and IAD prevalence survey. This combined prevalence survey was a facility wide 
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quality improvement activity, and also formed a component of the first author’s 
higher research degree, (results of the research have been published elsewhere, 
Campbell et al., 2014). Combining PI and IAD prevalence surveys into a single 
protocol is not routine clinical practice.  
Table 5.1  
IAD and PI Differentiation  
Parameter IAD  PI 
History Urinary and/or faecal 
incontinence 
Exposure to pressure/shear 
Symptoms Pain, itching, burning, 
tingling 
Pain 
Location Affects perineum, 
perigenital area; buttocks; 
gluteal fold; medial and 
posterior aspects of upper 
thighs; lower back; may 
extend over bony 
prominence 
Usually over bony 
prominence or associated 
with location of a medical 
device 
Shape/edges Affected area is diffuse with 
poorly-defined edges/may 
be blotchy 
Distinct edges or margins 
Presentation/depth Intact skin with erythema 
(blanchable or non-
blanchable), with/without 
superficial, partial thickness 
skin loss 
Presentation varies from 
intact skin with non-
blanchable erythema to full-
thickness skin loss. Base of 
wound may contain non-
viable tissue 
Other Secondary superficial skin 
infection (for example 
Candida) may be present 
Secondary soft tissue 
infection may be present 
Note. IAD = Incontinence-associated dermatitis, PI = pressure injury. Adapted with 
permission from Beeckman, D., Campbell, J., Campbell, K., Chimentao, D., Coyer, F., 
Domansky, R.,  …Wang, L. (2015). Proceedings of the Global IAD expert panel. 
Incontinence-associated dermatitis: Moving prevention forward. Wounds International. 
Retrieved from www.woundsinternational.com (see Appendix G). 
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Potential benefits of combining PI and IAD surveys may include; improved PI data 
accuracy as a result of improved surveyor education, access to new and valuable IAD 
and incontinence data, allowing for a more comprehensive understanding of skin 
integrity risks and injuries within the facility and importantly, and value adding to 
costly PI surveys by means of simultaneously capturing IAD and PI data at minimal 
or no extra cost to the facility. 
Poor understanding of the prevalence of both PIs and IAD, as well as lesion 
misclassification can have implications for patient outcomes, delivery of quality care, 
resource allocation, PI prevalence data accuracy and skin integrity benchmarking 
(Baharestani et al., 2009a; Beeckman et al., 2015; Beeckman, 2016; National 
Pressure Ulcer Advisory et al., 2014). An opportunity exists to improve the 
understanding of these skin injuries in the acute care setting, by way of combining PI 
and IAD prevalence surveys and simultaneously obtaining valuable PI and IAD 
prevalence data.  
Objective 
The objectives of this paper were to review PI prevalence before (2009-2010) 
and after (2011-2013) the commencement of the protocol combining PI and IAD 
surveys, and to review IAD prevalence data after the commencement of the protocol 
combining PI and IAD surveys (2011-2013). 
Methods 
Design 
PI prevalence results from surveys conducted between 2009 and 2013 were 
examined. IAD prevalence results from surveys conducted between 2011-2013 were 
examined. 
Setting and sample  
This study was conducted at a 929-bed major acute care teaching hospital in 
Australia. Hospitalised adults aged 18 aged years or older admitted to the facility on 
the days of the surveys were eligible for inclusion. Patients were surveyed from 
Internal Medicine, Surgery, Critical Care, Cancer Care, and Women’s and Newborn 
services (only non-obstetric patients were included from Women’s and Newborn 
service). Patients from the Mental Health service were excluded from the surveys. 
Pressure injury and incontinence-associated dermatitis prevalence formulae  
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PI prevalence was calculated as the total number of participants with one or 
more PIs detected on skin inspection on the survey days, divided by the total number 
of participants. In 2011, the prevalence of IAD amongst incontinent patients was 
calculated as the total number of IAD cases in the sample divided by the total 
number of incontinent participants (see Figure1) (Campbell et al., 2014). In 2012 and 
2013, incontinence prevalence was not calculated, as the prevalence of incontinence 
was not recorded in these surveys. The change in formula would have impacted on 
the ability to benchmark effectively. Therefore, for these years, the prevalence of 
IAD was calculated by the total number of IAD cases in the sample, divided by the 
total number of participants in the sample. 
Measures 
Pressure injury classification: All PIs were staged according to the PI staging 
guidelines accepted for use in Australia at the time of each survey (Australian 
Wound Management Association, 2012; National Pressure Ulcer Advisory Panel and 
European Pressure Ulcer Advisory Panel, 2009).  
Incontinence-associated dermatitis classification: IAD was classified in 2011 
according the Skin Assessment Tool (Kennedy & Lutz, 1996). This tool was 
designed to provide a cumulative IAD severity score and was used for the research 
component of the project. In the 2012 and 2013 surveys no IAD severity instrument 
was used, IAD was reported as present or absent. The presence of superimposed 
fungal infection was not recorded in the 2012-2013 surveys. 
Procedures 
PI prevalence survey methodology used by Queensland Health for the 
surveys 2009-2013, was based on methodology developed by Prentice, Stacey and 
Lewin in 2003. IAD prevalence survey methodology followed best practice 
guidelines available at the time (Beeckman, Woodward, Rajpaul, & Vanderwee, 
2011; Defloor et al., 2006; Junkin & Selekof, 2007; Prentice et al., 2003).  
Prior to data collection for all surveys, surveyors (registered nurses, 
occupational therapists, physiotherapists and medical practitioners seconded from the 
facility) were trained in the use of the survey instruments, skin inspection procedures 
and assessment and classification of PIs. In the 2011-2013 surveys, surveyor 
education was expanded to include accurate differentiation between IAD, clinical 
presentation of fungal infections as well as identification and staging of PIs. Inter-
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rater reliability was established at the conclusion of all education sessions by scores 
on written multiple-choice tests, and tests using clinical photographs. The surveys 
conducted between 2009-2010 included photographs of a variety PIs. The surveys 
conducted between 2011-2013, included clinical photographs of IAD, fungal 
infections as well as a variety of PIs. The tests required participants to accurately 
identify and stage PIs (for the tests conducted for the 2009-2010 surveys), and 
differentiate between IAD, clinical evidence of fungal infection and PI, as well as 
accurately stage PIs (for surveys conducted in 2011-2013). In all years, surveyors 
were required to achieve a score of 85% to participate in the survey. The use of 
photographs to test inter-rater reliability has been used previously (Beeckman, 
Schoonhoven, Boucque, Van Maele, & Defloor, 2008; Beeckman et al., 2007; 
Defloor & Schoonhoven, 2004).  
The surveys were conducted over two days. Teams of two surveyors 
conducted skin inspections on all eligible, consenting patients. Any loss of skin 
integrity in the pelvic region was classified as either, IAD, PI or fungal infection. PI 
risk assessment, skin integrity documentation in medical records, the use of pressure 
redistributing equipment and demographic data were collected for all participants. In 
addition, in 2011 (as a component of the first author’s research), data were collected 
on continence status, stool frequency and quality, and IAD severity. When patients 
were off the ward at the time of data collection, the surveyors returned later to 
include those patients where possible. To ensure accuracy, expert skin integrity 
nurses conducted independent skin inspections on the same day, on all patients 
reported by the surveyors to have a PI, IAD or clinical evidence of a fungal infection. 
Results 
Between 2009 and 2013, 2126 patients participated in the facility wide PI 
prevalence surveys (see Table 5.2). Overall, PI point prevalence decreased from 
12.8% in September 2009 to 6.3% in October 2013 (see Figure 5.1). Hospital-
acquired PI point prevalence decreased from 12.7% in June 2010 to 4.0% in October 
2013, with the community-acquired PI point prevalence ranging from 3% - 2.2% 
over the period (see Table 5.2 and Figure 5.1).  
No IAD or incontinence data were recorded in 2009 and 2010. The research 
component of the project was conducted in 2011, with fewer patients consenting to 
participate in the research than participated in the PI prevalence survey. This explains 
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the difference in the denominator between the IAD data (N = 376) and the PI data (N 
= 459) for 2011 (see Table 2). In 2011, the prevalence of incontinence was 24% (n= 
91) and the prevalence of IAD for the entire sample (N = 376) was 10% (n = 38),  
Table 5.2  
Pressure Injury Prevalence Survey Data Summary, 2009-2013  
 September 
2009 
(N = 500) 
n (%) 
June 
2010 
(N = 50) 
n (%) 
November 
2011 
(N = 459) 
n (%) 
 
November 
2012 
(N = 273) 
n (%) 
October 
2013 
(N = 444) 
n (%) 
One or more PIs  64 (12.8) 68 (15.1) 43 (9.4) 23 (8.4) 28 (6.3) 
One or more 
hospital-acquired 
PIs 
50 (10) 57 (12.7) 30 (6.5) 15 (5.5) 18 (4.0) 
One or more 
community-
acquired PIs 
15   (3.0) 12   (2.6) 15 (3.3) 8   (2.9) 10 (2.2) 
 
 
 
Figure 5.1 Pressure injury prevalence from September 2009 to October 2013  
 
with the prevalence of IAD for incontinent patients (n =91) being 42% (n = 38), 
(Campbell et al., 2014). The prevalence of IAD (N = 273) in 2012 was 3.6% (n = 10) 
and in 2013 (N = 444), 2.7% (n =12).  
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Discussion 
The requirement for accurate, valid and reliable skin integrity prevalence data 
within the acute care setting is essential for understanding the scope of a problem 
(Coggon, Barker, & Rose, 2003), for evaluation of skin injury prevention protocols, 
and increasingly prevalence data is being used as an indicator of quality care 
(Baharestani et al., 2009). The survey data demonstrate a sustained decrease in PI 
prevalence from the 2010 survey through to 2013 inclusive of the 2011survey, where 
the PI and IAD prevalence surveys were combined into a single procedure. The 
facility PI prevalence is consistent with national and international downward trends, 
including hospital acquired PI prevalence (Miles et al.2013; Mulligan et al., 2011; 
Stotts, Brown, Donaldson, Aydin, & Fridman, 2013; Vanderwee, Clark, Dealey, 
Gunningberg, & Defloor, 2007; Vanderwee et al., 2011; Vangilder et al., 2009; 
Victorian Quality Council, 2008). Survey data also demonstrated a sustained 
decrease in IAD prevalence. The downward PI prevalence trend from 2011 may be 
explained in part by improved differentiation of PI and IAD as a result of more 
comprehensive surveyor education, which may ultimately improve prevalence data 
accuracy, and result in lower PI prevalence. However, the effect of the combined 
survey protocols on PI prevalence cannot be quantified. Other factors that may have 
contributed to the downward PI prevalence trend during that period include, ongoing 
clinician PI education programs, ongoing utilisation of PI prevention champions in 
clinical areas, and the introduction of a system whereby financial penalty was applied 
to Queensland hospitals by the Queensland Department of Health if a patient 
developed a preventable stage III or IV hospital acquired PI (Queensland 
Government, 2013). Improved surveyor education, effective collection of data 
without the need to increase personnel, material or financial resources and 
importantly no increased survey participation burden experienced by patients 
demonstrated the utility of combining PI and IAD surveys.  
Overall, the unique surveys provided important data on both PI and IAD 
prevalence. Subsequently, key aspects of the combined protocol, that is, improved 
surveyor education and recording the presence of IAD as a component of data 
collection was adopted as standard practice for ongoing PI prevalence surveys within 
the facility. 
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PI and IAD prevalence 
The sustained decrease in the facility’s PI prevalence demonstrated in the 
surveys is consistent with downward national and international PI prevalence trends. 
Wound prevalence surveys conducted in Western Australian public hospitals 
between 2007-2011 (Mulligan et al., 2011), found PI prevalence ranged between 
12% - 9%, with hospital acquired PI prevalence ranging between 7% - 9%. In 
Victoria, Australia, state-wide PI prevalence surveys conducted in 2003, 2004 and 
2006 found the prevalence of PIs ranged between 26%-18% respectively, with 
approximately two thirds of PIs sustained in hospital in all three surveys (Victorian 
Quality Council, 2008). Surveys conducted at a metropolitan hospital in Queensland 
(Miles et al., 2013) reported hospital acquired PI prevalence rates ranging from 8% 
in 2009, 4% in 2012, with overall PI prevalence ranging from 12 % in 2009 to 6% in 
2012.  
Internationally, a large American study, conducted over eight years (Stotts et. 
al., 2013) reported PI prevalence data from 78 acute care hospitals (nearly 260 000 
patients). This study found the hospital acquired PI rate decreased from 10% in 2003 
to 2% in 2010. Another large study (Vangilder et al., 2009) in the United States 
found PI prevalence in acute care hospitals in 2008 -2009 to be 13% and 12% 
respectively, with the hospital acquired prevalence being 6% and 5% respectively. A 
Belgian study (Vanderwee et al., 2011), found a PI prevalence of 12% in 143 
hospitals. Consistent with the national and international downward PI prevalence 
trends, the facility data demonstrates continuing reductions in PI and hospital 
acquired PI prevalence. 
It can be speculated that a portion of the PI prevalence reduction between 
2011 and 2013 may be attributed to improved surveyor accuracy regarding 
differentiation of PIs and IAD as a result of the more comprehensive surveyor 
education provided prior to participation in these surveys. Traditionally, PI surveys 
focused on establishing inter-rater reliability with regard to accurate identification 
and staging of PIs only. While difficulty with differentiating PI and IAD is 
recognised (Beeckman et al., 2008; Beeckman et al., 2007; Defloor & Schoonhoven, 
2004), the impact of misclassified lesions on PI prevalence data has not been 
reported in the literature, nor quantified in the facility.  
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The majority of published IAD data comes from the aged care or critical care 
environment. The IAD prevalence in critical care is reported to be 36% (Bliss et al., 
2011), with the prevalence of IAD ranging between 6% and 22% in aged care 
(Beeckman et al., 2010; Bliss, Savik, Harms, Fan, & Wyman, 2006). The 2011 IAD 
survey (see Campbell et al., 2014) found that 24% of participants were incontinent 
and of those who were incontinent, 42% had IAD (Campbell et al., 2014). A 2007 
study conducted in the acute care setting in the United States reported the prevalence 
of incontinence to be 19%, with IAD present in 20% of those who were incontinent. 
IAD trend data is not available nationally or internationally to enable comparison 
with the facility IAD data. The facility downward IAD prevalence trend between 
2011-2013 may be due to the comprehensive surveyor education requiring accuracy 
in differentiation between PI, IAD and fungal infections as well as facility wide 
ongoing education for clinicians regarding IAD. Similar to PI prevalence data, 
prospective IAD data is necessary for benchmarking and tracking quality care over 
time.  
Drivers for combining surveys  
The impetus for combining the PI and IAD prevalence surveys into a single 
procedure in 2011 was based on the facility’s need to understand the prevalence of 
incontinence and IAD in its population. Parallels between PI and IAD survey 
procedures such as common patient populations, the requirement for comparable 
surveyor education, establishment of inter-rater reliability, and the requirement for 
participants to undergo a pelvic skin inspection (Arnold-Long, Reed, Dunning, & 
Ying, 2011; Campbell et al., 2014; Junkin & Selekof, 2007; National Pressure Ulcer 
Advisory et al., 2014), meant that combining the survey protocols was 
straightforward. In addition, the practical and logistical requirements for an IAD 
prevalence survey are almost identical to the requirements for the routine PI survey 
conducted each year in the facility. 
It is accepted that direct skin inspection is the gold standard for obtaining PI 
prevalence data, with the caveat that surveyors have adequate skill in classifying PIs 
and differentiating them from other lesions such as IAD (Baharestani et al., 2009; 
Black & Langemo, 2012; Defloor et al., 2005). The rationale for the recommendation 
of skin inspection as the primary data source is based on the understanding that 
documentation in regard to PI is often inadequate (Baharestani et al., 2009a). It 
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would therefore be consistent then, that data obtained from direct skin inspection 
would also be the gold standard practice for IAD prevalence survey methodology. In 
light of the fact that a thorough pelvic skin inspection is required for both PI and IAD 
prevalence data collection, combining the survey protocols does not result in any 
further survey participation burden for the patient.  
It is well recognised that clinicians face difficulties when differentiating 
between PIs and IAD (Defloor et al., 2006; Mahoney et al., 2011). These lesions 
have different aetiologies and as such require different prevention and management 
strategies. Subsequently, misclassification can have a significant impact on patient 
outcomes, data accuracy, benchmarking, and resource allocation (Beeckman et al., 
2015; Defloor et al., 2006; Mahoney et al., 2011; Voegeli, 2011). In 2007, the 
NPUAP (Black et al., 2007) issued a statement with the description of stage II PI, 
stating that this category should not be used to describe ‘skin tears, tape burns, 
perineal dermatitis, maceration or excoriation’ (p. 40). This raised awareness of the 
fact that until that time most superficial pelvic lesions were classified as a stage II PI 
(Doughty, 2012). In Queensland, a funding penalty is applied by the Queensland 
Department of Health to a hospital, if a patient develops a stage III or IV hospital-
acquired pressure injury. This disincentive means that a stage III hospital-acquired PI 
will incur a funding penalty for the care provider of $30,000, and a stage IV hospital-
acquired PI will incur a funding penalty of $50,000 (Queensland Government, 2013). 
Accordingly, a misclassified pelvic lesion (for example IAD erroneously classified as 
a stage III PI) has the potential to attract a penalty of $30,000 for the healthcare 
provider. Accurate differentiation of PIs and IAD is therefore of utmost importance 
for patients and healthcare providers alike. 
The utility of combining the PI and IAD surveys was persuasive. The 
combined survey utilised the same number of surveyors and support staff, meaning 
no increase in personnel or financial resources was necessary. In addition, the data 
collection was completed in the same time as the previous annual PI surveys that is, 
over two days. Therefore, combining the PI and IAD protocols maximised value 
from the costly and resource intensive annual PI prevalence survey. While a cost-
effectiveness analysis was not undertaken in the 2011-2013 surveys, any minor cost 
increase as a result of extra time taken recording IAD data would have been offset by 
the benefits of having access to the additional data. An additional positive outcome is 
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that anecdotally, IAD awareness is improved for staff that participate as surveyors, 
and subsequently champion IAD awareness in their respective clinical areas. Extra 
time was required to develop resources for the combined survey including 
educational materials and data extraction forms. However, this was seamlessly 
integrated into the routine planning for the annual PI prevalence survey. As a result, 
valuable data regarding the burden of IAD and incontinence became available to the 
facility enabling comprehensive understanding of the burden of these conditions. 
Prevalence studies are difficult and costly to perform, and require a 
significant number of adequately trained personnel. In view of the high cost of 
conducting these studies, and the financial and clinical imperative that resultant data 
are accurate, it is logical to combine the PI and IAD surveys into a single protocol. 
Further, documenting and reporting of these valuable metrics is crucial given the 
appreciation of the association between incontinence and IAD as risk factors for PI 
development. Utilising protocols that aid in the understanding of the burden of 
incontinence and IAD in patients vulnerable to PI is surely the next logical step in 
quality improvement. 
Limitations 
As discussed, no international agreement exists as to an IAD prevalence 
survey methodology, or methodology combining PI and IAD surveys, which leads to 
study limitations. An IAD severity instrument was not utilised for the 2012 and 2013 
surveys, rather, the presence or absence of IAD was reported. PI data were reported 
in all surveys by stage and location as collective totals. Therefore, it was not possible 
to report the prevalence of stage 1 or II pelvic PIs, or to investigate the prevalence of 
these PIs when IAD was included in data collection. An appreciation of incontinence 
is essential for the understanding of the epidemiology of IAD. The 2012 and 2013 
surveys did not collect incontinence data; therefore IAD is reported as a percentage 
of the entire sample rather than a percentage of incontinent participants. 
Opportunities exist to improve collection and reporting of survey data, as well as 
reaching agreement in regards to survey protocols, particularly formulae for 
calculating the prevalence of IAD.  
Conclusion 
This paper has proposed a unique protocol for conducting combined pressure 
injury and incontinence-associated dermatitis prevalence surveys. The data from the 
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combined surveys reveals downward trends in both PI and IAD prevalence. In 
addition, the combined protocol has been shown to be effective, practicable and 
achievable, without incurring additional costs to the facility, or placing additional 
burdens on patients to participate. The resultant IAD data is the first of its kind in 
Australia, and provides previously unknown IAD trend data for the acute care 
setting.  
PIs and IAD are both largely preventable skin injuries. During the last 
decade, there is a wider appreciation of the potentially serious complications of IAD, 
particularly IAD as a risk factor for superficial PI (Gefen, 2014).Therefore from a 
patient safety perspective, understanding the prevalence of IAD and incontinence 
constitutes a vital component of maintaining skin integrity (Campbell et al., 2015). 
Prevalence studies are difficult and costly to perform and require a significant 
number of adequately trained personnel. In view of the financial burden to the 
facility in conducting these studies, and the financial as well as clinical imperative 
that resultant data are accurate, combining PI and IAD surveys into a single protocol 
has multiple benefits. While this research could not quantify the extent of the 
influence of the combined protocol on PI prevalence data a sustained downward 
trend in PI prevalence was demonstrated. It is feasible therefore, to attribute a portion 
of the reduction in PI prevalence to improved accuracy in the classification of pelvic 
lesions. Recommendations for future surveys include determining agreement as to 
the definition of incontinence for IAD surveys, agreement as to the minimum data set 
required for a combined PI and IAD survey protocol, formulae for calculating and 
reporting IAD prevalence and finally, agreement as to an IAD severity classification 
instrument. Further research is required to evaluate PI and IAD prevention programs 
within the facility. In the future, PI prevalence surveys may evolve into broader, 
comprehensive skin integrity prevalence surveys, providing a rich source of data that 
will ultimately inform and guide skin integrity care and outcomes in acute care 
patients. 
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5.3 CHAPTER SUMMARY 
The results of Study 1 raised some important issues for the research facility in 
terms of the appreciation of the growing complexity of ageing patients who have 
multiple skin injury vulnerabilities. Traditional silo driven skin integrity care can 
result in an under-estimation of both the extent of skin integrity risks, and the extent 
of patients suffering a range of skin injuries within the facility. 
Consensus is required on several aspects of the combined prevalence survey 
methodology, including testing of the IAD severity categorisation instrument 
published by Beeckman et al. (2015), formulae for calculating IAD prevalence, and 
also, agreement on the format for the reporting of IAD prevalence data. However, 
this review has taken the first step in evaluating the effect that the combined IAD and 
PI surveys have on resultant PI prevalence data, as well as reviewing the utility of 
conducting combined PI and IAD prevalence surveys. While further research is 
warranted regarding consensus for the combined methodology, the success of the 
combined protocol presented in this publication provides a sound basis for 
continuing with the combined survey protocol. This publication represents an 
immediate and significant outcome of this research program, by way of improving 
the validity and reliability of the PI data, as well as presenting a survey protocol that 
provides access to IAD and incontinence data, which was not previously available to 
the facility.  
Following the combined PI and IAD prevalence study, the research facility 
adopted (following some minor adaptations) the survey procedures as part of the 
protocol for annual PI prevalence surveys. Further, in Queensland annual state-wide 
PI prevalence surveys are conducted by the Patient Safety and Quality Improvement 
Service Clinical Excellence Division and are known as the Queensland Bedside 
Audit (QBA). This group determines the minimum data set to be collected, 
preparation and distribution of educational materials, inter-rater reliability testing 
procedures, as well as data analyses and preparation of state-wide PI prevalence 
reports. From 2012, as a result of the combined IAD and pressure injury prevalence 
survey protocol adopted in the research facility, QBA developed and distributed new 
surveyor educational resources to facilitate improved inter-rater reliability for the 
state-wide PI surveys. In addition, the QBA data survey instrument was amended to 
include a category noting the presence of IAD (J. Whitmore, personal 
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communication, November 18, 2015). These procedural changes adopted by the 
research facility, and then by the Queensland Patient Safety and Quality 
Improvement Service represent the immediate and significant impacts of this 
research program. 
The following chapter presents the methods for Study 2 of this thesis which 
continues the exploration of the phenomenon of IAD in the acute care setting by 
investigating the role of Candida albicans colonisation in the aetiology of IAD. 
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Chapter 6: METHODS 
6.1 INTRODUCTION 
This chapter describes the research design, study participants, rationale and 
justification for the selection and use of the study instruments, study procedure, 
timeline, data analyses, ethical considerations and study limitations adopted to 
achieve the aims and objectives of Study 2. 
6.2 BACKGROUND 
Study 1 of this research program revealed that almost one quarter of patients 
were incontinent, with a high prevalence (42%) of IAD among incontinent patients. 
These results demonstrate the considerable extent of both conditions in the acute care 
setting. In addition, Study 1 found that nearly one third of patients with IAD had 
clinical evidence of Candida infection. 
 A reported complication of IAD is Candida infection (Beeckman et al., 2015; 
Farage, Miller, Berardesca, et al., 2007; Gray et al., 2007; D.Voegeli, 2013). The 
diagnosis of Candida infection, however, is predominantly informed by a 
presumptive diagnosis based on the clinical presentation of the perineal skin. It is 
known that Candida spp. are the most common fungal human commensal organisms,   
with colonisation being a necessary antecedent to infection (Kumamoto, 2011; 
Moran et al., 2012; Odds et al., 2006). Candida colonisation is common in the 
gastrointestinal and genito-urinary systems, with faecal Candida colonisation 
equivalent to rectal colonisation levels (Odds, 1988). Furthermore, incontinence and 
the subsequent use of occlusive incontinence containment aids increases skin 
moisture, temperature, and skin pH, which in turn fosters ideal conditions for 
proliferation of certain skin microorganisms, particularly Candida spp (Ali & 
Yosipovitch, 2013; Aly et al., 1978; Baroni et al., 2012; Fidel, 1999; Honig, 1983; 
Tsai & Maibach, 1999; Zhai & Maibach, 2002). 
In addition, it has been reported that certain factors predispose to Candida 
infection for example, age, gender, treatment with antibiotics, or the presence of 
diabetes. It is uncertain whether these factors influence Candida colonisation in acute 
care incontinent patients or those with IAD.  
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It is not clear whether there is an association between incontinence and 
Candida colonisation, that is, whether skin contact with urine and faeces, combined 
with the local skin environment resulting from wearing an incontinent pad influences 
the level of Candida colonisation. Alternatively, it is unclear if incontinence acts as a 
trigger for Candida to transform from commensal to pathogen, resulting in skin 
infection, specifically in incontinent patients or those with IAD, or those already 
colonised with Candida. Moreover, it is unclear if there are there factors that 
constitute risk factors for Candida colonisation in this sample. 
There is a paucity of data that identifies Candida colonisation in incontinent 
compared to continent acute care patients, as well as those with IAD. The purpose of 
Study 2 was to compare the prevalence of Candida colonisation at the perianal and 
inguinal sites between continent compared to incontinent patients, as well as those 
with IAD, and to identify risk factors for Candida colonisation in these patients.  
6.3 RESEARCH QUESTIONS 
The primary research questions guiding this study were: 
4. Is colonisation with Candida albicans more common at hospital admission 
in incontinent patients compared with continent patients? 
5. In incontinent patients (urinary or urinary and faecal), is there an 
association between Candida albicans colonisation and the clinical 
presentation of IAD on admission to hospital. 
The secondary research question was: 
6. In acute care medical patients, are gender, mobility, nutritional status, 
faecal frequency and quality, treatment with antibiotics, diabetes (Type 1 
or 2), age, or body mass index (BMI) risk factors for Candida 
colonisation? 
6.4 METHOD 
6.4.1 Design 
The research aims and questions in this study were best addressed using the 
empiricist paradigm, utilising a quantitative methodology. In many instances, it is not 
possible or ethical to manipulate the independent variable, thus, non-experimental 
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study designs must be used (Coggon, Barker & Rose, 2003). These designs are used 
to answer questions about groups, differences in one group or differences between 
more than one group (Coggon, Barker & Rose, 2003). 
This study utilised cross-sectional, observational methods. Observational 
studies collect, record, and analyse data without any control of the exposure status or 
study conditions; the researcher simply compares existing groups (Oleckno, 2008). 
In this study method, there is no manipulation of the independent (or explanatory) 
variable; therefore, a causal relationship cannot be established. However, this study 
method can yield important information about the relationship between the variables 
of interest (Oleckno, 2008).  
Further, in view of the scant data identifying Candida colonisation in this 
patient group, the present study was conducted as a pilot study. A pilot study is 
utilised to test methods and procedures to be used on a larger scale (Arain, Campbell, 
Cooper & Lancaster, 2010; Leon, Davis & Kraemer, 2010; Thabane et al., 2010) 
with respect to aspects of the research, such as recruitment, assessment procedures, 
and data collection tools. Alternatively, the pilot study may show that the proposed 
relationship between variables does not exist (Arain et al., 2010, Leon et al., 2010, 
Thabane et al., 2010). 
6.4.2 Measurements  
The data collection instrument was designed specifically for the study (see 
Appendix H). It included several instruments, including the Skin Assessment Tool 
(SAT) (Kennedy and Lutz, 1996) (see Appendix B), the Bristol Stool Form Chart 
(see Appendix G), the SGA (see Appendix H) and the mobility subscale of the 
Braden Scale for predicting pressure sore risk (see Appendix I). 
Independent variables  
The independent variables for this study were age, gender, length of hospital 
stay (LOHS), height and weight, primary admission diagnosis, co-morbid conditions 
regular medications, antibiotics, smoking status, continence status, stool frequency 
and quality, continence aid use, administration of enteral nutrition, nutrition and 
mobility status, and finally, presence and location of pressure injury. 
These independent variables were measured as follows. Age was defined in 
years at the participants last birthday, with data extracted from the medical record. 
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Gender was defined as male or female. Length of hospital stay (LOHS) was recorded 
in days, with admission and discharge dates extracted from the medical record. 
Height and weight data were extracted from the medical record, which allowed for 
the calculation of BMI (height/weight
2
 or kg/m2) The primary admission diagnosis 
and comorbid conditions were extracted from the medical record, and medication 
data, including antibiotics, route of antibiotic administration, excluding pro re nata 
(PRN) medication, were extracted from the medication chart. Smoking status was 
categorised as yes/no, as reported by the patient.  
Continence status was categorised as continent, incontinent of urine only, 
incontinent of urine and faeces, indwelling urinary catheter in situ but continent of 
faeces, indwelling urinary catheter in situ, but incontinent of faeces. Continence 
status was determined as reported by the patient or bedside nurse, or extracted from 
the bedside medical record. The presence and type of a urinary or faecal stoma was 
recorded. Stool frequency was categorised as ≤ 1 per day, 2-3 per day, > than 3 per 
day, as reported by the patient or bedside nurse or extracted from the bedside medical 
records. Stool quality was categorised according to the Bristol Stool Form Scale, 
(Lewis & Heaton, 1997) (see Appendix D) and collapsed into the dichotomous 
categories of ‘formed’ or ‘semi-formed/liquid’. This data was determined as reported 
by the patient or bedside nurse, or extracted from the medical record. Continence aid 
use was categorised as full brief or insert pad.  
The administration of enteral nutrition was recorded as yes/no. Nutritional 
status was measured by administration of the Subjective Global Assessment (SGA) 
by the research nurse (Agarwal et al., 2012; Detsky et al., 1987) (see Appendix I), 
and categorised as SGA-A, SGA-B, and SGA-C. Mobility status was categorised as 
immobile, very limited, slightly limited, or limitation. The mobility subscale from the 
Braden Scale for predicting pressure sore risk (Benoit & Mion, 2012) was used to 
assess mobility (see Appendix J) (Benoit & Mion, 2012; Bergstrom, Braden, 
Laguzza, & Holman, 1987).  
The presence of a PI was categorised as yes/no. If a PI was present, it was 
categorised according to the National Pressure Ulcer Advisory Panel pressure ulcer 
classification system of stage I - stage IV, unstageable or deep tissue injury (National 
Pressure Ulcer Advisory et al., 2014). The location of a PI was recorded as 
sacrum/coccyx, ischial tuberosity, or greater trochanter/hip.   
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Dependent Variables  
The dependent variables were the presence of IAD, IAD severity, and semi-
quantitative results of the microbiological cultures for Candida albicans or Candida 
spp.  
These dependent variables were measured as follows. The presence of IAD 
was determined following a pelvic skin inspection and categorised as yes/no. IAD 
was deemed to be present if any skin redness was detected, with or without erosion. 
IAD severity was categorised according to the SAT (Kennedy & Lutz, 1996, used 
with permission, see Appendices A and B) in the categories of skin redness, area of 
skin breakdown, erosion, and region affected. Clinical evidence of fungal infection 
was derived from the skin inspection and categorised as yes/no. Semi-quantitative 
results of the microbiological cultures for Candida albicans or Candida spp. were 
reported as scant, 1+, 2+ or 3+ and recorded on the study instrument for each patient.  
6.4.3 Instruments 
The Skin Assessment Tool  
The SAT (Kennedy and Lutz, 1996) was included as a component of the 
overall instrument to assess IAD severity, used with permission (see Appendices A 
& B). The SAT derives a cumulative IAD severity score, with a numerical score 
assigned according to severity within each of three categories: skin redness, area of 
skin breakdown (cm²); and erosion. A cumulative severity score (maximum score = 
10) is generated by adding scores in each category. A higher score indicates more 
severe IAD (Gray, 2007). The SAT was used by Beeckman and colleagues (2010) in 
a randomised controlled trial to investigate the effect of a specialised cloth compared 
to standard care in the prevention of IAD. The overall inter-observer reliability 
regarding skin observation using the SAT was κ =0.81 (95% CI, 0.69 - 0.87) 
(Beeckman et al., 2010). The SAT was also used in study one of this research 
program. Word descriptors were assigned in study one to correspond with IAD 
severity categories (that is, mild, moderate, severe, or extreme) in the SAT 
(Campbell et al., 2014) (see Chapter 4, Measures)  
Stool Quality Assessment 
This study collected data on stool form based on the Bristol Stool Form Scale 
(see Appendix D). The Bristol Stool Form Scale was devised as a means to describe 
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stool consistency in seven categories or types, ranging from Type 1-separate hard 
lumps, like nuts (hard to pass), to type 4-like a sausage or snake, smooth and soft, 
through to type 7-watery, no solid pieces, entirely liquid. Each category is 
accompanied by a representational diagram (Lewis & Heaton, 1997). Types 1 and 2 
equate to constipation, types 3 and 4 equate to normal stool and types 5-7 equate to 
diarrhoea (Abrams et al., 2010). Stool quality was collected in dichotomous 
variables. Categories from the Bristol Stool Form Scale types 1 – 4 were collapsed to 
the formed category, and types 5-7 were collapsed to the semi-formed-liquid 
category for this study. 
Subjective Global Assessment  
The SGA is a commonly used malnutrition assessment tool (see Appendix I), 
although no gold standard exists (Steenson, Vivanti, & Isenring, 2013). This tool is 
valid and reliable and assesses nutritional status based on patient history and physical 
examination (Agarwal et al., 2012; Detsky et al., 1987). Patient history queries five 
categories, including weight change, dietary intake change (relative to normal), 
gastrointestinal symptoms, functional capacity, disease, and relation to nutritional 
intake (Detsky et al., 1987). The physical examination includes loss of subcutaneous 
fat (triceps, chest), muscle wasting (quadriceps, deltoids), ankle oedema, sacral 
oedema, and ascites. Each category is scored as either normal (0), mild (1+), 
moderate (2+), or severe (3+). Results of both of these assessments are combined to 
produce an overall global rating: well nourished (SGA-A), moderately malnourished 
or suspected of being malnourished (SGA-B), and severely malnourished (SGA-C) 
(Agarwal et al., 2012; Detsky et al., 1987).  
A training session in use of the SGA was administered by a clinical dietitian 
and an assessment of several patients was then conducted together to ensure 
researcher competence with the use of the instrument.  
Braden Scale for Predicting Pressure Sore Risk 
The Braden Scale for Predicting Pressure Sore Risk (Benoit & Mion, 2012) is a 
validated tool widely used in a variety of healthcare settings (Kring, 2007). It 
contains six subscales, including mobility. The mobility categories are: completely 
immobile, very limited, slightly limited, and no limitations, with accompanying 
explanation for each category (Benoit & Mion, 2012). Convergent construct validity 
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has been reported for the mobility subscale of the instrument (Powers, Zentner, 
Nelson, & Bergstrom, 2004).  
6.4.4 Sample size 
There are no microbiological data reporting perianal and inguinal Candida 
albicans colonisation levels in the acute care patient population. Study 1 provided 
data on the prevalence of incontinence, IAD, and the presence of fungal infection 
(based on the clinical judgement of the research assistants). There was insufficient 
data available for a sample size calculation for this study, as computing a sample size 
would require guessing key equation elements, resulting in an invalid output. 
It was anticipated that 80-85 patients would be recruited, with 27-28 patients 
in each group (that is, continent, incontinent of urine only, and incontinent of urine 
and/or faeces  
Setting 
This study was conducted in the Internal Medicine Service (IMS) wards of the 
Royal Brisbane and Women’s Hospital (RBWH), Brisbane, Australia. Recruitment 
and enrolment took place between April and October 2014. The RBWH is a 929-bed, 
major teaching hospital in southeast Queensland, Australia, that provides care over a 
comprehensive range of specialities. It is the largest tertiary referral hospital in 
Queensland, providing care in 2012 to almost 94,000 inpatients, 520,000 outpatients 
and 72,000 emergency department presentations (Royal Brisbane and Women's 
Hospital Marketing and Communications, 2013a). The IMS has approximately 240 
overnight beds and is comprised of over 16 specialty medical areas (Royal Brisbane 
and Women's Hospital Marketing and Communications, 2013a).   
6.4.5 Participants 
The study population was comprised of patients admitted to all acute care 
wards in the hospital’s IMS who met the eligibility criteria over a consecutive seven-
month period. The IMS comprised eight acute wards, with 174 patient beds, with 
average bed occupancy of 97%.  
The findings of Study 1 informed the decision to select the IMS as the setting 
for Study 2, with the prevalence of incontinence (30%) and IAD (42% among 
incontinent patients) being higher in this admitting service than in the other admitting 
services.  
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Inclusion and Exclusion Criteria 
The inclusion criteria were: consenting inpatients of the IMS wards aged 18 
years and over; and expected admission time of three or more days.  
The exclusion criteria were: expected short admission time, of less than three 
days, or where data could not be collected within 48 hours of admission; current 
treatment with systemic or topical antifungal agents; presence of a dermatological 
condition requiring topical or systemic treatment, which potentially disrupts the 
normal skin microbiota; current radiation treatment to the pelvic area; and pregnant 
or breastfeeding.  
6.4.6 Procedure 
The investigator approached the Executive Director (ED) and Director of 
Nursing (DON) of the IMS to negotiate access to the wards to collect the study data. 
Project implementation information sessions, written information, and posters were 
used to inform staff and patients about the study. The principal investigator was 
contactable to answer any questions of the staff or patients regarding the research.  
The research nurses visited each medical ward from Monday to Friday, where 
the Nurse Manager or shift co-ordinator identified patients admitted within the last 
48 hours. If the newly admitted patient met the study inclusion criteria (this was 
determined by the bedside nurse together with the research nurse) the patient was 
asked by the bedside nurse if they were willing to hear information about the study 
from the research nurse. The patient was then approached by a research nurse and 
invited to participate in the study. A written information sheet was provided and left 
with the patient or their representative to consider. Contact details of the researcher 
were available on the patient information form for any questions the patient may 
have had. Written consent was obtained from each participant or their substitute 
decision-maker (National Health Medical Research Council, 2000) (see Appendices 
K & L). The researchers liaised with the Nurse Manager or shift co-ordinator, as well 
as the bedside nurse to arrange a suitable time for screening. Every effort was made 
to align the data collection with routine care in an effort to minimise patient 
disruption. Data was collected within 48 hours of admission.  
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Skin Inspection  
A skin inspection of the pelvic girdle (perianus, perineum, groins, buttocks 
labia/scrotum, and lower abdomen) was conducted to detect skin redness, skin 
erosion and severity, area and location of skin lesions, or the presence of fungal 
infection based on clinical appearance or the presence and category of pressure 
injuries. Findings of the skin inspection were recorded on the data collection 
instrument. The total time required for patients to participate in the study was 10-20 
minutes. Patient dignity and privacy was maintained at all times.  
Microbiological testing 
Microbiological samples were collected from the perianal and inguinal sites 
of study participants. These anatomical regions were selected for microbiological 
sampling, as Candida albicans is known to be present in faeces and found as a 
commensal organism in the perianal region (Fidel, 1999). The moist environment of 
the inguinal region (particularly in the incontinent patients) also supports Candida 
albicans colonisation (Anaissie et al., 2003; Fidel, 1999).  
Each patient had two microbiological specimens collected. A dry flocked 
swab (without transport medium) was pre-moistened in an ampoule of saline, with 
excess saline removed by pressing the swab to the side of the ampoule. The inguinal 
site was sampled rolling the swab from the proximal inguinal fold to a distance of 
approximately six centimetres. One swab was used for collection of both the right 
and left inguinal specimens. The perianal specimen was collected from the anal verge 
using a rolling action, with any faecal matter removed from the skin prior to 
specimen collection. 
Pathology request forms were signed by the Director of Dermatology, 
RBWH. Specimens were transported to the laboratory as per the usual ward 
procedure. Specimens were cultured directly to Sabouraud’s medium for yeasts and 
incubated at 37° Celsius (98.6° Fahrenheit) for 48-72 hours. Chloramphenicol and 
gentamycin were added to the medium to inhibit bacterial growth on the plate. A 
germ tube test was performed to identify Candida albicans. The specific ability of 
Candida albicans to form germ tubes or hyphal outgrowths from blastospores when 
incubated in serum for two hours at 37°C (98.6°F) is presumptive evidence of the 
organism, with the germ tube test being the traditional specific test for rapid 
identification of Candida albicans (Leyden & Kligman, 1978; Moran et al., 2012; 
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Odds, 1988). The results specified either Candida albicans or non-albicans species. 
The laboratory did not culture other organisms. The results of the microbiological 
cultures were reported by the laboratory as scant, 1+, 2+ or 3+. 
The results of scant, 1+, 2+ and 3+ represent the density of Candida albicans 
present following specimen culture. The culture results should be considered in 
conjunction with a clinical assessment to diagnose the presence of a Candida 
infection (I. Robertson, personal communication, October 10, 2013). Results were 
entered into the hospital pathology reporting system, which enabled them to be 
accessed by the principal investigator.  
6.4.7 Risk management 
Incontinence skin care followed the standard protocol of the clinical area. 
This protocol included cleansing with a soft cloth and pH neutral soap-free cleanser 
or water, followed by application of skin barrier product containing either acrylate 
teropolymer, dimethicone, or zinc oxide. If a patient in the study developed IAD or 
Candida infection, they were managed according to hospital protocol and/or medical 
treatment orders. 
Routine hospital reporting procedures were followed in the IMS for those 
patients identified with IAD or a Candida albicans infection. Record of enrolment 
into the study and microbiological sample collection was entered into the patient’s 
chart. The bedside nurse and treating medical team were informed of any adverse 
findings. 
6.4.8  Data management  
Data were documented for each patient on a paper-based case report form, 
developed by the researcher. Data were de-identified for patient confidentiality by 
creating a master log of patients and unit record numbers, and assigning a sequential 
study number. The hospital number and ward were recorded. It was necessary to 
collect data in a potentially re-identifiable form to ensure microbiological data was 
recorded accurately for each participant. The identity of participants was not 
disclosed. 
The master log was kept as a separate form in a separate location (electronic 
forms were password protected), thus ensuring the information on the data collection 
forms could not be linked to any specific patient (or hospital area). All data 
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collection forms and the master log were held by the principal investigator and did 
not include the patient name or bed number. At the completion of the data collection, 
the electronic master log identifying the observation form that corresponded with the 
patient record number was deleted. All data was consequently de-identified for both 
the investigators and supervisors.  
6.4.9 Data analysis 
All data were entered into the IBM SPSS Statistics for Windows (Version 
22.0, Armonk, NY, USA). A random 10% of data were cross-checked for accuracy 
by the researcher. Incomplete data was coded as missing data. Descriptive statistics 
were used to describe sample characteristics (means and standard deviations for 
continuous variables; frequencies and percentages for categorical variables). 
Characteristics were compared between the three groups. Bivariate analyses using 
descriptive correlational statistics (χ2 test for independence with Yates continuity 
correction and Fisher’s exact test where expected cell counts were less than five for 
categorical variables, and one-way, between groups analysis of variance (ANOVA) 
with post-hoc analysis using the Tukey test for continuous variables). Candida 
albicans colonisation was compared between continent and incontinent participants, 
and between incontinent participants with and without IAD. The level of statistical 
significance was set at p ≤ 0.05, to reduce the risk of Type I errors (Oleckno, 2008). 
Normality of the data distribution scores was tested using the Kolmogorov-Smirnov 
statistic.  
6.4.10 Ethical considerations 
Ethical approval for this study was granted by the RBWH Human Research 
Ethics Committee and the Queensland University of Technology. Human Research 
Ethics Committees (see Appendices M, N & O).  
Informed consent 
Participation in this study required written consent from the patient or their 
representative (National Health Medical Research Council, 2000) (See Appendices 
L, & M). 
Written information was provided to each patient prior to obtaining consent. 
The principal investigator was available to answer any questions by the patient 
throughout the study. Patients or their representative were informed they were able to 
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withdraw from the study during or after data collection without comment, penalty or 
compromise to their current treatment 
Patient dignity  
Patient dignity and privacy was maintained at all times. Skin examination and 
specimen collection was conducted behind closed doors or drawn curtains. 
Negotiation with the patient and bedside nurse allowed for a suitable time for the 
skin inspection to be arranged. Every effort was made to integrate the skin 
examination and specimen collection with the routine care to minimise disruption. 
Any questions asked of patients were similar to those asked during routine patient 
care.  
Confidentiality  
A coding mechanism (previously detailed) ensured no individual could be 
identified. De-identified study participant forms were stored at the Queensland 
University of Technology, Royal Brisbane and Women’s Hospital campus in a 
locked filing cabinet and locked office. Password control was used to access 
computer stored data and only the principal investigator had direct access to this 
information. The data enrolment log was shredded at the completion of the data 
collection.  
6.5 CHAPTER SUMMARY 
The conceptual framework presented in Chapter 2 and the results of Study 1 
presented in Chapter 4 informed the development of Study 2. This chapter has 
presented the rationale for selection of the quantitative method for the study, while 
the study questions guided the study design. The study participants, study setting, 
procedure, and rationale for selecting the study instruments were explained. In 
addition, the study variables, statistical analysis, and ethical considerations were 
described for Study 2 of this research program. The following Chapters 7 and 8 
present the results of the study, as well as Publications 4 and 5.  
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Chapter 7:   CANDIDA ALBICANS COLONISATION, 
INCONTINENCE-ASSOCIATED 
DERMATITIS AND CONTINENCE STATUS 
IN THE ACUTE CARE SETTING: A PILOT 
STUDY 
7.1 INTRODUCTION 
This chapter comprises Study 2 and Publication 4 of this thesis.  
The aim of this study was to compare Candida colonisation in incontinent 
and continent patients and those with IAD. In addition, this study aims to explore 
which variables in the Skin Safety Model (SSM) are supported by the findings of this 
study  
This study addressed the following research questions 
4. Is colonisation with Candida albicans more common at hospital admission 
in incontinent patients compared with continent patients?  
5. In incontinent patients (urinary or urinary and faecal), is there an 
association between Candida albicans colonisation and clinical 
presentation of IAD at admission to hospital? 
In view of the understanding of the role of endogenous Candida organisms in 
subsequent Candida infection, accurate data explaining the epidemiology of Candida 
colonisation that compares incontinent with continent patients, as well as those with 
IAD is likely to contribute to the understanding of IAD and incontinence-associated 
Candida infections  
To date, the only data regarding the prevalence of Candida albicans infection 
related to IAD in the general adult acute care population are from Study 1 of this 
research program (Campbell et al., 2014), and a study conducted by Junkin and 
Selekof (2007). Data from both studies relied on the clinical judgement of research 
assistants who were specifically trained in study protocols to distinguish between 
different perineal lesions. However, it is unknown if there is agreement between 
clinical assessment and presumptive diagnosis and microbiologically proven 
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diagnosis of Candida albicans infections. There is limited quantitative evidence for 
the prevalence of Candida albicans colonisation or infection demonstrated by 
microbiological testing associated with either incontinence or IAD in the adult 
hospital population. A study in a long-term care facility of elderly inpatients with 
IAD found that 63% were colonised with Candida (Foureur et al., 2006). However, 
this study did not have a non-IAD comparison group.  
Understanding the association between Candida albicans and IAD is 
important for several reasons. Firstly, baseline data are important to understand the 
potential pathogenic Candida reservoir in the adult inpatient population. Secondly, it 
is not known whether Candida albicans colonisation plays a role in the pathogenesis 
of IAD. Therefore, establishing baseline Candida colonisation data is a vital step in 
understanding the natural history of fungal infection related to IAD. Finally, IAD is a 
prevalent skin injury in incontinent individuals; therefore, understanding the 
pathogenesis of this condition is a critical component of the broader healthcare 
priority of maintaining skin integrity. Overall, Candida infection in patients with 
incontinence or IAD poses a serious threat to patient outcomes and merits further 
research.  
The following manuscript represents Study 2 and Publication 4 of this thesis: 
Campbell, J., Coyer, F., Mudge, A., Robertson, I., & Osborne, S. Candida 
albicans colonisation, incontinence-associated dermatitis and continence status in the 
acute care setting: A pilot study. This manuscript has been accepted for publication 
in the International Wound Journal. 
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7.2 PUBLICATION 4 
Candida albicans Colonisation, Continence Status, and Incontinence-Associated 
Dermatitis in the Acute Care Setting: A Pilot Study 
   
Abstract 
Candida albicans is the most prevalent human fungal commensal organism, 
and is reported to be the most frequent aetiological organism responsible for 
infection associated with incontinence-associated dermatitis. However, it remains 
unclear whether incontinence predisposes a patient to increased Candida 
colonisation, or whether incontinence acts as a trigger for Candida infection in those 
already colonised. The purpose of this cross-sectional observational pilot study was 
to estimate colonisation rates of Candida albicans in continent compared to 
incontinent patients, and patients with incontinence-associated dermatitis. Data were 
collected on 81 inpatients of a major Australian hospital, and included a pelvic skin 
inspection and microbiological specimens to detect Candida albicans at hospital 
admission. The mean age of the sample was 76 years (SD = 12.22), with 53% being 
male. Incontinent participants (n = 53) had a non-significant trend towards greater 
Candida colonisation rates at the perianal site (43% versus 28%), χ2(1, N = 81) = 
4.453, p = .638, and the inguinal site (24% versus 14%), χ2(1, N = 81) = 6.868, p = 
.258 than continent participants (n = 28), respectively. The incontinent subgroup with 
incontinence-associated dermatitis (n = 22) showed no significant difference in 
colonisation rates compared to those without incontinence–associated dermatitis χ2(1, 
N
 
= 53) = 000, p = 1.00. Understanding the epidemiology of colonisation may have 
implications for prevention of Candida infection in these patients.  
 
Key words: Candida albicans, colonisation, incontinence, incontinence-associated 
dermatitis, cross-sectional study 
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Key Messages 
 This is the first study to provide data on the Candida albicans colonisation 
rates of continent compared to incontinent acute care patients and those with 
incontinence-associated dermatitis.  
 On admission to hospital, there was a non-significant trend towards greater 
Candida albicans colonisation in incontinent compared to continent patients. 
 Incontinence-associated dermatitis was common among incontinent patients. 
 No significant association was found between Candida colonisation and 
clinical presentation of incontinence-associated dermatitis on admission to 
hospital. 
 Accurate estimates of Candida colonisation in patients with incontinence-
associated dermatitis, and continent compared to incontinent patients may 
contribute to understanding factors that regulate Candida colonisation and 
transformation to Candida infection in this group. 
Introduction  
Candida, a genus of yeasts, is the most common fungal commensal organism 
in humans, and is responsible for a wide range of mucosal and invasive diseases 
(Clancy & Nguyen, 2012; Fidel, 1999; Odds, 1988). Systemic infection by Candida 
(predominately Candida albicans) is the leading cause of nosocomial fungal 
bloodstream infection, with a mortality rate of 30%-40% (Clancy & Nguyen, 2012; 
Lionakis, 2014; Magill et al., 2014). Candida albicans is the most common fungal 
human mucosal coloniser, with oropharyngeal and vulvovaginal the most frequent 
Candida mucosal infection sites. These mucosal Candida infections are responsible 
for considerable morbidity, discomfort, and decreased quality of life for affected 
individuals (Revankar & Sobel, 2012). For example, 65% of denture wearers will 
experience Candida-associated denture stomatitis, while up to 75% of women will 
experience an episode of vulvovaginal Candida infection (Fidel, 1999; Revankar & 
Sobel, 2012). 
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Candida species (spp.) form part of the normal mucosal microflora and can 
colonise several anatomical sites, with the organism being present in the 
gastrointestinal and genito-urinary tracts of up to 80% of individuals (Moran et al., 
2012), Under certain conditions, Candida can transform from an innocuous 
commensal organism to a harmful pathogen (Fidel, 1999). The primary source of 
both invasive and superficial Candida infection is endogenous, with colonisation 
being a necessary antecedent to infection (Kumamoto, 2011; Moran et al., 2012; 
Odds et al., 2006). The high frequency of occurrence, morbidity, and mortality 
associated with superficial and mucosal Candida infections, coupled with the ability 
of the organism to grow in a wide range of conditions means that Candida infections 
are important human diseases (Fidel, 1999; Moran et al., 2012). 
In adults, Candida infections have been associated with a condition known as 
incontinence–associated dermatitis (IAD). (Beeckman et al., 2015; Black et al., 2011; 
Bliss & Powers, 2011; Gray et al., 2007). This is an irritant contact dermatitis that 
can occur as a consequence of skin exposure to urine and/ or faeces as a result of 
incontinence. IAD is characterised by inflammation and erythema, and may present 
with blisters, erosion, or serous exudate (Beeckman et al., 2015; Gray et al., 2007), is 
a painful, complex condition, and can result in increased morbidity and length of stay 
for hospital patients (Doughty et al., 2012; Gray et al., 2007). Commonly, IAD is 
complicated by a fungal infection, with Candida albicans being reported as the most 
frequent aetiological organism (Beeckman et al., 2015; Gray et al., 2007). Candida 
infections associated with incontinence or IAD can present clinically as either as a 
bright red maculopapular rash spreading from a central area, with characteristic 
satellite lesions at the margins of the rash extending into normal skin, or present with 
non-specific confluent papules, making clinical diagnosis difficult (Beeckman et al., 
2015; Habif, 2015). 
It has been reported that Candida infections play a central role in the 
pathogenesis of diaper dermatitis in infants (Bonifaz et al., 2013; Dixon, Warin, & 
English, 1969; Dorko et al., 2003; Ferrazzini et al., 2003; Jefferson, 1966; Leyden & 
Kligman, 1978; Montes, Pittillo, Hunt, Narkates, & Dillon, 1971). Several studies 
have shown significantly higher rates of Candida colonisation in oral, inguinal, and 
perianal sites in infants with diaper dermatitis than those without, with colonisation 
rates correlating with the severity of the diaper dermatitis (Ferrazzini et al., 2003; 
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Montes et al., 1971). Despite the reported frequency of Candida infections as a 
complication of adult IAD (Beeckman et al., 2015; Black et al., 2011; Bliss & 
Powers, 2011; Gray et al., 2007), the role of Candida colonisation or infection has 
not been widely considered in the pathogenesis of adult IAD. It remains unclear 
whether incontinence predisposes to increased Candida colonisation, or whether 
incontinence acts as a trigger for Candida to transform from commensal to pathogen 
in those already colonised. Furthermore, it is unclear whether Candida plays a role in 
the pathogenesis of IAD in incontinent individuals. Understanding the epidemiology 
incontinence-associated Candida infections requires accurate estimates of Candida 
of colonisation in continent compared to incontinent patients, as well as those with 
IAD. Knowledge of the epidemiology of Candida colonisation in these situations 
may guide assessment and prevention strategies for these patients. 
Aims and research questions 
The purpose of this study was to identify the rate of Candida albicans 
colonisation in incontinent patients compared to continent patients and those with 
IAD. The specific research questions were: 
4. Is colonisation with Candida albicans more common at hospital admission 
in incontinent patients compared with continent patients? 
5. In incontinent patients (urinary or urinary and faecal), is there an 
association between Candida albicans colonisation and clinical 
presentation of IAD at admission to hospital? 
Methods 
Study design 
An observational cross-sectional study design was used. 
Study setting and sample 
This study was conducted in the Internal Medicine Service (IMS) wards at a 
929-bed major acute care metropolitan teaching hospital in Australia. The facility 
provides a comprehensive range of specialities, delivering care in 2012 to almost 
94,000 inpatients, 520,000 outpatients, with 72,000 emergency department 
presentations. The IMS has approximately 240 beds, and is comprised of over 16 
specialty medical areas, including general medicine, cardiology, dermatology, 
endocrinology, infectious diseases, renal, rheumatology, and thoracic medicine.  
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This study used a purposive sample of participants in three groups; (1) 
continent; (2) incontinent of urine, but continent of faeces; (3) incontinent of both 
urine and faeces (double incontinence). 
Inclusion and exclusion criteria 
Hospitalised adults aged 18 years or older admitted consecutively to all wards 
in the IMS, with an expected hospital stay of three or more days, and where data 
could be collected within 48 hours of admission were eligible for inclusion in the 
study. Excluded patients were those who had current treatment with systemic or 
topical antifungal agents, a pre-existing skin condition, those receiving radiation 
treatment to the pelvic area, or those who were pregnant or breastfeeding. 
Procedures 
Patient recruitment and enrolment took place from April - October 2014. 
Prior to data collection, all research nurses (n = 3) were trained in the study 
procedures, use of the data collection instrument (see Appendix H), pelvic skin 
inspection, identification of IAD, clinical presentation of Candida infection, and 
pressure injuries, as well as the technique for the collection of the microbiological 
specimens. Research nurses screened and enrolled patients admitted consecutively to 
the IMS. The research nurses visited each medical ward Monday to Friday, where the 
Nurse Manager or shift co-ordinator identified patients admitted within the last 48 
hours. If the newly admitted patient met the study inclusion criteria (this was 
determined by the bedside nurse together with the research nurse), the patient was 
asked by the bedside nurse if they were willing to receive information about the 
study from the research nurse. Written consent was obtained from each participant 
(see Appendices K & L). Data were collected from participants within 48 hours of 
admission, and extracted from medical records, with supplementary information 
sought from the patient and the bedside nurse, a pelvic skin inspection (perianus, 
perineum, groins, buttocks, labia/scrotum, and lower abdomen) was conducted, as 
well as collection of microbiological specimens. 
Each patient had two microbiological specimens collected with a dry flocked 
swab (without transport medium), pre-moistened in an ampoule of saline (as per the 
laboratory protocol). The inguinal specimen was collected using one swab, and the 
perianal specimen was collected from the anal verge, with any faecal matter removed 
from the skin prior to specimen collection.  
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Specimens were cultured directly to Sabouraud’s medium for yeasts and 
incubated at 37° Celsius (98.6° Fahrenheit) for 48-72 hours. Chloramphenicol and 
gentamycin were added to the culture medium to inhibit bacterial growth on the 
plate. Candida albicans was identified by performing a germ tube test. The ability to 
form germ tubes after incubation in serum for two hours at 37°C (98.6° Fahrenheit) 
is presumptive evidence of Candida albicans (Leyden & Kligman, 1978; Moran et 
al., 2012). The laboratory reports specified either Candida albicans or non-Candida 
albicans spp. Semi-quantitative results were reported as scant, 1+, 2+, and 3+. The 
laboratory did not culture for other pathogens. Results were entered into the facility 
pathology reporting system. Routine hospital reporting procedures were followed for 
those patients identified with IAD, Candida infection, or any adverse findings. 
Measures 
Candida colonisation: In this study, the presence of any Candida albicans or 
Candida spp. at either the perianal or inguinal sites was classified as colonised 
(Fidel, 1999; Jarvis, 1996; Sobel et al., 1998). 
Incontinence: Incontinence is the primary risk factor for the development of 
IAD (Beeckman et al., 2015; Gray et al., 2007). It is defined as the inability to 
control the flow of urine and or faeces at any time in the previous 24 hours (Junkin & 
Selekof, 2007). In this study, patients with an indwelling urinary catheter were 
deemed continent for the purpose of data analysis. The presence of an indwelling 
catheter negates the irritant effects of urine on the skin. This categorisation is 
consistent with previous studies (Campbell et al. ,2014; Halfens et al., 2013; Junkin 
& Selekof, 2007). Patients were recruited according to continence status, that is, 
continent, incontinent of urine only, or incontinent of both urine and faeces (double 
incontinence). Continence status was determined by a combination of patient self-
report, clinical documentation, and communication with the bedside nurse. 
Incontinence-associated dermatitis (IAD): IAD is defined as the presence of 
any skin redness and/or erosion caused by skin contact with urine and/or faeces 
(rather than other sources of moisture) on the buttocks, coccyx, rectal area, labia, 
scrotum, lower abdomen, upper thighs, gluteal cleft, or groins in an incontinent 
patient (Beeckman et al., 2015). IAD severity was determined using the skin 
assessment tool (SAT) (Kennedy & Lutz, 1996) (used with permission, see 
Appendices A & B). The SAT derives a severity score (maximum score = 10), by 
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adding scores within categories of skin redness, area of skin breakdown (cm²), and 
erosion. Word descriptors were designated to match IAD severity categories 
(Campbell et al., 2014). 
Clinical presentation of a Candida infection: Clinical presentation of Candida 
infection was determined by a physical assessment conducted by the research nurse. 
Candida infections associated with incontinence or IAD commonly present as a 
central maculopapular rash with characteristic satellite lesions at the margins of the 
rash extending into normal skin. These rashes may also present as non-specific 
confluent papules in patients with IAD (Beeckman et al., 2015; Habif, 2015). In 
darker skin tones, the central area of fungal infection may be darker (Beeckman et 
al., 2015). 
Incontinence-associated Candida infection: The term 'incontinence-associated 
Candida infection' has been used to ensure clarity with reference to incontinence, 
IAD, and Candida infections. Terms commonly used in the literature, such as 
secondary Candida infection or superimposed Candida infection, imply a causal 
relationship between IAD and Candida infection, however this relationship is 
uncertain. Incontinence-associated Candida infection was measured by culturing the 
microbiological specimens collected for the study. 
Patient descriptors: Demographic data (age, gender, ward, and length of stay), 
admission diagnosis, co-morbidities, current medications, as well as height, weight, 
continence status, incontinence containment product, and presence of faecal or 
urinary stoma were recorded on a study specific data collection instrument (see 
Appendix H). Pressure ulcers were identified and staged according to current 
international guidelines for staging pressure ulcers (National Pressure Ulcer 
Advisory et al., 2014). Malnutrition was measured using the Subjective Global 
Assessment (SGA) (see Appendix I), a valid and reliable tool, which assesses 
nutritional status based on patient history and physical examination (Agarwal et al., 
2012; Detsky et al., 1987; Steenson et al., 2013). Results of both of these assessments 
are combined to produce an overall global rating; well nourished (SGA-A), 
moderately malnourished or suspected of being malnourished (SGA-B), and severely 
malnourished (SGA-C) (Agarwal et al., 2012; Detsky et al., 1987). Mobility status 
was measured because immobility has been associated with incontinence (Miu, Lau, 
& Szeto, 2010). The immobility subscale from the Braden Scale for predicting 
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pressure sore risk was used (Bergstrom et al., 1987) (see Appendix J) and 
administered by the research nurse. Convergent construct validity has been reported 
for the mobility subscale of the instrument (Powers et al., 2004). Mobility categories 
were; immobile, very limited, slightly limited, and no limitations (Bergstrom et al., 
1987). 
Ethical considerations  
The study was approved by the Human Research Ethics Committees for both 
the research site and the university. The study was conducted in accordance with 
ethical standards set forth in the 1975 Helsinki Declaration (see Appendices M, N & 
O). 
Data Analysis 
All data were entered into the IBM SPSS Statistics for Windows (Version 
22.0, Armonk, NY, USA). A random ten per cent of data entry was crosschecked for 
accuracy by the first author. Descriptive statistics were used to describe sample 
characteristics (means and standard deviations for continuous variables, frequencies 
and percentages for categorical variables). Characteristics were compared between 
the three groups. Bivariate analyses using descriptive correlational statistics (χ2 test 
for independence with Yates continuity correction and Fisher’s exact test where 
expected cell counts were less than five for categorical variables, and one way 
between groups analysis of variance (ANOVA) with post-hoc analysis using the 
Tukey test for continuous variables). Candida albicans colonisation was compared 
between continent and incontinent participants, and between incontinent participants 
with and without IAD. Normality of the data distribution scores was tested using the 
Kolmogorov-Smirnov statistic.  P values less than .05 were considered statistically 
significant.  
Results 
Over six months 1,777 adult inpatients were assessed for eligibility (see 
Figure 7.1), with 362 patients not meeting the inclusion criteria, while 1,333 patients 
were eligible, but not enrolled. Recruitment targets for each group took varying times 
to meet. The recruitment target was for 28 participants in each group. The 
recruitment target for the continent group was reached within two months; the target 
for the urinary incontinent group was reached within three months, while the 
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recruitment target for the doubly incontinent group took six months to reach 25 
participants. This meant that while recruiting for the doubly incontinent group only, 
it was still necessary to screen all new admissions and record those who met 
eligibility criteria for the study (n = 1,083). However, whilst these patients were 
eligible, they were not enrolled as they belonged to groups whose recruitment targets 
had already been met (that is continent or incontinent of urine only) (see Figure 7.1). 
A total of 82 patients were recruited to the study. Data for 81 patients were available 
for analysis, as one patient withdrew consent prior to data collection  
All variables were found to follow normal distributions. The mean age of the 
sample was 76 years (SD = 12.22), with 53%, (n = 43) being male. The mean number 
of comorbidities and regular medications for each participant was five (SD = 2.02) 
and eight (SD = 3.10) respectively. Of the total sample, 35% (n = 28) of participants 
were continent, 35% (n = 28) were incontinent of urine but continent of faeces, and 
31% (n = 25) were incontinent of both urine and faeces. Table 7.1 provides an 
overview of the characteristics of these three groups. Overall, the urinary incontinent 
group was significantly associated with a higher BMI F(2, 67) = 3.9, p = .025 than 
the continent and doubly incontinent groups. Double incontinence was significantly 
associated with older age, F(2, 78) = 5.3, p =.007, immobility, or very limited 
mobility, χ2(2, N = 81) = 25.9, p < 0.001), as well as the risk of malnutrition or 
malnutrition, χ2 (2, N = 81) = 15.2, p = .003.  
Candida albicans was present at the perianal site in 31% (n = 25) and the 
inguinal site for 15% (n = 12) of the sample, while non-albicans spp. were present at 
the perianal site in 7% (n = 6) and in the inguinal site for 6% (n = 5) of the sample. 
Incontinent participants (n = 53), showed a non-significant trend towards higher 
colonisation with Candida albicans or Candida spp. (43%, n = 23) at the perianal 
site compared to continent (n = 28) participants (28%, n = 8), χ2 (1, N = 81) = 4.453, 
p = .638. At the inguinal site, there was a non-significant trend towards higher 
colonisation with Candida albicans or Candida spp. 24% (n = 13) of incontinent 
participants compared to 14% (n = 4), χ2 (1, N = 81) = 6.868, p = .258. 
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Figure 7.1 Patient enrolment, eligibility and exclusion diagram. 
 
Figures 7.2 and 7.3 show the frequency of Candida albicans and Candida 
spp. according to continence status at the perianal and inguinal sites respectively. 
The highest semi-quantitative level of Candida albicans at the perianal site was 1+ 
(8.6%, n = 7) and at the inguinal site 1+ (2.5%, n = 2). The highest semi-quantitative 
level of Candida spp. at both perianal and inguinal sites was 3+ (1.2%, n = 1).  
 
Assessed for eligibility, 
(within 48 hours of 
admission) 
(n = 1777)  
 Excluded (n = 362) 
Younger than 18 years (n = 19) 
Admission less than 3 days (n = 42)  
No consent obtained (n = 122) 
Non IMS patient (n = 167) 
   Pregnant or breastfeeding (n = 2)  
   Current radiation treatment (n = 1) 
   Pre-existing skin condition (n = 9) 
Enrolled 
(n =82) 
Data available for analysis 
(n = 81)  
Eligible but not enrolled (n = 1333) 
Declined participation (n = 88) 
RN decision (n = 97) 
Death imminent (n = 15)  
Research nurse unavailable (n = 50) 
Eligible but continent (n = 1083) 
 
 
Withdrew prior to data 
collection 
(n = 1) 
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Table 7.1 
Sample Characteristics (N = 81)   
 Continent 
(n = 28) 
 
 
n (%) 
 
Incontinent 
of urine 
(n = 28) 
 
n (%) 
 
Incontinent of 
urine and 
faeces 
(n = 25) 
n (%) 
SGA
a
 score
b
 
  A- Normal 
  B- At risk of malnutrition 
  C- Malnourished 
 
20 (71.4) 
  4 (14.3) 
  4 (14.3) 
 
18 (64.3) 
  8 (28.6) 
  2   (7.1) 
 
  6 (24) 
12 (48) 
  7 (28) 
 
Mobility
c
 
  No limitation 
  Slightly limited 
  Very limited 
  Completely immobile 
 
 
12 (42.9) 
10 (35.7) 
  5 17.9)   
  1 (3.6) 
 
   
  5 (17.9) 
13 (46.4) 
  9 (32.1) 
  1   (3.6) 
 
   
  0   (0) 
  5 (20) 
15 (60) 
  5 (20) 
 
Pressure ulcer
d 
 
   
  1 (3.6) 
  
  1   (3.6) 
   
  4 (16) 
 
Diabetes -Type 1 & 2
e
 
 
11 (39) 
 
 
12 (43) 
 
 
10 (40) 
 
a
SGA = Subjective global assessment.  
bχ2(2, N = 81) = 15.2, p = .003. 
cχ2(2, N = 81) = 25.9, p < .001. 
dχ2(2, N = 81) = 3.17, p = .236. 
eχ2(2, N = 81) = 1.0, p = .1.26. 
 
 
IAD was present in 41% (n = 22) of the incontinent patients (n = 53). There 
was no significant difference between the type of incontinence (that is urinary only 
or double incontinence) in those with IAD, χ2(2, N = 53) = .044, p =.833. IAD 
severity ranged from mild 73% (n = 16), to moderate (27%, n = 6). Perianal Candida 
albicans or Candida spp. colonisation rates showed no significant difference in 
participants with IAD (n = 10) compared to the incontinent participants without IAD 
(n = 31), (45%, n =10), compared to 42%, n =13), respectively, χ2(1, N = 53) = .000, 
p = 1.000. Inguinal Candida albicans or Candida spp. colonisation rates showed no 
significant difference in participants with IAD compared to incontinent participants 
without IAD (27%, n = 6, compared to 23%, n = 7), χ2(1, N = 53) = .000, p = 1.000. 
Clinical signs of a Candida infection were observed in 18% (n = 4) of participants  
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Figure 7.2 Continence status and Candida albicans and non-albicans spp. 
colonisation rates at the perianal site (N = 81). 
 
 
 
Figure 7.3 Continence status and Candida albicans and non-albicans colonisation at 
the inguinal site (N = 81). 
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with IAD, with the presence of Candida confirmed with microbiological testing in 
75% (n = 3) of those participants.  
Discussion 
This study is the first to provide surveillance data indicating the extent of 
Candida albicans colonisation at perianal and inguinal sites in continent and 
incontinent acute care patients and in those patients with IAD. We found no 
significant difference in colonisation rates between continent and incontinent patients 
at either the perianal or inguinal sites, although there was a trend towards higher 
Candida colonisation rates in incontinent patients. Candida colonisation rates 
between incontinent patients with and without IAD showed no difference. The rate of 
incontinence-associated Candida infection in patients with IAD was lower than we 
anticipated. Despite general acceptance that Candida infection is a common 
complication of IAD (Beeckman et al., 2015; Gray et al., 2007; Gray et al., 2011; 
Junkin & Selekof, 2007; Nix & Haugen, 2010), data presenting microbiological 
confirmation of Candida infections in patients with a clinical presentation of IAD is 
scant.  
Despite the ubiquitous presence of Candida albicans as a human commensal 
(Fidel, 1999; Moran et al., 2012) there is a paucity of data that identifies Candida 
colonisation rates in continent compared to incontinent acute care adults. Candida 
colonisation varies greatly depending on the anatomical site. The highest 
colonisation rates are in the genitourinary and gastrointestinal tracts (Moran et al., 
2012; Odds, 1988), with vaginal colonisation rates reported to range between 10% -
20% in asymptomatic women of childbearing age (Revankar & Sobel, 2012; Sobel et 
al., 1998). Rectal colonisation is reported to range from 8% to 29% in hospitalised 
patients (Barlow & Chattaway, 1969; Hilton & Warnock, 1975; Rose & Kurup, 
1977; Smits, Prior, & Arblaster, 1966), with no difference found between faecal and 
rectal colonisation rates (Odds, 1988). One study reports inguinal colonisation of 
hospital patients to be three percent (Somerville, 1972). Odds (1988) found oral 
Candida colonisation to range between 6% and 70%, with a mean of 41% in a 
compilation of studies. Overall, our study was unable to demonstrate an association 
between continence status and Candida colonisation. Moreover, we found no 
association between faecal frequency and/or quality and Candida colonisation. 
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It has been reported that patients with double incontinence and/or liquid 
faeces are more likely to develop IAD (Beeckman et al., 2015; Gray et al., 2007). It 
is proposed that the association between double incontinence or frequent liquid 
faeces and IAD is linked to the presence of digestive enzymes in faeces (higher in 
liquid faeces) that are capable of damaging the stratum corneum (Beeckman et al., 
2015). The higher water content in liquid faeces is also damaging to the skin barrier 
(Gray et al., 2007). In addition to a higher risk of developing IAD, Candida infection 
is frequently cited as a common complication of IAD (Beeckman et al., 2015). 
Therefore, it is reasonable to expect an association between Candida colonisation 
and IAD. However, empirical data to support this is limited. Amongst our patients 
with IAD, 45% were colonised with Candida albicans or spp, similar to the 
colonisation rate in incontinent, non-IAD patients (42%). Limited data is available in 
the literature to enable comparison of Candida colonisation between adult patients 
with and without IAD. In one of the few studies to present such data, Foureur et al., 
(2006) reported Candida infection prevalence to be 63% in a group of elderly 
patients (mean age = 85 years) in a long-term care unit who presented with IAD. 
Furthermore, our study found no association between the type of incontinence and 
IAD. Moreover, in our study, patients with urinary incontinence had higher Candida 
colonisation rates at the perianal site than doubly incontinent patients (43% versus 24 
%) respectively. 
In contrast to the limited empirical data available reporting associations 
between Candida and IAD in adults, there is a multiplicity of data reporting 
associations with Candida colonisation and diaper dermatitis in infants (Dixon et al., 
1969; Ferrazzini et al., 2003; Montes et al., 1971). Two paediatric studies (Brookes 
et al., 1971; Warin & Faulkner, 1961) found no difference in Candida colonisation 
between infants with and without diaper dermatitis. On the other hand, several 
paediatric studies found higher Candida colonisation rates in infants with diaper 
dermatitis (Dixon et al., 1969; Ferrazzini et al., 2003; Montes et al., 1971). 
Associations between Candida colonisation and Candida infection in infants with 
diaper dermatitis raise questions about the possible role of Candida in the aetiology 
of the condition. Paediatric data should be extrapolated to adults with caution, due to 
differences between the subjects, such as skin physiology, health status, and 
medications. However, unlike paediatric data regarding diaper dermatitis and 
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associated Candida colonisation and infection, there is very little data available 
investigating these associations in adults with IAD.  
Data reporting microbiological confirmation of incontinence-associated 
Candida infection following a clinical diagnosis is scarce. We found 18% of 
participants with IAD showed clinical signs of a Candida infection, which was 
subsequently confirmed with microbiological testing in 75% of cases. The study by 
Fourer and colleagues (2006) found that 60% of the initial clinical infection 
diagnoses were confirmed on mycological swab cultures or histological examination. 
One reason for the scarcity of microbiological data may be that in the clinical setting, 
microbiological testing for the presence of Candida associated with IAD is not 
routine practice. This may be because cultures require a 48-72 hour period for a 
reliable result (Revankar & Sobel, 2012). Usually, a presumptive diagnosis is made 
based on clinical presentation, which is then followed by empirical treatment. 
According to Odds (1988), accuracy of the diagnosis of superficial forms of Candida 
infections is contentious, as clinical presentation of superficial infections may be 
characteristic of Candida, but not unique to it. Microbiological confirmation of 
Candida is required, combined with careful evaluation of the clinical presentation for 
a diagnosis of Candida infection to be made. Conversely, the presence of 
microbiologically demonstrated Candida at superficial sites is not indicative of 
infection without due consideration of the clinical presentation (Odds, 1988).  
The differences in characteristics between the urinary incontinent group and 
the doubly incontinent groups in this study are worthy of comment (see Table 7.1). 
The patients in the urinary incontinent group compared to the doubly incontinent 
group were younger, tended to be female, were well nourished or overweight, and 
generally had no major mobility limitations. In comparison, the participants who 
were doubly incontinent were older, malnourished or at risk of malnutrition, and 
were either completely immobile or had very limited mobility. These characteristics 
may reflect differences in the underlying cause and severity of incontinence. Double 
incontinence appeared to be a manifestation of frailty, while urinary incontinence 
was likely to be related to obstetric/gynaecological risk factors (for example parity), 
menopause, and obesity. 
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Limitations 
Several limitations need to be acknowledged for this study. This was a pilot 
study intended to provide initial estimates of colonisation rates in this population. 
Post hoc power calculations show that the study had 80% power to detect a 
difference of 35% (for example, 45% in the incontinent group vs 10% in the 
continent group), and the observed differences were much smaller (10% at the 
inguinal site and 15% at the perianal site), which may help to inform sample size 
calculations for further studies in this area. The study was conducted in a single 
centre and single admitting service; therefore, the data may not be generalisable to 
other acute care settings or admitting services. Larger multi-site studies including a 
variety of acute care admitting services would be of value in the future. While every 
effort was made to recruit all eligible patients, respondents who were older tended to 
consent to participation more frequently, with the majority of patients who declined 
participation under 50 years of age. This may have biased the sample. Many of those 
respondents made comments that reflected the belief that incontinence was an old 
person’s problem and therefore not relevant to them. Further, the nature of the skin 
inspection and collection of microbial samples can be intrusive and may have 
influenced the decision not to participate.  
Microbiological testing for Candida albicans only was based on the extensive 
literature identifying Candida albicans as the most common human fungal coloniser 
and pathogen (Fidel, 1999; Moran et al., 2012). However, we found those with non-
albicans spp. constituted higher colonisation severity compared to Candida albicans. 
Future studies would benefit from identifying all Candida species that may be 
present. 
Conclusion 
This is the first study to report the colonisation rates of Candida albicans in 
continent and incontinent hospitalised adults as well as those with IAD. Candida 
colonisation was common at the perianal and inguinal sites at admission to hospital. 
We found no significant difference in Candida colonisation between continent and 
incontinent patients or those with IAD, although there was a non-significant trend 
towards Candida colonisation in those who were incontinent. 
Candida albicans is reported as the most common aetiological agent in 
incontinence-associated Candida infection, with the primary source of pathogen 
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being an individual’s endogenous commensal organisms (Clancy & Nguyen, 2012; 
Fidel, 1999). Therefore, awareness of the patterns and frequencies of Candida 
colonisation in these patients is imperative for improving understanding of factors 
that regulate colonisation and potential transformation to Candida infection, 
particularly in incontinent patients. Further research is warranted to understand 
specific factors that precipitate Candida infections in incontinent adults. 
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7.3 CHAPTER SUMMARY 
Study 2 is the first study to provide data that contribute to the understanding 
of Candida colonisation rates in acute care patients according to continence and IAD 
status. Study 2 found that overall, on admission to hospital, regardless of continence 
status (N = 81), Candida was present at the perianal site in 38% of patients, and the 
inguinal site for 21% of patients. On admission there was a non-significant trend 
towards more frequent Candida albicans colonisation in incontinent than in 
continent patients. Candida was present at the perianal site in 43% of incontinent 
participants compared to 28% of continent patients. At the inguinal site, more 
incontinent (24%) patients were colonised with Candida than continent (14%) 
patients were colonised with Candida.   
While there are several studies that identify high levels of Candida organisms 
in both paediatric patients with diaper dermatitis (Ferrazzini et al., 2003) and older 
patients with IAD (Foureur et al., 2006), until now, there has been no analysis that 
compares baseline Candida colonisation data between incontinent and continent 
patients. The study presented in Publication 2 found that incontinence is associated 
with older age and places patients at risk for the skin injuries of IAD and pressure 
injury. Furthermore, developing IAD places a patient at risk of developing a Candida 
infection. These consequences of older age and incontinence are important for both 
the patient and the healthcare provider. Therefore, a crucial step in understanding 
these consequences is to understand patterns of Candida colonisation in these 
specific patient groups. This study provides unique Candida colonisation data for 
these patients.  
This study also provides evidence to support the inclusion of several 
constructs in the Skin Safety Model (SSM). Study 2 demonstrated significant 
associations between several study variables and the first construct of the model, 
potential contributing factors to skin injury. Patient factors identified by the model 
include advanced age, incontinence, poor nutrition and mobility limitation. Study 2 
showed that double incontinence was significantly associated with older age, 
immobility, or very limited mobility, as well as the risk of malnutrition or 
malnutrition. This also supports the inclusion of a range of variables as potentially 
contributing to skin injury in the SSM. The study investigated the variables,. 
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comorbidities and number of concurrent medications. While these variables were not 
significantly associated with older age, the mean age of the sample was 76 years (SD 
= 12.22). Further studies with a larger sample size may demonstrate associations 
between these variables.  All of the patients in Study 2 were exposed to one or more 
acute situational stressors (the first construct of the SSM) by virtue of their hospital 
admission.  
Of the incontinent patients (n = 53) in Study 2, 41% developed IAD, with 
18% of those presenting with a fungal infection. This supports the incluson of the 
second construct in the model, that is, that skin exposure to urine and/or faeces can 
result in a skin injury (IAD), the third construct of the model, which can 
subsequently lead to an infection (Candida), which is the final construct of the 
model. 
The following chapter presents Publication 5, which investigated potential 
risk factors for Candida colonisation. 
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Chapter 8: RISK FACTORS FOR CANDIDA 
COLONISATION AT THE PERIANAL AND 
INGUINAL SITES IN PATIENTS ADMITTED 
TO ACUTE MEDICAL WARDS   
8.1 INTRODUCTION 
This chapter comprises the following manuscript, which represents Study 2 
two and Publication 5 of this of this thesis. 
Campbell J., Coyer, F., Mudge A., & Osborne S. Risk factors for Candida 
colonisation at the perianal and inguinal sites in patients admitted to acute medical 
wards. (This manuscript is to be submitted to Journal of Hospital Infection). 
This study addressed the following research question: 
6. In acute medical patients, are gender, mobility, nutritional status, faecal 
frequency and quality, treatment with antibiotics, diabetes (Type 1 or 2), 
age, or body mass index (BMI) risk factors for Candida colonisation?  
Study 2 presented a unique contribution to understanding the differences 
between Candida colonisation in continent, and incontinent patients and those with 
IAD. While the results of Study 2 did not reveal a significant association between 
Candida colonisation, incontinence, or IAD, other factors may have confounded this 
relationship. The publication presented in this chapter (Publication 5) investigated 
whether there were specific risk factors for Candida colonisation in these patients. It 
is a short report that analysed data from the study reported in Chapter 7, Publication 
4.  
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8.2 PUBLICATION 5 
Risk Factors for Candida Colonisation at the Perianal and Inguinal Sites in 
Patients Admitted to Acute Medical Wards  
Summary  
Candida albicans is the most common human fungal commensal organism. It 
can transform from commensal organism to harmful pathogen in certain situations, 
with colonisation a necessary precursor to infection. Candida has been reported to 
have an aetiological role in paediatric diaper dermatitis. While Candida infections 
have been associated with incontinence-associated dermatitis in adults, there is 
limited understanding of the risk factors for perianal and inguinal colonisation in 
adults. Understanding the risk factors for Candida colonisation in this group may 
enhance the understanding of Candida infection. This exploratory study investigated 
potential risk factors for Candida colonisation in a sample of continent and 
incontinent adult acute care medical inpatients (N = 81). We found on admission, 
42% (n = 34) of patients were colonised with Candida. Colonisation was not 
significantly associated with age, gender, obesity, diabetes, or diarrhoea, however, 
there was a trend to greater antibiotic use, poorer nutritional status, and mobility 
limitation in the colonised group. 
Key words: Candida albicans, colonisation, incontinence-associated dermatitis, 
incontinence, antibiotics 
Introduction  
Candida albicans is the most common human fungal commensal organism, 
with colonisation occurring in 30%-60% of healthy individuals (Odds, 1988). There 
are certain conditions in which commensal organisms can transform into pathogens 
and result in mucocutaneous Candida infections (Fidel, 1999; Odds, 1988). 
Colonisation is almost always a precursor to infection (Fidel, 1999). Candida 
infections have been reported to be a complication of incontinence-associated 
dermatitis (IAD) in adults (Beeckman et al., 2015). In infants, Candida has been 
reported to have an aetiological role in diaper dermatitis (the paediatric equivalent to 
adult IAD) (Dixon et al., 1969; Ferrazzini et al., 2003), however; it is uncertain 
whether Candida may have an aetiological role in IAD in adults. In view of the 
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relationship between Candida colonisation and possible transformation to infection, 
as well as the understanding of the relationship between paediatric diaper dermatitis 
and Candida colonisation, it is logical then, that incontinence may lead to Candida 
colonisation. A recent observational study (under review for publication) did not find 
a significant association between incontinence and Candida colonisation or IAD, but 
other risk factors such as age, gender, administration of antibiotics, or the presence of 
diabetes reported as risk factors for Candida colonisation (Moran et al., 2012; Odds, 
1988) may have confounded this relationship. There is limited evidence regarding 
risk factors for Candida colonisation at the perianal or inguinal regions of acute care 
medical patients. The aim of this study was to explore potential risk factors 
associated with perianal and inguinal Candida colonisation in a purposive sample of 
continent and incontinent adult patients in order to enhance understanding of 
pathogenesis of IAD. 
Aims and research questions 
In order to advance the understanding of Candida colonisation and infection 
in incontinent patients and those with IAD, the aim of this exploratory study was to 
identify risk factors for Candida colonisation in patients admitted to acute care 
medical units. 
The research question was: 
6. In acute care medical patients, are gender, mobility, nutritional status, 
faecal frequency and quality, treatment with antibiotics, diabetes (Type 1 or 
2), age, or body mass index risk factors for Candida colonisation? 
Methods 
This cross-sectional observational study was conducted in the Internal 
Medicine Service (IMS) wards at a 929-bed major acute care metropolitan teaching 
hospital in Australia. Purposive sampling recruited three groups, (1) continent; (2) 
incontinent of urine, but continent of faeces; (3) incontinent of both urine and faeces. 
Hospitalised adults aged 18 years and older admitted consecutively to all wards in 
the IMS who had an expected hospital stay of three days or more days, and where 
data could be collected within 48 hours of admission were eligible for inclusion in 
the study. Excluded patients were those receiving treatment with systemic or topical 
antifungal agents, had a dermatological condition as the admission diagnosis, were 
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receiving radiation treatment, or were pregnant or breastfeeding. Patient recruitment 
and enrolment took place between April and October 2014. Detailed recruitment 
methods are reported elsewhere (see Publication 4, Chapter 7).  
Candida colonisation was defined as the presence of Candida albicans or 
other Candida spp. at either the perianal or inguinal site, identified systematically by 
two dry flocked swabs. transported immediately to the laboratory, and cultured in 
Sabourand’s medium. The laboratory reported Candida albicans or non-Candida 
albicans spp. in semi-quantitative manner (scant, 1+, 2+, and 3+).  
Potential explanatory variables were explored on the basis of a literature 
review to determine risk factors for Candida colonisation or infection. These were 
identified as age, gender, comorbid diabetes, antibiotic treatment, body mass index, 
nutritional status, mobility status, continence status, and stool quality (Dan, Segal, 
Marder, & Leibovitz, 2006; Fanello et al., 2006; Fidel, 1999; Moran et al., 2012; 
Odds, 1988). Nutritional status was measured using the Subjective Global 
Assessment (SGA), a validated assessment tool which reports nutritional status as 
well nourished (SGA-A), moderately malnourished (SGA-B), and severely 
malnourished (SGA-C). Mobility status was measured using the categories from the 
Braden scale for predicting pressure injury: immobile, very limited, slightly limited, 
and no limitations. Faecal quality was based on the Bristol Stool Form scale, 
collapsed into a dichotomous variable (formed, and semi-formed-liquid) for analyses. 
The study was approved by the Human Research Ethics Committees for both 
the research site and the university.  
All data were entered into the IBM SPSS Statistics for Windows (Version 
22.0, Armonk, NY, USA). Descriptive statistics were used to describe sample 
variables (means and standard deviations for continuous variables; frequencies and 
percentages for categorical variables). Bivariate analyses were conducted using 
descriptive correlational statistics (χ2 test for independence with Yates continuity 
correction when expected cell frequency is less than ten or Fisher’s exact test when 
expected cell frequency is less than five and independent-samples-t-test for 
continuous variables). P values less than .05 were considered statistically significant.  
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Results  
A total of 81 patients were recruited to the study. The mean age of the sample 
was 76 years (SD = 12.22), with 53%, (n = 43) of being male. Overall, 35% (n = 28) 
of the participants were continent, 35% (n = 28) were incontinent of urine, but 
continent of faeces, and 31% (n = 25) were incontinent of both urine and faeces. Of 
the total sample, 41.9% (n = 34) of participants were colonised with Candida, 33.4% 
(n = 27) with Candida albicans, and 8.6% (n = 7) with other Candida species. 
Colonisation at both sites occurred in 17.3% (n = 14) participants, and at the perianal 
area only in 21.0% (n = 17), and 7.7% (n = 3) at the inguinal site only. There were no 
significant differences in age between the group with Candida colonisation (M = 
77.4 years, SD = 11.8) and the group with no colonisation (M = 75.0 years, SD = 
12.5), t(79) = .875), p = 0.38. No significant differences in BMI were found between 
those with Candida colonisation, (M = 28.9 kg/m2, SD = 12.0) and those with no 
colonisation  (M = 29.7 kg/m2, SD = 8.7), t(68) = .320, p = 0.75. The significance of 
the differences between risk factors are shown in Table 8.1. Although there was a 
trend towards greater antibiotic use, poorer nutritional status, and greater mobility 
limitation in the colonised group, none of these risk factors were statistically 
significant. The significance of the difference between diarrhoea, diabetes and 
Candida colonisation is shown in Table 8.1.  
 Discussion 
This exploratory study investigated risk factors for Candida albicans 
colonisation at perianal and inguinal sites in typical internal medicine patients, 
purposively recruited to represent both continent and incontinent patients. We found 
over 40% of newly admitted medical patients were colonised with Candida at these 
sites, revealing a significant potential pathogenic reservoir in the inpatient 
population. Colonisation was not significantly associated with age, gender, obesity, 
diabetes, or diarrhoea, however, there was a trend to greater antibiotic use, poorer 
nutritional status, and mobility limitation in the colonised group. 
Our overall colonisation rate (42%) was double that of a study by Schulte and 
colleagues (2015) who reported a perianal colonisation rate of 19%. Reasons for this 
difference is unclear, but may be accounted for, in part, by difference in average age 
between our sample (mean age 76 years) and Schulte and colleagues’ (2015) sample 
(mean age 56 years), with older age potentially contributing to the higher  
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Table 8.1  
Frequencies, Percentages and χ2 Scores for the Risk Factors forNot Colonised (n = 
47) and Colonised (n = 34) (N = 81) 
 Not 
colonised 
(n = 47)  
 
Colonised 
(n = 34)  
(χ2) p 
 n (%) n (%)   
Gender 
Female 
Male 
 
 
20 (42.5) 
27 (57.44)    
 
18 (52.9) 
16 (34.0) 
 
 
   .855 
 
.355 
Patients receiving antibiotics (oral or 
intravenous) at time of data collection 
No  
Yes 
 
 
35 (74.4) 
12 (25.5) 
 
 
 
18 (52.9)  
16 (34.0) 
 
 
 3.146 
 
 
.076 
Diabetes (Type 1 or 2) 
      No 
      Yes 
 
 
26 (55.3) 
21 (44.6) 
 
 
22 (64.7) 
12 (35.3) 
 
 
   .384 
 
 
.536 
Mobility 
No limitation 
Slightly limited 
Very limited 
Completely immobile 
 
 
13 (27.6) 
15 (31.9) 
16 (34.0) 
  3   (6.4) 
 
 4  (11.7) 
13 (38.2) 
13 (38.2) 
  4 (11.7) 
 
 3.404 
 
.340 
Stool frequency 
     1 per day     
     2-3 per day    
     > 3 per day 
 
 
 
29 (61.7) 
15 (31.4) 
  3   (6.4) 
 
23 (67.6) 
10 (29.4) 
  1   (2.9) 
 
  .588 
 
.799 
 
Stool quality 
Formed 
Semi-formed/liquid 
 
 
30 (63.8) 
17 (36.1) 
 
24 (47.4) 
10 (29.4) 
 
  .406 
 
.635 
SGA
a
 score  
A- Normal 
B- At risk of malnutrition 
C- Malnourished 
 
28 (59.5) 
13 (27.6) 
  6 (12.7) 
 
16 (47.4) 
11 (32.3) 
  7 (20.5) 
 
 
1.468 
 
.480 
a
SGA = Subjective global assessment. 
colonisation in our study. Older age has been identified as a risk factor for mucosal 
Candida infection and colonisation (Moran et al., 2012; Odds, 1988). Consistent with 
the study conducted by Schulte and colleagues (2015), we found a trend towards 
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greater colonisation in those with poorer nutrition status and impaired mobility, 
common markers of frailty and old age in this population. 
Association between the presence of liquid faeces and/or increased faecal 
frequency and Candida infection or colonisation at the perianal or inguinal site 
remains unclear. Faecal colonisation with Candida has been reported to be 26% for 
hospital patients (Odds, 1988). This indicates that faecal contact with the perianal 
region may result in skin exposure to Candida organisms. It is feasible to expect 
increased skin exposure to faeces and therefore increased exposure to Candida 
organisms in patients with diarrhoea may result in higher Candida colonisation rates 
at the perianal or inguinal area. In addition, administration of broad-spectrum 
antibiotics have also been found to increase Candida colonisation in the gastro-
intestinal tract by disrupting the bacterial microbiome and allowing Candida 
albicans to proliferate (Fanello et al., 2006; Pittet, Monod, Suter, Frenk, & 
Auckenthaler, 1994; Schulte et al., 2015). Our study found no association between 
Candida colonisation and diarrhoea, however, there was a trend toward higher 
antibiotic use and Candida colonisation. Other factors reported to influence 
colonisation or infection are specific to certain patient groups and anatomical sites, 
for example, women have a vaginal Candida colonisation rate of 10% - 20% during 
the childbearing years, with pregnancy and the use of estrogen medications 
associated with even higher asymptomatic colonisation rates, although 
postmenopausal women have much lower vaginal Candida colonisation rates than 
women of childbearing age, (Dan et al., 2006; Revankar & Sobel, 2012). It is 
uncertain if vaginal Candida colonisation rates are similar to perianal and inguinal 
Candida colonisation rates in the same women. Our study showed no association 
with Candida colonisation and gender. Some evidence shows that Candida 
colonisation is higher in individuals with diabetes (Moran et al., 2012). However; 
consistent with other studies (Fanello et al., 2006; Fanello, Bouchara, Jousset, 
Delbos, & LeFlohic, 2001; Schulte et al., 2015) we found no association between 
Candida colonisation and diabetes. 
Several limitations need to be acknowledged. Our findings are limited by the 
small sample size and inclusion criteria, which limit generalisability to other acute 
care settings or admitting services. The mean age was old (76 years), which may bias 
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results, as older age is reported to be a risk factor for Candida colonisation and 
infection.  
Conclusion 
In summary, this small, yet unique study is the first to investigate risk factors 
for Candida colonisation at the perianal and inguinal sites of acute medical patients. 
This study found that Candida colonisation was common in the inguinal and perianal 
region of adult medical patients at admission to hospital, however, there was no clear 
association with risk factors. Further studies are needed to advance the understanding 
of risk factors for Candida colonisation in acute care medical patients. Importantly, 
this may inform future prevention and management strategies in groups identified as 
being at risk for increased Candida colonisation and subsequent infection.  
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8.3 CHAPTER SUMMARY 
This chapter presented the results of a study investigating potential risk 
factors for Candida colonisation. It was found that colonisation was common at the 
perianal and inguinal sites of adult medical patients at baseline. Colonisation was not 
significantly associated with specific risk factors; however, there was a trend to 
greater antibiotic use, poorer nutritional status, and mobility limitation in the 
colonised group. This investigation provides data that will inform further research 
into risk factors for Candida colonisation in acute care patients.  
This study also provides evidence to support the inclusion of several 
constructs in the Skin Safety Model (SSM). The variables gender, mobility, 
nutritional status, faecal frequency and quality, treatment with antibiotics, diabetes 
(Type 1 or 2), age, or BMI were investigated to determine if they are risk factors for 
Candida colonisation. There was a trend towards greater antibiotic use, poorer 
nutritional status, and greater mobility limitation in the colonised group, none of 
these risk factors were statistically significant. The inclusion of the factors advanced 
comorbidities, mobility limitation and poor nutrition in the first construct of the 
model is supported by empirical evidence, however, studies with larger sample sizes 
are required to investigate this trend  and to support the inclusion of the variable in 
the model.  
The following chapter presents a discussion of the results and limitations of 
the studies conducted for this research program.  
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Chapter 9: DISCUSSION AND LIMITATIONS 
9.1 INTRODUCTION 
This chapter discusses the conceptual framework developed to underpin this 
thesis, the Skin Safety Model (SSM), as well as its strengths and limitations. This is 
followed by a discussion of the results, implications and limitations of Study 1, 
Publications 2 and 3, and Study 2 and Publications 4 and 5 and a discussion of the 
significance of the combined research.   
The aims of this thesis by publication were to explore the phenomenon of 
incontinence-associated dermatitis (IAD) in the acute care setting by investigating 
the prevalence of IAD in an Australian acute care setting, and also investigating the 
epidemiology of Candida colonisation and infection associated with continence 
status and IAD in these patients. Furthermore, this research aimed to present a new 
conceptual model in which to reconceptualise the phenomenon of IAD within the 
broader domain of maintaining skin integrity in this setting. An additional aim of the 
research was to test key constructs (selected based on gaps in the research) of the 
proposed model.  
9.1.1 Conceptual framework: Skin Safety Model 
The literature review revealed a multitude of skin integrity frameworks, 
practice guidelines, and consensus documents that address the aetiology, prevention, 
and management of specific skin injuries, including IAD (Beeckman et. al., 2015; 
Black et al., 2011; Callan et. al., 2011; Carville et al., 2007; DeFloor, 1999; Gray et 
al., 2007; LeBlanc & Baranoski, 2011; McNichol et al., 2013). These injury-specific 
frameworks and guidelines are crucially important in the skin integrity domain, draw 
together global expert consensus from a variety of skin integrity sub-specialties, and 
supported by the most contemporary skin integrity research. However, while there 
are several frameworks that deal with IAD aetiology (Beeckman, Schoonhoven, 
Verhaeghe, Heyneman, & Defloor, 2009b; Brown & Sears, 1993; Jeter & Lutz, 
1996; Newman, 2001) and several proposed IAD severity classification tools 
(Beeckman et al., 2015; Borchert et al., 2010; Junkin & Selekof, 2008; Kennedy & 
Lutz, 1996; Nix, 2002), there was no comprehensive and holistic framework that 
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conceptualised IAD as an integral component of the much broader imperative of 
maintaining intact skin, specifically in the acute care patient.  
As a result, the current approach to skin integrity, which is underpinned by 
multiple, injury-specific frameworks, can result in duplicated, fragmented, or missed 
care (Blackman et al., 2014; Campbell et al., 2015; Kalisch et al., 2009; Shortell & 
Singer, 2008). This approach is driven, in part, by the imperative for healthcare 
providers to improve key patient safety indicators, avoid penalties in the form of 
sanctions or financial disincentives, or meet accreditation requirements (Eagar et al., 
2013). According to Shortell and Singer (2008), the greatest barrier to patient safety 
is the inherent fragmentation of the system of care. Consistent with this assertion, it 
can be argued that fragmentation of the system of skin integrity care poses a threat to 
skin safety within the acute care setting. 
Furthermore, parallels can be seen between current siloed and somewhat 
fragmented approaches to maintaining skin integrity, and biomedical models of 
disease. Biomedical models of disease focus on aetiology arising from cellular and 
pathological processes, explaining a disease or condition, and exclude psychosocial 
or environmental conditions (Wade & Halligan, 2004). Service delivery in the acute 
care setting is structured around the biomedical model of disease, which, while 
successful in many respects, can also foster specialised care delivery in specialised 
departments, rather than a fully integrated continuum of care (Wade & Halligan, 
2004), with the complexity and individuality of the patient lost in the specialty silo 
(Shortell & Singer, 2008). The influence of the biomedical model of disease and the 
resultant focus on specialised care specific to maintaining skin integrity is reflected 
in the presence of multiple, injury-specific skin integrity conceptual frameworks. 
These injury-specific paradigms, with attendant narrow solutions, are neither 
sustainable, nor desirable in the modern healthcare environment (Shortell & Singer, 
2008). 
The rationale for developing a new conceptual framework was based on the 
imperative for a new paradigm to guide and unify skin integrity care in the hospital 
setting. The rapidly changing environment of contemporary healthcare, that is, 
ageing populations, the dramatic increase in chronic disease, and the overwhelming 
growth in healthcare cost, mean that the number of older, frailer, immobile, and 
incontinent individuals occupying acute care beds will continue to increase in 
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ensuing decades. Overall, these changes provide the impetus for developing a new 
and innovative framework that breaks down silos, and facilitates cost-effective, 
efficient, patient-centred care. Innovative, unified, and effective care in the skin 
integrity domain needs to be underpinned by a conceptual framework that is 
comprehensive, holistic, and patient-centred, and that integrates a range of 
antecedents and possible skin injuries into a single model. However, no such model 
existed. The SSM was developed and tested to address this gap.  
The SSM was developed from a review of the relevant literature, drawing on 
a range of frameworks, consensus documents, and position papers in the skin 
integrity, patient safety, and quality improvement literature. The critical point of 
difference between the SSM and other skin integrity frameworks lies in the 
conceptualisation of the overarching construct of skin integrity. The SSM proposes a 
reconceptualisation of multiple dimensions of skin integrity into a holistic, integrated 
framework, underpinned by the goal of maintaining skin integrity. This unified 
perspective recognises the complexity of maintaining skin integrity, and integrates 
the influence of multiple contributing factors that arise within the patient, the 
patient’s interaction with the hospital environment, as well as further interaction with 
acute situational stressors. The SSM accommodates multiple skin injuries into a 
single document, providing a unique and practical framework to guide clinicians in 
the understanding of the factors influencing skin integrity in the acute care patient. 
Overall, the SSM provides a new perspective that contrasts with the traditional siloed 
approach of managing skin integrity. 
Positioning the patient’s experience of a skin injury as a central outcome of 
the SSM is novel. While a patient may sustain a skin injury, the experience of that 
injury is embedded in the domain of wellbeing, or more accurately, the disturbance 
of wellbeing. According to Augustin and colleagues (2012), in order to assess 
wellbeing, it is essential to approach patients with a wound as a complex individual, 
with specific and individual needs across the domains of physical, mental, social and 
spiritual/cultural wellbeing and to focus on their experiences, as well as have a 
thorough understanding of their medical condition, quality of life, and how the 
wound impacts on their everyday living. The experience of a skin injury can 
encompass multiple dimensions that may interact. These experiences can include 
pain, infection, extended length of hospital stay, disfigurement, disability, or even 
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death. In contrast to traditional skin integrity frameworks where the patient 
experience of a wound is overlooked, the patient experience of the skin injury is a 
central construct of the SSM. Hence, the SSM provides a framework that guides the 
clinician to appreciate skin integrity and/or injury outcomes from the patient 
perspective. 
Health care providers and patients can have very different perspectives and 
goals regarding the outcome of an episode of care. For example, the healthcare 
provider may be focused on the goals of healing the skin injury, preventing 
deterioration or preventing additional skin injuries. In contrast, the patient may be 
focused on the goals of dealing with pain associated with the skin injury, regaining 
functional ability following a skin injury, or needing to leave hospital in a timely 
manner (Porter, 2010). Healthcare outcomes are often measured against individual 
medical services that have been provided in individual departments, rather than 
measured against an entire episode of care (Porter, 2010; Pronovost et al., 2014). 
According to Porter (2010), outcomes are inherently multidimensional and should be 
a reflection of the success in meeting patient needs, rather than a narrow measure 
pertaining to fragmented aspects of a larger episode of care. A crucial first step in 
reducing the disparity between patient and consumer expectations is to locate the 
patient experience as a central healthcare outcome, which is a novel focus of the 
SSM. 
Empirical support for the Skin Safety Model 
The findings of this research support the inclusion of a number of constructs 
in the SSM. This research investigated one skin injury, (IAD), from a range of 
potential skin injuries identified by the SSM. Therefore, not all constructs of the 
SSM were tested by this research. However, the SSM was developed from empirical 
research, and expert consensus, which supports the construct validity of the model.  
Answers to the Study 1 research questions revealed important prevalence data 
on incontinence, IAD and the products used for continence and perineal skin care. 
The high prevalence of incontinence and IAD in this study has implications for 
patient safety. Clinical governance is concerned with ensuring that health care 
delivery is safe and appropriate for the needs of the patient (Youngberg, 2013). As 
highlighted in Chapter 2 (Section 2.2.1), effective clinical governance is a critical 
determinant of patient safety and quality outcomes. This study provides prevalence 
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data that can guide skin safety protocols and procedures at the level of clinical 
governance. Given the responsibility that clinical governance has in responding to 
and managing prevalence data, the serious prevalence results revealed by Study 1 
indirectly support the validity of including the construct of clinical governance in the 
SSM.  
 Study 1 also found that incontinence was associated with advancing age, 
while Study 2 found an association between urinary and faecal incontinence, 
advancing age, impaired mobility and under-nutrition. These elements are identified 
in the first construct of the model - multiple contributing factors to skin injury. Both 
studies highlighted that skin assessment, a systems factor in the first construct of the 
model, is vital for the accurate classification and differentiation of IAD, PI and 
clinical evidence of fungal infection. Both studies confirmed that the presence of 
exacerbating elements (that is urine and/or faeces and moisture), the second construct 
in the model, was necessary for the development of the potential skin injury (the 
third model construct), IAD. Study 1 also found that IAD was more common in those 
with semi-formed or liquid stool. Study 2 tested the final construct of the model, 
potential outcomes of skin injury by examining infection, in this case with Candida 
albicans. The research found that infection was a common outcome of IAD and 
incontinence. Overall, the research findings supported the inclusion of the constructs 
proposed in the SSM, specifically those applicable to IAD in the acute care patient. 
Although the data presented in Publication 3 (Chapter 5) did not directly test 
the constructs of the SSM, the results underline the importance of the construct of 
clinical governance in the model. Clinical governance sets the patient safety and skin 
safety agenda within organisations (Youngberg, 2013), and is underpinned by 
information that guides decision making, evaluation of improvement or performance 
initiatives and informs resource allocation. In a similar way patient safety and quality 
are underpinned by the requirement for information (Australian Commission on 
Safety and Quality in Healthcare, 2010; Youngberg, 2013). Therefore, skin integrity 
prevalence data forms an integral component of the ability of the organisation to 
deliver safe care, and, as such, is required for effective clinical governance. 
Publication 3 presented a review of PI and IAD data that was collected over a five-
year period. During that time, the important initiative of combining the PI and IAD 
prevalence data was introduced. This meant that the organisation had access to  
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previously unrecorded IAD data, and subsequently gained an insight into the 
considerable prevalence of the skin injury within the facility. Therefore, the findings 
presented in Publication 3 indirectly support the inclusion of clinical governance as a 
systems factor in the first construct of the SSM, as it is this body that has the 
responsibility to maintain and respond to prevalence data.  
All of the included constructs and their relationships were based on evidence, 
so while not all constructs were tested in this research, their inclusion was considered 
valid. Furthermore, the significant results found in Studies 1 and 2 indicate that the 
model shows great promise in providing a new theory with which to address the 
challenges of maintaining skin integrity for older adults in contemporary hospitals.  
9.2 DISCUSSION OF RESEARCH QUESTIONS 
9.2.1 Prevalence of incontinence  
In answer to research question 1 regarding the prevalence of incontinence in 
the acute care setting, Study 1 found that this prevalence in the Australian setting was 
24%. Among the incontinence sub-sample, double incontinence (combined urinary 
and faecal) was the most common (50.5%), followed by faecal incontinence (35%), 
while the least prevalent type was urinary incontinence (14%). 
The study contributed important data on the prevalence of incontinence and 
revealed that nearly one in four hospitalised patients were incontinent. The 
prevalence of incontinence in Study 1 is consistent with the findings of Junkin and 
Selekof (2007) who reported a prevalence of 19.7%. On the other hand, Ostaskiewicz 
and colleagues (2008) reported a prevalence of urinary incontinence ranging between 
10%-43% and faecal incontinence ranging between 7%-33%. However, these results 
may be called into question because of the unreliable measurement of using self-
reports. These data differ from the results of Study 1, although the difference may be 
due, in part, to the difference in study methods. Data on incontinence in the 
Australian acute care setting are limited (Ostaskiewicz et al., 2008), so Study 1 
provides valuable insight to fill this gap.   
Incontinence carries a high risk of developing IAD; therefore, it is vitally 
important to collect incontinence data in order to understand the extent of risk that 
exists for the development of IAD in a facility (Eresser et. al., 2005).  Moreover, in 
order to develop IAD, a patient must first be incontinent (Beeckman et. al., 2015). 
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Study 1 found that almost one quarter of patients were incontinent, and, therefore, at 
risk of developing IAD. This data highlights the alarming number of patients at risk 
of developing a skin injury, namely IAD, within the acute care setting. As a 
component of the safety and quality obligations, healthcare providers are required to 
be cognisant of injury risks that exist for their patients (Youngberg et. al., 2013). 
However, the substantial risk that exists for the development of IAD in the acute care 
setting has been mostly unrecognised by healthcare providers. Gathering 
incontinence and IAD data in the same study highlights the imperative of 
understanding both conditions, and contributes valuable data that inform the level of 
risk that exists for IAD.  
Furthermore, population ageing (United Nations, 2011; World Health 
Organisation, 2011), and the burgeoning prevalence of chronic disease and geriatric 
syndromes (Inouye et. al., 2007; Lakhan et.al., 2011; Scommegna, 2012; World 
Health Organisation, 2011), means that the prevalence of incontinence is set to rise. 
Therefore, the results from Study 1 demonstrate that the importance of improving the 
understanding of the prevalence of the condition in vital in informing management 
protocols and developing risk mitigation strategies for this important problem. 
9.2.2 Prevalence of IAD  
In answer to research question 2 regarding the prevalence of IAD in the acute 
care setting, Study 1 found that of the patients who were incontinent, the prevalence 
of IAD was an alarming 42%, whereas Junkin and Selekof (2007) found a much 
lower prevalence of IAD of 20%. The reasons for this difference are unclear, but 
may be due to the differences in IAD prevention and management protocols and 
product use between the research facilities.  
Study 1 also found that almost a third of incontinent patients with IAD had an 
infection indicative of a fungal infection. Data for comparison is limited; however, 
the results of Study 1 differ from the results of the Junkin and Selekof study (2007) 
who reported the presence of a fungal rash in only 10% of incontinent patients. The 
reasons for the higher prevalence of a rash indicative of a fungal infection may be 
associated with the higher prevalence of IAD in Study 1 compared to the Junkin and 
Selekof (2007) study. The high prevalence of patients in Study 1 with IAD and a 
fungal rash indicates that infection associated with incontinence and IAD is a serious 
problem that merits further investigation.  
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The answers to research questions 1 and 2 reinforce the importance of having 
empirical knowledge of the prevalence of health conditions as a key component of 
quality healthcare delivery. In Australia, the National Health performance framework 
serves to support performance assessment planning and benchmarking in the health 
sector nationally, as well as supporting comparisons of Australia’s health 
internationally (Australian Institute of Health and Welfare, 2014). The first construct 
in the National Health Performance Framework relates specifically to the necessity 
of understanding the prevalence of disease, disorder or injury or other health-related 
states (Australian Institute of Health and Welfare, 2014). Furthermore, the core 
constructs of the Australian Safety and Quality Framework are driven by 
information, consumer-centred and organised for safety (Australian Commission on 
Safety and Quality in Healthcare, 2010), highlighting the imperative for empirical 
information in the delivery of safe and high quality healthcare. It is clear that 
prevalence data is a key form of information guiding healthcare decision-making. In 
the skin integrity domain, understanding the prevalence of PIs has underpinned 
clinical governance decision-making in regard to patient and skin integrity programs 
and informed decisions regarding quality initiatives, strategic planning, resource 
allocation, clinical governance, benchmarking, as well tracking outcomes of clinical 
initiatives (Pieper & National Pressure Ulcer Advisory, 2012)  
Beyond PI prevalence, it is increasingly important to understand the 
prevalence of other skin injuries in the acute care population. As discussed in 
Chapter 2, acute care patients may be exposed to multiple skin vulnerabilities, and 
there can be the temptation to utilise prevalence data in silos that is similar to the 
delivery of care in silos. While the specific prevalence data is valuable when used in 
this manner, it may be more be valuable when used to understand broader 
perspectives of skin integrity risk and injury within an organisation. Comparing and 
contrasting prevalence data from different injuries may reveal previously missed 
trends or relationships, or shed light on the influence a particular skin injury may 
have on another. For example, an organisation may focus enormous resources on 
lowering an unacceptable pressure PI rate, but be unaware of the prevalence of IAD 
or incontinence among its patients. The SSM can provide further insight into the 
overarching, holistic nature of skin vulnerability and help break down the tendency 
to utilise prevalence data in silos, that is, used to monitor one skin injury in isolation. 
  
Chapter 9: Discussion and Limitations                              175 
The use of the SSM can help illuminate relationships between various conditions or 
skin injuries. For example, an appreciation of the prevalence of incontinence is 
essential to understanding the magnitude of risk for IAD in a facility, while 
understanding the prevalence of incontinence and IAD can shed light on the scope of 
risk for Candida infection faced by these patients. Further, it is now understood that 
both incontinence and IAD are risk factors for pressure injury (Beeckman et al., 
2014; Gefen, 2014; National Pressure Ulcer Advisory et al., 2014). Therefore, an 
appreciation of the prevalence of all of these conditions is imperative for the delivery 
of safe and quality healthcare.  
To date, Study 1 is the only Australian acute care IAD prevalence study. The 
study was conducted in conjunction with the facility's annual pressure injury 
prevalence survey, and as such, demonstrated the utility of combining data collection 
for incontinence, IAD, and PI prevalence into a single activity. The conduct of Study 
1 highlighted the need for consensus to be reached regarding IAD prevalence 
methodology, the use of an IAD categorisation instrument, formulae for calculating 
IAD prevalence, and also agreement on the format for reporting IAD prevalence 
data. Publication 3 of this thesis highlighted these issues, as well as reviewed 
pressure injury prevalence before and after the introduction of the combined 
protocol. This publication also discussed the practicability of combining the two 
protocols. 
A significant contribution of Study 1 was that it highlighted the success of the 
combined pressure injury and IAD prevalence survey methodology. The research 
facility has subsequently, with minor adaptations, adopted the combined protocol as 
standard procedure for its annual pressure injury prevalence surveys. In addition, 
from 2012, as a result of the combined IAD and pressure injury prevalence survey 
protocol adopted in the research facility, the state-wide Queensland Bedside Audit 
(QBA) conducted by the Patient Safety and Quality Improvement Service Clinical 
Excellence Division developed and distributed new surveyor educational resources to 
facilitate improved inter-rater reliability for the state-wide pressure injury prevalence 
surveys, as well as including a category noting the presence of IAD on the data 
extraction form, (J. Whitemore, personal communication, November 18, 2015). 
These procedural changes adopted by the research facility and then by the 
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Queensland Patient Safety and Quality Improvement Service represent the immediate 
and significant impacts of this research program. 
Prevalence studies are difficult and costly to perform and require a significant 
number of adequately trained personnel. In view of the high cost of conducting these 
studies, and the imperative that resultant data are valid and reliable, it is logical to 
combine the PI and IAD audits into a single protocol. While the cost-effectiveness of 
combining these activities was not evaluated in this research, the combined survey 
was conducted over the same two-day time period as was routinely allocated for the 
annual facility PI audit, using the same number of research assistants. This indicates 
that no additional time or personnel costs were incurred by the facility. However, the 
facility gained valuable and previously unknown data regarding the magnitude of 
incontinence, IAD, and fungal infection, thus adding enormous value to an already 
costly annual PI audit. Organisational awareness of the magnitude of these issues is a 
key first step in developing a strategic, multi-level response to skin integrity risks 
and challenges. Further, baseline data is vital for ongoing evaluation of interventions 
and benchmarking within the facility and between organisations.  
A further contribution of Study 1 was the training of the 32 research 
assistants to accurately classify IAD and fungal infections, and differentiate them 
from PIs. Difficulty in distinguishing between these lesions is well-documented in 
the literature (Beeckman et al., 2008; Defloor et al., 2006; Doughty, 2012; 
D.Voegeli, 2011) and has implications for the accuracy of prevalence data, and more 
widely, clinical practice and organisational performance indicators. These research 
assistants gained valuable, new clinical assessment skills to take back to their 
respective clinical areas. However, most importantly, misclassification of these 
lesions has important implications for patient outcomes, in that the different skin 
injuries have different aetiologies and require different prevention and management. 
The inter-rater reliability training represented an important improvement in the skills 
of the research assistants to accurately classify pelvic skin lesions and thereby 
improve the accuracy of the prevalence data.  
9.2.3 Products for continence and skin care 
In answer to research question 3 regarding the products worn to manage 
incontinence and the products provided at the bedside for perineal skin care, Study 1 
found that the most common aids worn by incontinent patients were disposable 
  
Chapter 9: Discussion and Limitations                              177 
incontinent briefs (77%); soap/water and disposable washcloths were the most 
common incontinence clean-up products at the bedside for incontinent patients 
(60%), moisturising products were present at the bedside of 34% of patients, with 
skin protection products present at the bedside of 57% patients. These results are 
consistent with the findings of Junkin and Selekof (2007) who found that 73% of 
patients wore disposable products to manage double incontinence, 54% of patients 
had washcloths at the bedside and that dimethicone containing skin protectant was 
the most common (47%) at the bedside. The current best practice recommendations 
for the prevention and treatment of IAD include appropriate management of 
incontinence, and a systematic and structured approach to skin care, following three 
steps: (i) gentle cleansing, (ii) skin protection and (iii) restoration of skin barrier 
function using a moisturising product where appropriate (Beeckman et. al., 2015). 
However the study found that the lack of available products at the bedside of many 
suggests there may be a gap between care recommendations and skin care practice.  
9.2.4 Candida colonisation  
In answer to research question 4 on whether colonisation with Candida 
albicans is more common at hospital admission in incontinent patients than in 
continent patients, Study 2 found that on admission there was a non-significant trend 
towards more frequent Candida albicans colonisation in incontinent than in 
continent patients. Candida was present at the perianal site in 43% of incontinent 
participants compared to 28% of continent patients. At the inguinal site, more 
incontinent (24%) patients were colonised with Candida compared to continent 
(14%) patients were colonised with Candida. Overall, on admission, colonisation 
was common, with Candida more frequently present (38%) at the perianal site, and 
lower (21%) at the inguinal site. There is limited data available from previous studies 
for comparison. However, Schulte et al. (2015) reported a lower perianal 
colonisation rate (19%) than the present study, with the average age of the sample 
being 56 years (SD = 15.2). The reasons for the differences in colonisation may be 
explained by the difference in the average age of the samples, which was 76 years 
(SD = 12.22) with the participants in Study 2. Data from Study 2 fills a gap in the 
comparative understanding of the epidemiology of Candida colonisation between 
continent and incontinent hospital patients, and reveals an important, potentially 
pathogenic reservoir of Candida in this group. It also provides important data to 
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inform future studies investigating Candida colonisation and infection in these 
patients. 
9.2.5 Candida colonisation and IAD 
In answer to research question 5 regarding the association between Candida 
albicans colonisation and clinical presentation of IAD at admission to hospital, Study 
2 found that the prevalence of IAD was high (41%) among incontinent patients; 
however, clinical signs of a Candida infection were observed in less than half (18%) 
of patients with IAD. No significant association was found between Candida 
colonisation and the clinical presentation of IAD on admission to hospital.  
Infection with Candida albicans has been found to be a common 
complication of IAD (Beeckman et al., 2015; Foureur et al., 2006; Gray et al., 2007); 
thus, it is feasible to expect a higher level of colonisation in patients with IAD. 
However, no significant association was found between Candida colonisation and 
clinical presentation of IAD on admission to hospital in the present study. No data 
from previous studies were available to compare Candida albicans colonisation 
levels in continent and incontinent patients, but the study by Foureur and collegues 
(2006) found that Candida prevalence in patients with IAD was high (63%). 
Although there was no continent group data reported in the Foureur and colleagues 
(2006) study, their finding is much higher than the prevalence of Candida 
colonisation in patients with IAD in Study 2. The reasons for the difference are 
unclear but may be due to the difference between patient admission time, with the 
patients in Fourer and colleagues (2006) study being long-term rehabilitation 
patients, compared to the patients in Study 2 whose data was collected within 48 
hours of admission. It may be that length of stay in a healthcare facility influences 
Candida colonisation levels. 
Study 2 advances the understanding of the epidemiology of Candida albicans 
colonisation in patients with IAD and the understanding of Candida colonisation in 
incontinent when compared to continent patients. Further, this research presents a 
new and novel frame of reference for investigating the association between Candida 
albicans and IAD. Candida albicans is the most prevalent human fungal commensal 
that can cause a wide range of mucosal and invasive diseases, with the primary 
source of both invasive and cutaneous Candida infection being endogenous. 
Importantly, colonisation with Candida is a necessary antecedent of infection 
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(Kumamoto, 2011; Moran et al., 2012; Odds et al., 2006). The gap in the 
understanding of the epidemiology of Candida colonisation in these patients was 
surprising, in light of the understanding of Candida colonisation being a precursor to 
Candida infection.  
This is the first study to investigate the differences in Candida albicans 
colonisation between continent and incontinent patients and those with IAD in the 
acute care setting. It remains unclear whether incontinence predisposes to increased 
Candida colonisation, or whether it acts as a trigger for Candida infection in those 
already colonised. While the role of Candida albicans in the aetiology of diaper 
dermatitis has been investigated in the paediatric domain (Bonifaz et al., 2013; 
Dixon, Warin, & English, 1969; Dorko et al., 2003; Ferrazzini et al., 2003; Jefferson, 
1966; Leyden & Kligman, 1978; Montes, Pittillo, Hunt, Narkates, & Dillon, 1971), 
this question has had limited consideration in adults with IAD (Foureur et al., 2006). 
Study 2 has provided valuable data that can contribute to the understanding of the 
natural history of Candida albicans colonisation in relation to continence status and 
in patients with IAD, which may in turn lead to improved understanding of the 
pathogenesis of Candida infection and IAD in incontinent patients. In addition, this 
data may inform sample size calculations for future studies. Study 2 also provides 
important baseline data and understanding of the feasibility of conducting a larger 
study to investigate these research questions.  
9.2.6 Risk factors for Candida colonisation 
In answer to research question 6 regarding risk factors for Candida 
colonisation, Study 2 found there was no significant association with Candida 
colonisation and gender, mobility, nutritional status, faecal frequency and quality, 
treatment with antibiotics, diabetes (Type 1 or 2), age, or body mass index (BMI). 
However, there was a non-significant trend towards an association between 
colonisation and greater antibiotic use, poorer nutritional status, and greater mobility 
limitation in the colonised group. These factors have been reported in the literature as 
predisposing to candidiasis or increased Candida colonisation levels (Al-Attas & 
Amro, 2010; Anaissie et al., 2003; Dorko et al., 2003; Ferrazzini et al., 2003; Fidel, 
1999; Lionakis, 2014; Odds, 1988; Sobel et al., 1998). The results may have been 
non-significant due to the small sample size in this study. Study 2 has provided 
valuable data that addressed the gap in the understanding of possible risk factors for 
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Candida colonisation. This understanding of the risk factors for Candida 
colonisation in acute care patients may assist in developing targeted strategies that 
may prevent Candida infection.  
9.3 LIMITATIONS 
The following section presents a discussion of the research limitations and 
their potential impact on the outcome of the results.  
The SSM presented in this thesis is not a risk assessment tool, rather, it is a 
framework designed to guide clinicians and healthcare providers in the recognition 
and consideration of the complexity of skin injury aetiology and outcomes. Although 
the model is comprehensive and based on expert consensus and evidence, it is a new 
model that requires refinement from future research. 
A limitation of this research was the small sample size and the 
generalisability of the results. Study 1 was conducted at a single centre, while data 
for Study 2 were collected in a single admitting service, and a single centre. 
Therefore, the results may be limited in their generalisability to other acute care 
specialties or settings. Study 2 was a pilot study conducted to test the feasibility of 
the study design, recruitment, study instruments microbiological sampling, to 
provide initial estimates of colonisation rates in this population, and, to investigate 
associations between variables of interest, that is, Candida colonisation, continence 
status and IAD. Post hoc power calculations showed that this study had 80% power 
to detect a difference of 35% (for example 45% in the incontinent group compared to 
10% in the continent group). The observed differences were much smaller (15% at 
the perianal site and 10% at the inguinal site), and may help inform sample size 
calculations in future studies. Larger, multi-site studies with recruitment from a range 
of acute care specialties would be of value in the future to improve the precision and 
generalisability of the results.  
Several limitations need to be acknowledged with regard to patient 
recruitment. The intrusive nature of direct clinical examination and microbiological 
sampling of the pelvic girdle can be uncomfortable and may have constrained 
enrolment (69% for Study 1). Every effort was made to enrol all eligible participants. 
Of the patients who declined to participate in Study 2, 48% informed the researcher 
they were not comfortable with the skin inspection and the specimen collection 
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aspects of the study, while 33% respondents made comments that reflected the belief 
that incontinence was an ‘old person’s problem’ and therefore not relevant to them. 
Data was not collected on the age of eligible patients that declined to participate. 
Overall, the majority of patients who declined to participate in Study 2 were younger 
than age 50, which may mean that sampling may have been biased with regard to the 
age of participants.  
A further limitation of the study regarding recruitment and enrolment was 
that substitute decision-makers declined participation for four patients who were 
doubly incontinent. This meant that the recruitment target of 28 participants in the 
doubly incontinent group was not met, which may have biased the study results. In 
each case, the reason cited for non-participation by the substitute decision-maker was 
that the patient was not incontinent. This discrepancy between the bedside nurse 
report and the family member's perception regarding the continence status of their 
relative may be a reflection of the broader stigma, fear, and shame associated with 
incontinence, and subsequently presents a barrier for researchers in this area. 
In addition, a limitation that may have decreased recruitment, particularly for 
the doubly incontinent group, was research participation fatigue. This was stated by 
14% of patients as the reason for declining participation. These patients made 
comments to the researchers, such as ‘I really want to help, but I have had three 
different groups of medical students examine me today and I’m exhausted’, ‘they 
asked me to be a patient for the doctor’s exams and I have been downstairs for three 
hours being interviewed by student doctors’, ‘I’m already in another study’. This 
meant that potentially eligible patients were unable to be enrolled. 
A further limitation of this study was the number of patients that did not 
reach the study endpoint, which was deemed to be the collection of two or more sets 
of data. This, in turn, limited collection of longitudinal data. The primary reason 
many patients did not reach the study endpoint was a short length of hospital stay 
(that is, less than three days). Of the 81 patients enrolled, more than half (58%) had 
only one set of data collected and were discharged prior to any further data 
collection, with 42% of patients having two sets of data collected, followed by 7% of 
patients having three sets of data collected, and only one patient having four sets of 
data collected (see Figure 9.1). 
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Figure 9.1 Participant numbers at data collection time-points. 
The low number of participants with longitudinal data sets meant that time-
to-event data analyses, although preferable, were not possible; therefore, inferences 
could not be made regarding the role of Candida colonisation in the pathogenesis of 
IAD. In response to the low number of patients reaching the study endpoint, the 
research team and statistician conferred, and it was decided to amend the research 
design from an observational time-to-event cohort study to an observational study, 
and recruit all eligible incontinent patients at baseline, regardless of IAD status. 
A further limitation was that patients experienced multiple and competing 
demands on their time, energy and physical presence, which limited opportunities to 
collect repeat data, which reduced longitudinal data available for analyses. Reduced 
length of hospital stays, intensive patient interventions, and reduced hospital bed 
numbers result in increased care intensity (Aitken et al.; 2014). Increased care 
intensity is consistent with the recruitment experience in this study and the comments 
made to researchers during this process. Many participants reported that several 
medical teams had visited them in one morning, and some had also been visited by 
several allied health professionals. Coupled with the number of health professionals 
delivering care was the burden for the patients of blood tests, x-rays, or procedures. 
This meant that research nurses often made multiple attempts to collect data but the 
patient was either off ward, with a care provider, or too exhausted, resulting in repeat 
data not being collected.  
Other limitations of the study resulted from the instrument used. The IAD 
Severity Assessment Tool (SAT) was used to measure IAD severity (Kennedy & 
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Lutz, 1996), which requires researchers to estimate the area and depth of skin 
breakdown, which is difficult and subjective. This subjectivity may have influenced 
data accuracy and, therefore, reduced the reliability of the results.  
A further limitation was that Candida albicans was the only species reported 
in a semi-quantitative manner by the laboratory. This may have limited the 
specificity of the results. While the study showed that Candida albicans was the 
most frequent species present, the level of non-albicans colonisation had the highest 
severity. The decision not to specify other non-albicans species present on 
microbiological culture, or to report the semi-quantitative results on non-albicans 
culture was based on extensive literature identifying Candida albicans as the most 
common human fungal coloniser and pathogen (Fidel, 1999; Moran et al., 2012; 
Odds, 1988). Future studies would benefit from identifying all Candida species that 
may be present. 
Both studies collected a large proportion of categorical and dichotomous data. 
As a result, data analyses and subsequent results may have lacked precision, 
compared to the use of continuous data where possible. Further studies would benefit 
from larger sample sizes and the use of rating scales, where appropriate, to allow for 
the collection of continuous variables, and, therefore, the utilisation of more 
sophisticated statistical analyses.  
9.4 CHAPTER SUMMARY 
The combined significance of the research program lies in its contribution of 
new and unique insights into the phenomenon of IAD in the acute care setting in 
broad and specific ways. The development of the SSM provides comprehensive and 
holistic framework to guide skin integrity care in the acute care patient, as well as a 
framework to guide the research for this thesis. This broad view of the requirement to 
maintain skin integrity in the acute care setting was followed by research that 
investigated the prevalence of IAD and incontinence in the acute care setting, and 
Candida albicans colonisation rates in continent and incontinent patients and those 
with IAD. Both of these studies investigated specific aspects of maintaining skin 
integrity. Significant gaps were addressed in the understanding of the prevalence of 
IAD in acute care, and the understanding the natural history of Candida colonisation 
in this group.  
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In addition, several constructs of the SSM were tested by the research. There 
is significant evidence to support the inclusion of these constructs in the model, 
resulting in a new theoretical model that is based on empirical evidence. 
Underpinned by the SSM, the results showed an understanding of IAD and 
associated infection at this specific level is essential to inform the broader 
understanding of the phenomenon of IAD in the acute care setting. The SSM can 
help guide the understanding of the contextualisation of IAD in terms of its 
relationships, interactions, and implications for a range of other skin integrity 
challenges and outcomes in the acute care setting. 
The following chapter presents a summary of the research findings, 
recommendations arising from this research, and conclusions of the thesis. 
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Chapter 10: CONCLUSION AND 
RECOMMENDATIONS 
10.1 INTRODUCTION 
The final chapter of this thesis highlights the main findings and contribution 
of the research. This is followed by recommendations for clinical practice, education, 
policy, and future research. The final section presents the conclusions for this thesis. 
The aim of this thesis was to explore the phenomenon of incontinence-
associated dermatitis (IAD) in the acute care setting. This involved an investigation 
of the prevalence of IAD, and an exploration of the epidemiology of Candida 
colonisation and infection associated with continence status and IAD in acute care 
patients. Furthermore, this research aimed to present a new conceptual model in 
which to reconceptualise the phenomenon of IAD within the broader domain of 
maintaining skin integrity in this setting. An additional aim of the research was to 
test key constructs of the proposed model  
10.2 RESEARCH CONTRIBUTION 
The research program for this thesis provided several significant 
contributions in theory and research findings. 
A significant contribution of Study 1 was to highlight the considerable and 
previously un-identified prevalence of IAD in the Australian acute care setting. IAD 
is one disruption to skin integrity in a range of possible nosocomial skin injuries in 
older acute care patients. However, the magnitude of this significant skin injury was 
unknown in the Australian acute care setting, with limited data available on its 
prevalence in the acute care setting internationally. In addition, Candida infection is 
reported to be a common complication of IAD. Even though it is understood that 
Candida is the most common human fungal commensal organism, there was little 
data available to quantify Candida colonisation rates in continent compared to 
incontinent patients in order to understand the association between continence status 
and Candida colonisation levels. Furthermore, it was unknown if differences in 
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Candida colonisation levels existed in incontinent patients with or without IAD, or if 
there were risk factors for Candida colonisation in this group. 
 This thesis has made a considerable contribution to the understanding of the  
phenomenon of IAD in the acute care setting. Study 1, the first of its kind in 
Australia, shed light on the magnitude of the problem, revealing that a significant 
number of acute care patients were incontinent and, therefore, at risk of developing 
IAD, while a significant number of these had actually developed IAD. Study 2, also 
the first of its kind, investigated the unique question of Candida colonisation levels 
and possible associations with continence and/or IAD status, as well as potential risk 
factors for Candida colonisation. While no significant association was demonstrated 
between continence status and IAD, Study 2 demonstrated a non-significant trend 
towards higher Candida colonisation levels at the perianal and inguinal sites in 
incontinent compared to continent patients. However, no significant association was 
demonstrated between Candida colonisation and incontinent patients with or without 
IAD. Furthermore, no factors emerged as risk factors for Candida colonisation in this 
group. These findings offer new empirical evidence that highlights an association 
between incontinence and Candida colonisation, which has not previously been 
considered in adults. This novel frame of reference regarding Candida colonisation, 
continence status and IAD offers a new direction for future research. Furthermore, 
understanding patterns of Candida colonisation in these patients may help to predict 
patients who may be at risk of colonisation or infection, which in turn may assist in 
developing prevention and treatment strategies in the future.  
The most important contribution of the SSM is to offer a novel 
comprehensive and holistic conceptualisation of skin injury for acute care patients. 
The Skin Safety Model proposes relationships between a multitude of risk factors 
that may influence the development of a range of skin injuries. In addition, it 
proposes risk factors that may not traditionally be conceptualised for skin integrity, 
but which can have a direct impact on skin integrity outcomes. A salient example of 
this is the direct association between the prevalence of incontinence and the 
subsequent magnitude of risk the development of IAD in a facility. 
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10.3 RECOMMENDATIONS  
From the results of the studies in this thesis, eight recommendations are made 
in the domains of clinical practice, education, healthcare policy and future research. 
10.3.1 Clinical practice 
Recommendation 1: Adopt the constructs in the Skin Safety Model to facilitate 
comprehensive, holistic skin integrity care. 
An appreciation of the concepts proposed in the Skin Safety Model in clinical 
practice can encourage clinicians and healthcare providers to reframe the manner in 
which skin integrity is conceptualised and managed for older acute care patients. The 
findings from the research program suggest that a fundamental change is required, 
that is, a paradigm shift away from preventing a specific skin injury (a traditional 
siloed, specialist approach) and toward a broader, holistic goal of skin injury 
prevention. This may include preventing pressure injuries, as well as IAD and skin 
tear prevention, thus providing holistic skin integrity care. Depending on an 
individual patient’s circumstances, it may require implementing a suite of 
interventions that are not traditionally associated with maintaining skin integrity. For 
example, a mobility and toileting program could have positive impacts on functional 
status and continence, while simultaneously reducing the risk of IAD, Candida 
infection, and pressure injury.  
Recommendation 2: Combine pressure injury, IAD, and incontinence prevalence 
surveys into a single protocol. 
The Skin Safety Model proposes inter-relationships between a range of 
diverse, yet shared risk factors for skin injury. Consequently, improving 
understanding of the prevalence of these diverse skin injury risks and skin injuries in 
a facility is imperative for the delivery of holistic skin integrity care. Prevalence 
surveys that produce accurate and valid data are an essential for underpinning 
clinical and governance decisions that ultimately influence skin integrity outcomes. 
Support for this recommendation was demonstrated in Publication 3 of this 
thesis. The single IAD, incontinence and PI survey protocol, conducted for Study 1 
of this research, provided the healthcare facility with a multitude of valuable skin 
integrity data that was not previously collected by the facility. As a result of this 
research, the facility has adopted this combined protocol, and is likely to have 
improved understanding of the skin integrity risks that exist for its patients. 
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However, in the future, it would also be prudent to include skin tears in in a skin 
inspection prevalence survey, allowing benchmarking of a range of common 
hospital-acquired skin wounds. 
Recommendation 3: Include IAD and incontinence prevalence data with pressure 
injury data for benchmarking activities. 
The prevalence of these other nosocomial skin injuries warrants inclusion in 
skin integrity benchmarking activities. Benchmarking is a process of comparative 
evaluation in healthcare, whereby an organisation can measure and compare its 
performance and processes with others and identify high levels of performance, as 
well as areas for improvement (Ettorchi-Tardy, Levif, & Michel, 2012). 
Benchmarking is a component of continuous quality improvement and can take place 
within an organisation, as well as externally (Ettorchi-Tardy et al., 2012). According 
to Eagar and colleagues (2013) the strongest evidence regarding improving quality 
and safety exists for the use of benchmarking systems. Pressure injury prevalence 
data is widely used for benchmarking (Stotts et al., 2013); however, including IAD 
and incontinence prevalence data is consistent with the ultimate goal of improving 
quality and safety specifically in the domain of maintaining skin integrity. 
Recommendation 4: Employ microbiological testing to confirm the presence of 
incontinence- associated Candida infection. 
The results of Study 2 suggested the need to confirm incontinence-associated 
Candida infection with microbiological testing in order to improve diagnostic 
accuracy. The current clinical practice is for presumptive diagnosis and empirical 
treatment of a Candida-like rash. This may lead to over- or under-diagnosis of the 
infection. Therefore, microbiological testing to confirm the presence of Candida, 
coupled with careful consideration of the clinical presentation is likely to improve 
the accuracy of diagnosing incontinence-associated Candida infection.  
10.3.2 Education 
Recommendation 5: Develop and deliver skin integrity education programs to health 
professionals, particularly at undergraduate and postgraduate levels that focus on 
comprehensive and integrated skin integrity models of care. 
Several recommendations for education at different levels arise from this 
research. Firstly, the need to deliver more comprehensive skin integrity education 
programs to health professionals, with the focus on understanding and addressing 
complexity and diversity of skin integrity risk and skin vulnerability in the acute care 
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patient. These relationships are highlighted in the Skin Safety Model. Furthermore, 
emphasis on the patient experience of skin injury and input from affected consumers 
in the development and delivery of skin integrity education programs is likely to 
assist in strengthening the delivery of patient-centred skin care. These education 
programs may be best provided at undergraduate and postgraduate levels for nurses, 
medical practitioners, and other healthcare providers, as well as professional 
development programs for experienced professionals. Secondly, as study one 
highlighted, clinicians face challenges when differentiating pressure injuries and 
IAD. Therefore, it is imperative that any education programs regarding pressure 
injury severity classification contain a mandatory training on how to differentiate 
between pressure injury, IAD, and fungal infections. 
Finally, both undergraduate and postgraduate education programs should 
include education specifically designed to improve the accuracy of the diagnosis of 
incontinence-associated Candida infection, including specific training on the clinical 
presentation of the infection, as well as the requirement for microbiological 
confirmation.  
10.3.3 Healthcare policy  
Recommendation 6: Include strategies in future health and policy standards that 
acknowledge and address the broader dimensions of maintaining skin integrity. 
In Australia, the National Safety and Quality Health Service (NSQHS) 
standards provide a nationally consistent statement about the level of care consumers 
can expect. These standards are linked to the national safety and quality accreditation 
scheme for healthcare service organisations, and they include an entire standard 
concerned with preventing and managing pressure injuries. (Australian Commission 
on Safety and Quality in Healthcare, 2015). Feedback was provided by the PhD 
candidate to the NSQHS (based on Publications 1 and 2 of this thesis) recommending 
that that future standards include strategies that encompass the broader dimensions of 
maintaining skin integrity, rather than the current focus on PI prevention only. There 
is scope to implement innovative, evidence-based policies and protocols that 
facilitate new and comprehensive approaches to maintaining skin integrity.  
 The facility involved in this research has adopted these recommendations in 
response to the results of this research program. The review and expansion of the 
terms of reference of the Pressure Injury Prevention Committee means that the 
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committee now has governance and leadership responsibilities for a range of 
iatrogenic skin injuries, including pressure injuries IAD and skin tears. 
Accompanying the new terms of reference for the committee was an official name 
change from the Royal Brisbane and Women’s Hospital (RBWH) Pressure Injury 
Prevention Committee to the RBWH Skin Safety Committee (personal 
communication from Kelly McDonagh, 30th November, 2011). In addition, 
combined pressure injury and IAD prevalence surveys are now the standard protocol 
at this facility. This example of the implementation of this recommendation offers a 
guide for its adoption by other facilities and organisations. 
Furthermore, in Queensland annual state-wide pressure injury prevalence 
surveys are conducted by the Patient Safety and Quality Improvement Service 
Clinical Excellence Division and are known as the Queensland Bedside Audit 
(QBA). As a result of the success of the combined IAD and pressure injury 
prevalence survey protocol adopted in the research facility, in 2012, QBA developed 
and distributed new surveyor educational resources to facilitate improved inter-rater 
reliability for the state-wide PI surveys, as well as an updated data survey instrument 
that included a category noting the presence of IAD (J. Whitmore, personal 
communication,18
th
 November, 2015). The implications of the adoption of this 
recommendation are twofold. Firstly, organisations could gain a comprehensive 
understanding of the risk and burden of nosocomial skin injury, beyond PI, that 
exists in their organisations, and secondly, this broad understanding of skin integrity 
status affords opportunities to formulate and implement comprehensive and holistic 
skin safety policies, procedures and quality improvement activities, that can be 
innovative, efficient and effective. Future research 
Recommendation 7: Further testing of the Skin Safety Model. 
The findings of this thesis provide a basis for further research in several 
areas. Further testing is required to validate the constructs of the SSM in a variety of 
clinical settings with larger sample sizes. In addition, further research is required to 
enable the operationalisation of the model. 
Recommendation 8: Replicate Studies 1 and 2 in larger, multi-centre studies. 
Replicating Study 1 involving large patient cohorts both in Australia and 
internationally would provide more comprehensive epidemiological data regarding 
the prevalence of IAD, incontinence, and fungal infection. In addition, this could 
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serve as baseline data for benchmarking these conditions. However, further research 
is required to reach international agreement regarding standardised methods for IAD 
data collection.  
Study 2 could be replicated in multi-centre research sites, with larger sample 
sizes that could provide a more powerful test of hypotheses. Furthermore, Study 2 
tested for Candida albicans only, and while this is the most frequent colonising 
organism, future studies would benefit from testing for all Candida species to gain a 
more comprehensive understanding of the patterns of colonisation of all Candida 
species in these patients.  
Due to the recruitment challenges faced in Study 2 associated with the 
difficulty in collecting longitudinal data, the research aim of determining the 
aetiological role of Candida colonisation in the development of IAD was not 
addressed. An important consideration in future studies would be to ensure their 
design and recruitment strategies facilitate optimum enrolment and retention, as well 
as to plan for an adequate recruitment timeframe in order to collect collection of 
longitudinal data.   
10.4 CONCLUSION 
This thesis has advanced the understanding of the phenomenon of IAD in the 
acute care setting and delivered a new skin integrity framework in which to 
contextualise this skin injury. The objectives of this research have been fulfilled on 
several levels. Overall, it can be seen that this thesis has addressed several significant 
gaps in the skin integrity field of study. Firstly, the development of the SSM offered 
a previously unavailable comprehensive and integrated framework to guide skin 
integrity care in the acute care setting. Secondly, the understanding of the burden of 
IAD in the Australian acute care setting was unknown. Study 1 addressed this lack of 
quantitative data, which was the first IAD prevalence study in an Australian acute 
care hospital. Finally, understanding of the epidemiology of Candida albicans 
colonisation in relation to continence status and IAD was inadequate. Study 2 
addressed this gap. In turn, data from Studies 1 and 2 provided validation of the SSM 
that could facilitate comprehensive, holistic, evidence-based decision-making and 
practice in the skin integrity field of practice. 
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The Skin Safety Model offers a novel framework in which to contextualise a 
range of nosocomial skin injuries, including IAD, into a single approach for 
application in the acute care setting. The model offers a new, holistic perspective that 
unifies divergent and siloed approaches to maintaining skin integrity. Drawing 
together the critical determinants of nosocomial skin injury, as well as multiple 
potential skin injuries into a single model, the SSM positions the patient experience 
of the injury rather than the actual injury as the central outcome. This overarching 
approach to maintaining skin integrity in the acute care patient sets this framework 
apart from others as a new approach to the conceptualisation of skin integrity care in 
this setting. Furthermore, the SSM can guide understanding of the complexity and 
multidimensional nature of skin vulnerability, as well as the imperative of 
maintaining skin integrity in this setting. The model has implications for shifting the 
paradigm of skin care from a siloed, fragmented approach concerned with preventing 
a PI to a comprehensive and integrated approach to maintaining skin integrity. This 
shift in skin integrity care may improve patient outcomes, patient safety and quality 
initiatives, nosocomial skin injury risk assessment and management, as well as 
influence skin integrity research.  
Specifically, Study 1 revealed the alarming prevalence of IAD in the 
Australian setting. IAD is a painful, costly condition that exposes patients to the risk 
of the serious complications of perineal infection or PI. However, the burden of this 
serious skin injury was unknown in Australia. The study presented compelling 
evidence that IAD is a skin injury revealing that almost one quarter of hospitalised 
patients were incontinent and, therefore, at risk of developing IAD, with more than 
40% of these incontinent patients having developed IAD. This data has implications 
for patient safety and the obligation to prevent nosocomial injury, and warrants 
urgent attention. 
Study 2 presented an innovative perspective, advancing understanding of and 
investigating previously unexplored dimensions of the epidemiology of Candida 
colonisation, continence status and IAD. The results of Study 2 provide previously 
unavailable empirical data on Candida colonisation, with specific comparisons of 
continent and incontinent patients. The study also presents unique quantitative data 
on the Candida colonisation levels of patients with IAD who had not developed 
clinical evidence of a Candida infection.  
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Internationally, contemporary healthcare faces the challenge of reform. The 
drivers for healthcare reform can be found in the increasing demand for healthcare 
services as a result of ageing populations, growing rates of chronic disease, increased 
consumer expectations, and the requirement to deliver healthcare that is safe and of 
high quality (American Nurses Association; 2008; Australian Government, 2014; 
Shortell & Singer, 2008). There are urgent imperatives for modern healthcare to 
transition to a system whereby the complex, multidimensional, and long-term 
healthcare needs of patients can be accommodated in effective, efficient, and 
equitable ways, with quality and safety at the heart of all reform (American Nurses 
Association; 2008; Australian Government, 2014; Shortell & Singer, 2008). As such, 
quality and safety imperatives form an integral element in healthcare reform. In fact, 
these values of safety, information and consumer-centered care underpin the 
Australian Safety and Quality Framework (Australian Commission on Safety and 
Quality in Healthcare, 2010). At the heart of healthcare reform is a requirement for 
new paradigms that recognise and accommodate the complexity of the contemporary 
patient. The Skin Safety Model provides such a paradigm, is consistent with the 
goals of healthcare reform, and offers a clinical reframe of the complex skin integrity 
needs of acute care patients. An imperative of this recalibration of the approach to 
skin integrity management in contemporary healthcare is that it is evidence-based 
and consumer-centred. These dimensions of skin integrity care are addressed by this 
thesis. 
In the coming years, the number of older, incontinent patients is set to rise in 
acute care settings. Consequences of incontinence include the risk of developing 
IAD, the risk of developing an incontinence-associated Candida infection, or even 
developing a pressure injury. These are serious sequale of incontinence and represent 
challenges for patients and healthcare providers alike. By providing a new 
framework in the form of the Skin Safety Model to guide clinicians in understanding 
the complexities of skin safety in vulnerable older adults, as well as presenting data 
regarding the prevalence of IAD, and data enhancing the understanding of Candida 
colonisation, this thesis has made a substantial contribution towards a deeper and 
more comprehensive understanding of the phenomenon of IAD in the acute care 
setting.   
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Appendix A: Skin Assessment Tool (Kennedy & Lutz, 1996) 
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Appendix B: Permission to use the Skin Assessment Tool (SAT) 
-----Original Message----- 
From: Jill Campbell <jillcampbell18@gmail.com> 
To: ktulcer <ktulcer@aol.com> 
Sent: Thu, Aug 29, 2013 3:08 am 
Subject: Kenned-Lutz SAT tool 
Dear Karen,  
I am a PhD candidate at Queensland University of Technology in Brisbane Australia. My 
thesis topic is exploring the incontinence-associated dermatitis in the acute care setting. The 
thesis will be presented by publication. 
 I am conducting an observational prospective IAD prevalence study and a prospective 
observational time to event study exploring candida infection and IAD. 
  
I would like to request your permission to use the SAT for these studies. I look forward to 
hearing from you soon. 
  
Kind Regards 
Jill 
  
Jill Campbell RN, BHealthSc(Nursing) Grad Dip (Wound Care) 
Clinical Nurse Skin Integrity  
Royal Brisbane & Women's Hospital Butterfield Street 
Herston Qld 4006 Australia 
Email; jillcampbell18@gmail.com  
Work; Jill_Campbell@health.qld.gov.au  
 
From: Karen Kennedy-Evans [mailto: ktulcer@aol.com]  
Sent: Thursday, August 29, 2013 1:59 PM 
To: jillcampbell18@gmail.com 
Cc: jlutzmail@aol.com 
Subject: Re: Kenned-Lutz SAT tool 
 
  
Absolutely. 
We give permission. 
  
Please keep us updated as to your progress and let us know if we can help. 
  
I have a new e-mail.  Ktulcer@me.com. 
 Thank you. Karen Lou Kennedy-Evans 
ktulcer@aol.com 
 
Good luck with your thesis. Let us know if we can help. 
  
Jim Lutz, MS, CCRA 
Lutz Consulting LLC 
Medical Writing Services 
411 Dogwood DR 
Buellton, CA 93427-6810 
805-245-0374 (CELL/Work) 
805-688-3461 (FAX) 
E-Mail: jlutzmail@aol.com 
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Appendix C: Data collection instrument for Study 1 
Complete this form for all patients 
Patient UR: Ward: Sex:  Male      Female   DOB (year):  
Verbal Consent                       Yes                   No  
PRESSURE INJURY PRESENT (tick all that apply) 
sacrum/coccyx               Stage          Ischial tuberosities                    Stage    
buttock                           Stage     Trochanter/hip                           Stage    
CONTINENCE STATUS   STOOL QUALITY & FREQUENCY 
Continent    Y   NB If patient continent, no further 
questions to be answered. 
Stool Quality 
Formed     Semi formed       Liquid  
Incontinent urine only Y   Stool Frequency 
less than 3 per day    more than 3 per day    
Incontinent; Urine and Faeces  Y  Stoma Urinary Y   Stoma Faecal Y  
Urinary catheter insitu      
 
Faecal containment device  Y      
CONTINENCE AIDS  (mark all that apply) 
Tab pad        Pull up pad          Insert pad       Underpad        Urodome   
CONTRIBUTING  FACTORS (mark all that apply) 
Antibiotics    Oral       IV     Enteral tube feeding  Y        Type: 
INCONTINENCE CLEANUP & SKIN PROTECTION PRODUCTS AT BEDSIDE  (specify all products present) 
Cleanse (eg soap, water & cloth; no rinse cleanser, wipes): 
Moisturiser (eg creams, lotions): 
Barrier Protection (eg zinc cream, barrier sprays): 
Topical Medication:         Antifungal            Other; Please state 
SKIN REDNESS 
None                     Y     N  
Mild redness          (blotchy & non-uniform) Y     N  
Moderate redness (severe in places but non-uniform appearance) Y     N  
Severe redness    (uniformly red in appearance) Y     N  
AREA of SKIN BREAKDOWN 
None Y     N  
Small area (< 20cm²) Y     N  
Moderate area (20-50cm²) Y     N  
Large area (50cm²) Y     N  
EROSION SEVERITY (tick one only) REGION AFFECTED (tick all that 
apply) 
None Y     N  Buttocks Y     N  
Mild erosion involving epidermis 
only 
Y     N  Coccyx Y     N  
Moderate erosion involving 
epidermis & dermis with little or no 
exudate 
Y     N   
 
Rectal Area Y     N  
Severe erosion of epidermis with 
moderate involvement of dermis 
with low or no exudate 
Y     N  Scrotum/labia Y     N  
Lower abdomen Y     N  
Upper thighs Y     N  
Gluteal Cleft Y     N  
Extreme erosion of epidermis & 
dermis with moderate & persistent  
exudate 
Y     N  Groins Y     N  
Evidence of fungal infection/rash         Y     N   
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Appendix D: Bristol Stool Chart (Lewis & Heaton, 1997) 
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Appendix E: Ethics approval notification from Royal Brisbane and Women’s 
Hospital Human Research Ethics Committee for Study 1 
 
 Enquiries to: Odette Petersen Coordinator 
 Phone: 07 3636 5490 
 Fax: 07 3636 5849 
 Our Ref: HREC/11/QRBW/399 
 E-mail RBWH-Ethics@health.qld.gov.au  
Ms Jill Campbell 
Skin Integrity Services 
Level 1, Dr James Mayne Building 
Royal Brisbane & Women’s Hospital 
Herston     Q      4029 
 
 
Dear Ms Campbell, 
 
Re: Ref N
o
: HREC/11/QRBW/399:  Incontinence-associated dermatitis: A 
prevalence study in the acute care setting. 
 
Thank you for submitting the above project for ethical and scientific review.  This 
project was considered by the Royal Brisbane & Women's Hospital Human Research 
Ethics Committee (RBWH HREC) (EC00172) at their meeting on 17 October, 2011. 
 
I am pleased to advise that the Human Research Ethics Committee has granted approval 
of this research project on 01 November, 2011.   HREC approval is valid for three (3) 
years from  
01.11.2011 to 01.11.2014.   
 
This HREC is constituted and operates in accordance with the National Health and 
Medical Research Council’s (NHMRC) National Statement on Ethical Conduct in 
Human Research (2007), NHMRC and Universities Australia Australian Code for 
the Responsible Conduct of Research (2007) and the CPMP/ICH Note for Guidance 
on Good Clinical Practice.  Attached is the HREC Composition including specialties 
and affiliation with the Hospital (Attachment I). 
 
You are reminded that this letter constitutes ethical approval only.  You must not 
commence this research project at a site until separate authorisation from the District 
CEO or Delegate of that site has been obtained. 
 
The Royal Brisbane & Women’s Hospital Human Research Ethics Committee is constituted and operates according to the 
NHMRC’s National Statement on Ethical Conduct in Human Research (2007). 
Royal Brisbane & Women’s Hospital HREC 219     01.11.2011 
Ref No:  HREC/11/QRBW/399 
 
 
A copy of this approval will also be sent to the District Research Governance Office 
(RGO).  Please ensure you submit a completed Site Specific Assessment (SSA) Form to 
the RGO for authorisation from the CEO or Delegate to conduct this research at the 
Royal Brisbane & Women’s Hospital Metro North District. 
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The documents reviewed and approved include: 
 
Document    Version    Date    
Covering Letter    24 September 
2011  
Application: NEAF  2.0 
(2008)  
27 September 
2011  
NEAF signature pages of A/Prof Fiona Coyer &  
MS Kerri McLeod  
  29 September 
2011  
IAD Prevalence Study Protocol  1.0  26 September 
2011  
Curriculum Vitae of Jill Campbell  1.0  26 September 
2011  
Memorandum of approval from Safety & Quality Unit    26 September 
2011  
Response to Request for Further Information    25 October 2011  
Case Report Form  2  25 October 2011  
Response to Request for Further Information    27 October 2011  
Response to Request for Further Information    31 October 2011  
Email of support from MS Kelly McDonough, 
Program Coordinator, Safety & Quality Unit RBWH, 
Pressure Injury Prevention, 3Cs and Patient 
Identification  
  31 October 2011 
Participant Information Sheet:  Incontinence associated 
dermatitis; A prevalence study in the acute care setting 
(IAD prevalence study)  
4  31 October 2011  
Pressure Injury Prevalence Audit Patient Information 
Sheet  
  31 October 2011  
 
 
Please note the following conditions of approval: 
 
1. The Principal Investigator will immediately report anything which might warrant 
review of ethical approval of the project in the specified format, including: 
 Unforeseen events that might affect continued ethical acceptability of the 
project. 
Serious Adverse Events must be notified to the Committee as soon as 
possible.  In addition, the Investigator must provide a summary of the 
adverse events, in the specified format, including a comment as to 
suspected causality and whether changes are required to the Patient 
Information and Consent Form.  In the case of Serious Adverse Events  
occurring at the local site, a full report is required from the Principal 
Investigator, including duration of treatment and outcome of event. 
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2. Amendments which do not affect either the ethical acceptability or site 
acceptability of the project (e.g. typographical errors) should be submitted in 
hard copy to the HREC Coordinator.  These should include a covering letter 
from the Principal Investigator providing a brief description of the changes and 
the rationale for the changes, and accompanied by all relevant updated 
documents with tracked changes. 
 
3. Proposed amendments to the research project which may affect both the 
ethical acceptability and site suitability of the project must be submitted firstly 
to the HREC for review and, once HREC approval has been granted, then 
submitted to the Research Governance Office. 
 
4. Amendments to the research project which only affect the ongoing site 
acceptability of the project are not required to be submitted to the HREC for 
review.  These amendment requests should be submitted directly to the 
Research Governance Office (by-passing the HREC). 
 
5. Amendments to the research project which may affect the ongoing ethical 
acceptability of a project must be submitted to the HREC for review.  Major 
amendments should be reflected in a revised online NEAF (accompanied by all 
relevant updated documentation and a covering letter from the Principal 
Investigator, providing a brief description of the changes, the rationale for the 
changes, and their implications for the ongoing conduct of the study).  Hard 
copies of the revised NEAF, the cover letter and all relevant updated documents 
with tracked changes must also be submitted to the HREC Coordinator as per 
standard HREC SOP. Further advice on submitting amendments is available 
from 
http://www.health.qld.gov.au/ohmr/documents/ethics/researcher_userguide.pdf 
 
6. The HREC will be notified, giving reasons, if the project is discontinued at a site 
before the expected date of completion. 
 
7. The HREC will be notified, giving reasons, on any sponsor reports or other 
information which might affect the ongoing ethical acceptability in line with the 
requirements of the ICH GCP guidelines as annotated by the TGA: 
http://www.tga.gov.au/docs/pdf/euguide/ich/ich13595.pdf 
 
8. In accordance with Section 3.3.22 (b) of the National Statement the Principal 
Investigator will provide at least annual reports to the HREC, the first report 
being due on  
01.11.2012 and a final report is to be submitted on completion of the study. 
 
The District Administration and the Human Research Ethics Committee may inquire 
into the conduct of any research or purported research, whether approved or not and 
regardless of the source of funding, being conducted on Hospital premises or 
claiming any association with the Hospital, or which the  
 
Committee has approved if conducted outside Royal Brisbane & Women’s Hospital 
Metro North Health Service District. 
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Should you have any queries about the HREC’s consideration of your project please 
contact the HREC Coordinator on 07 3636 5490.  The HREC terms of Reference, 
Standard Operating Procedures, membership and standard forms are available from 
http://www.health.qld.gov.au/ohmr/html/regu/regu_home.asp 
 
Once authorisation to conduct the research has been granted, please complete the 
Commencement Form (Attachment II) and return to the office of the Human Research 
Ethics Committee.  
The HREC wishes you every success in your research. 
 
Yours sincerely, 
 
Dr Conor Brophy 
Chairperson RBWH Human Research Ethics Committee 
Metro North DISTRICT 
01.11.2011 
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Appendix F: Ethics approval notification from Queensland University of 
Technology Human Research Ethics Committee for Study 1 
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Appendix G: Permission to reproduce a Table from the publication; Best 
practice Principles, IAD: Moving prevention forward. Global Consensus 
document. 
Hi Jill 
I am so sorry for the delay in responding to you – I received this while away on business and it 
dropped down in my inbox. I am delighted that you have found the document so useful and would 
be pleased to grant permission to use the table on distinguishing IAD from pressure ulcers. If 
possible, please could you include a citation to the document and encourage people to download a 
copy online. 
Thank you for your encouragement and support 
Best wishes 
Kathy 
Kathy Day 
Publisher, Wounds UK and Wounds International 
Direct: +44 (0)20 7960 9655 
Mobile: +44 (0)7766 181 715 
Email: kathy.day@woundsgroup.com 
Wounds UK & Wounds International  
1.03 Enterprise House, 1-2 Hatfields 
London SE1 9PG, UK 
Tel: +44 (0)20 7627 1510 
A Schofield Healthcare Media Company 
Registered in England & Wales No. 5638775 
 
From: Jill Campbell <jill.campbell@hdr.qut.edu.au> 
Date: Wednesday, 22 April 2015 03:39 
To: Kathy Day <kathy.day@woundsgroup.com> 
Subject: Request permission to reproduce table 
 
Good afternoon Kathy, 
Greetings from Australia. I was fortunate to be one of the reviewers of the excellent IAD expert 
paper. 
As part of my PhD, I am currently writing a paper about the importance of differentiating between 
IAD and pressure ulcers as well as the importance of then reporting that differentiation data. I am 
writing to request permission to reproduce (from the Best practice Principles, IAD: moving 
prevention forward), Table 2, page 9, ‘Distinguishing IAD from pressure ulcers’. It would be of great 
benefit in supporting the argument for accurate classification of these painful lesions. 
  
I am really excited about how well the IAD  paper has been received by clinicians here in Queensland, 
Australia! They have said they really like the easy to read format & one RN  said it was great to have 
a ‘one stop shop’ for IAD information. 
So thank you and all involved for a fabulous and really useful publication. 
 Warm regards 
Jill  
 
Jill Campbell 
PhD Candidate 
Queensland University of Technology Level 5, Centre Clinical Nursing, RBWH, Herston. 
Phone 07 31381746Mobile 0419735144E 
Email; Jill.Campbell@student.qut.edu.au 
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Appendix H: Study 2 data collection instrument 
Subject Code: Intact Study       _ _ _ _                                                          
 
Date of admission;                      Date of recruitment;                            Date of 
discharge/death; 
 
LOHS (in days);                                              
Gender:  Male □      Female □        Weight               Height                                                                                        
Smoker Yes □       No □ 
  Comments 
Primary diagnosis 
 
 
  
Comorbidities: 
Please list 
 
 
 
 
   
Medications; 
Please list 
 
 
 
 
 
  
Antibiotics;  type                                                                                                                      
                       IV     Yes           No                           Date Commenced                                 
Date Ceased  
                      Oral     Yes           No                           Date Commenced                                 
Date Ceased  
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Subject Code: _ _ _ _                                                          
 
 Day 0    Day Day Day Day Day 
Date       
Continence Status       
Incontinent urine only Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Incontinent faeces only Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Incontinent urine and 
faeces 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
IDC insitu & 
incontinent faeces 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
IDC insitu & continent Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Stoma        
               Urinary Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
               Faecal Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Stool Frequency       
                      < 1 per 
day 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
                      2- 3 per 
day 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
                      > 3 per 
day 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Stool quality       
                     Formed Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
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                     Semi-
formed/liquid 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Continence aid use       
                    Full brief Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
                     Insert pad Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Antibiotics       
                     Type       
                     IV Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
                    Oral Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Enteral nutrition Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
SGA                 Score: 
A  B  C 
A       B       
C 
A       B       
C 
A       B       
C 
A       B       
C 
A       B       
C 
A       B       C 
Mobility        
Completely immobile Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Very limited Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
Slightly limited Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
No limitation Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        No 
 
 
 
 
 228                    Appendices 
Subject Code: _ _ _ _                                                          
Physical 
Examination: (SAT) 
(Kennedy & Lutz, 
1996) 
Day 0 Day Day Day Day Day 
Date       
Skin Redness       
               None Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
               Mild redness Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
               Moderate 
redness 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
               Severe 
redness 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Area of skin 
Breakdown 
      
              None Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
              Small 
(<20cm²) 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
              Moderate 
(20-50cm²) 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
              Large 
area(>50cm²) 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Erosion       
             Mild 
(epidermis only) 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
             Moderate 
(epidermis &  
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
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            dermis) 
little/no exudate 
            Severe 
erosion 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
            Extreme 
erosion 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Region affected;       
              Buttocks Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
              Coccyx Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
              Perianus Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
              Gluteal cleft Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
              
Scrotum/labia 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
               Groins Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
               Lower 
abdomen 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Presence of Candida 
rash (clinical 
appearance) 
      
 Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
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Subject Code:        _ _ _ _                                                          
 Day 0    Day Day Day Day Day 
Date       
 Swabs collected                             
                           
Perianus 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
                           
Groins 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
Yes        
No 
 Swab results;  enter 
result   
      
                            
Perianus 
      
 
 
                            
Groins 
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Appendix I: Subjective Global Assessment Tool 
Name:                                                                                                    Date:  
 Medical History   A B C 
WEIGHT Usual weight…………… Current weight………    
Wt change past 6 months Amount weight loss……. % weight loss……….    
0-<5% loss   *   
5-10% loss    *  
>10% loss     * 
Weight change past 2 weeks  Amount……………….    
No change; normal weight   *   
Increase to within 5%   *   
Increase (1 level above)   * *  
No change, but below usual wt    *  
Increase to within 5-10%    *  
Decrease     * 
DIETARY INTAKE      
No change; adequate   *   
No change; inadequate    *  
Change Duration of change…………...    
Suboptimal diet    *  
Full liquid    *  
Hypocaloric liquid     * 
Starvation     * 
Intake borderline; increasing   *   
Intake borderline; decreasing    *  
Intake poor; no change    * * 
Intake poor; increasing    *  
Intake poor; decreasing     * 
     
 GASTROINTESTINAL SYMPTOMS     
Frequency (never, daily, no. of times/week) Duration (<2wk, >2wk)    
Nausea …………………… ………………..    
Vomiting …………………… .……………….    
Diarrhoea …………………… ………………...    
Anorexia …………………… ………………...    
None; intermittent   *   
Some (daily >2 week)    *  
All (daily >2 week)     * 
      
FUNCTIONAL CAPACITY      
No dysfunction Duration of change …………….. *   
Difficulty with ambulation/normal activities   *  
Bed/chair-ridden     * 
 Change past 2 week      
Improved   *   
No change    *  
Regressed     * 
      
 Physical examination  A B C  
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Adapted from: Detsky et al., 1994
8
; Baxter Healthcare Corporation, 1993; McCann, 1996 (Ferguson, Bauer, 
Banks, Capra, 1996) © 
 
This is a consensus document from Dietitian/ Nutritionists from the Nutrition Education Materials  
 
 
 SUBCUTANEOUS FAT      
 Under the eyes  
Slightly bulging 
area  Hollowed look,  
     depression, dark  
     circles  
 Triceps  
Large space 
between  Very little space  
   fingers  between fingers, or  
     fingers touch  
 Biceps  
Large space 
between  Very little space  
   fingers  between fingers, or  
     fingers touch  
 MUSCLE WASTING      
 Temple  Well-defined Slight depression Hollowing,  
   muscle/flat  depression  
 Clavicle  
Not visible in 
Males; Some protrusion; Protruding/prominent  
   
may be visible 
but not may not be all the bone  
   
prominent in 
females way along   
 Shoulder  Rounded No square look; Square look; bones  
    acromion process prominent  
    may protrude   
 
Scapula/ribs 
 Bones not 
prominent; 
slightly   
  Mild depressions or Bones prominent;  
   no significant bone may show significant  
   depressions slightly; not all depressions  
    areas   
 Quadriceps  
Well rounded; 
no Mild depression Depression; thin  
   depressions    
 Calf  Well developed  Thin; no muscle  
     definition  
 Knee  
Bones not 
prominent  Bones prominent  
 
Interosseous muscle 
between  
Muscle 
protrudes;  Flat or depressed  
 thumb and forefinger  
could be flat in 
females  area  
 
OEDEMA (related to 
malnutrition)  No sign Mild to moderate Severe  
       
 
ASCITES (related to 
malnutrition)  No sign Mild to moderate Severe  
       
 
OVERALL SGA 
RATING  A B C  
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Appendix J: Braden Scale – For predicting pressure sore risk  
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Appendix K: Participant information and consent form, Study 2 
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Appendix L: Patient information and consent form, Person Responsible, Study 
2 
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Appendix M: Ethical approval notification from Royal Brisbane and Women’s 
Hospital Human Research Ethics Committee for Study 2 
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Appendix N: Administrative Review Approval Notification from Queensland 
University of Technology Human Research Ethics Committee Unit Approval for 
Study 2 
Dear A/Prof Fiona Coyer and Ms Jill Campbell 
  
Project Title:  Incontinence associated dermatitis and Candida detection: A 
prospective observational study in the acute care setting (InTACt Study) 
  
Ethics category Human - Administrative Review 
QUT approval number: 1400000048 (As per Royal Brisbane and Women's 
Hospital Human Resarch Ethics Committee., Approval number: HREC/13/QRBW/394) 
QUT clearance until: 19/12/2016 
  
We are pleased to advise that your application has been reviewed and 
administratively approved by the Chair, University Human Research Ethics 
Committee (UHREC) based on the approval gained from the responsible HREC. 
We note this HREC has awarded the project ethical clearance until 
19/12/2016. 
  
CONDITIONS OF APPROVAL 
Please ensure you and all other team members read through and understand 
all UHREC conditions of approval prior to commencing any data collection: 
   - Standard: Please see attached or 
www.research.qut.edu.au/ethics/humans/stdconditions.jsp 
   - Specific:   None apply 
  
Projects approved through an external organisation may be subject to that 
organisation's review arrangements. Researchers must immediately notify the 
QUT Research Ethics Unit if their project is selected for investigation / 
review by an external organisation. 
  
VARIATIONS 
All variations must first be approved by the responsible HREC before 
submission to QUT for ratification.  Once approval has been obtained please 
submit this to QUT using our online variation form: 
  www.research.qut.edu.au/ethics/humans/var/ 
  
MONITORING 
Please ensure you also provide QUT with a copy of each adverse event report 
and progress report submitted to the responsible HREC. 
  
Administrative review decisions are subject to ratification at the next 
available UHREC meeting. You will only be contacted again in relation to 
this matter if UHREC raises additional questions or concerns. 
  
Please don't hesitate to contact us if you have any queries. 
  
We wish you all the best with your research. 
  
Kind regards 
  
Janette Lamb on behalf of the Chair UHREC 
Research Ethics Unit  |  Office of Research  |  Level 4 88 Musk Avenue 
Kelvin Grove  | Queensland University of Technology 
p: +61 7 3138 5123  |  e: ethicscontact@qut.edu.au  |  w: 
www.research.qut.edu.au/ethics/ 
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Appendix O: Queensland Civil and Administrative Tribunal Notification of 
Approval for Study 2 
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Appendix P: Statement of Contribution of Co-Authors for the Thesis by 
Publication 
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